U.S. patent application number 10/244245 was filed with the patent office on 2003-02-27 for delivery devices.
Invention is credited to Hyodoh, Hideki, Konya, Andras, Wright, Kenneth C..
Application Number | 20030040772 10/244245 |
Document ID | / |
Family ID | 27382122 |
Filed Date | 2003-02-27 |
United States Patent
Application |
20030040772 |
Kind Code |
A1 |
Hyodoh, Hideki ; et
al. |
February 27, 2003 |
Delivery devices
Abstract
Self-expandable, woven intravascular devices for use as stents
(both straight and tapered), filters (both temporary and permanent)
and occluders for insertion and implantation into a variety of
anatomical structures. The devices may be formed from shape memory
metals such as nitinol. The devices may also be formed from
biodegradable materials. Delivery systems for the devices include
two hollow tubes that operate coaxially. A device is secured to the
tubes prior to the implantation and delivery of the device by
securing one end of the device to the outside of the inner tube and
by securing the other end of the device to the outside of the outer
tube. The stents may be partially or completely covered by graft
materials, but may also be bare. The devices may be formed from a
single wire. The devices may be formed by either hand or machine
weaving. The devices may be created by bending shape memory wires
around tabs projecting from a template, and weaving the ends of the
wires to create the body of the device such that the wires cross
each other to form a plurality of angles, at least one of the
angles being obtuse. The value of the obtuse angle may be increased
by axially compressing the body.
Inventors: |
Hyodoh, Hideki; (Sapporo,
JP) ; Konya, Andras; (Houston, TX) ; Wright,
Kenneth C.; (Houston, TX) |
Correspondence
Address: |
FULLBRIGHT & JAWORSKI L.L.P.
600 CONGRESS AVE.
SUITE 2400
AUSTIN
TX
78701
US
|
Family ID: |
27382122 |
Appl. No.: |
10/244245 |
Filed: |
September 16, 2002 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10244245 |
Sep 16, 2002 |
|
|
|
09496243 |
Feb 1, 2000 |
|
|
|
60118211 |
Feb 1, 1999 |
|
|
|
60125191 |
Mar 18, 1999 |
|
|
|
Current U.S.
Class: |
606/200 |
Current CPC
Class: |
A61F 2/0105 20200501;
A61F 2230/0067 20130101; A61F 2230/0093 20130101; A61F 2250/0039
20130101; D10B 2509/06 20130101; A61F 2230/0076 20130101; A61F
2/011 20200501; A61F 2220/005 20130101; A61F 2/962 20130101; A61F
2210/0004 20130101; A61B 2017/00526 20130101; A61F 2230/0069
20130101; A61F 2/07 20130101; A61F 2220/0058 20130101; A61F 2/04
20130101; A61F 2/90 20130101; A61F 2002/075 20130101; A61F
2230/0015 20130101; A61F 2/88 20130101; A61F 2230/0091 20130101;
D04C 3/48 20130101; A61F 2002/016 20130101; A61F 2002/018 20130101;
A61F 2220/0016 20130101; A61F 2/0108 20200501; A61F 2210/0014
20130101; A61F 2/95 20130101; A61F 2220/0075 20130101; D04C 1/06
20130101; A61F 2230/0006 20130101; A61F 2230/0078 20130101; A61F
2002/077 20130101; A61F 2002/9511 20130101; A61F 2230/001 20130101;
A61F 2230/008 20130101; A61F 2230/0065 20130101 |
Class at
Publication: |
606/200 |
International
Class: |
A61M 029/00 |
Claims
What is claimed is:
1. A device comprising: a plurality of shape memory wires woven
together to form a body suitable for implantation into an
anatomical structure, the body having first and second ends, the
shape memory wires crossing each other to form a plurality of
angles, at least one of the angles being obtuse, and both ends of
at least one shape memory wire being located proximate one end of
the body; wherein the value of the at least one obtuse angle may be
increased by axially compressing the body.
2. The device of claim 1, wherein the shape memory wires comprise
nitinol.
3. The device of claim 1, wherein the shape memory wires comprise
FePt, FePd or FeNiCoTi.
4. The device of claim 1, wherein the shape memory wires comprise
FeNiC, FeMnSi or FeMnSiCrNi.
5. The device of claim 1, wherein the shape memory wires each have
a diameter ranging in size from about 0.006 inches to about 0.012
inches.
6. The device of claim 1, wherein the plurality of shape memory
wires includes at least 6 shape memory wires.
7. The device of claim 1, wherein the body has a tubular shape with
a substantially uniform diameter.
8. The device of claim 1, wherein the body has a tapered shape with
a diameter that decreases from one end of the body to the other end
of the body.
9. The device of claim 1, wherein the body has a generally
hourglass shape.
10. The device of claim 1, wherein the body is hand woven.
11. The device of claim 1, wherein the body is machine woven.
12. The device of claim 1, further comprising a graft material
attached to the body.
13. The device of claim 12, wherein the graft material comprises
woven polyester.
14. The device of claim 12, wherein the graft material comprises
Dacron.
15. The device of claim 12, wherein the graft material comprises
polyurethane.
16. The device of claim 12, wherein the graft material comprises
PTFE.
17. The device of claim 12, wherein the graft material partially
covers the body.
18. The device of claim 1, further comprising: a first tube
configured to accept a guide wire; and a second tube configured to
fit over the first tube.
19. The device of claim 18, wherein the second tube is placed over
the first tube, one end of the body is secured to the first tube
and the other end of the body is secured to the second tube.
20. A device comprising: a body suitable for implantation into an
anatomical structure, the body having a first end, a second end and
being defined by at least n shape memory wires, wherein n is
greater than one, the n shape memory wires being arranged such that
the body comprises a first portion, the first portion comprising a
first woven portion and at least one strut, the shape memory wires
of the first woven portion crossing each other to form a plurality
of angles, at least one of the angles being obtuse, and both ends
of at least one shape memory wire being located proximate one end
of the body; wherein the value of the at least one obtuse angle may
be increased by axially compressing the body.
21. The device of claim 20, wherein the shape memory wires comprise
nitinol.
22. The device of claim 20, wherein the shape memory wires comprise
FePt, FePd or FeNiCoTi.
23. The device of claim 20, wherein the shape memory wires comprise
FeNiC, FeMnSi or FeMnSiCrNi.
24. The device of claim 20, wherein the body further comprises a
second portion adjacent the first portion, the second portion
comprising a second woven portion, and the second portion having
n+x shape memory wires, wherein x is at least one.
25. The device of claim 20, wherein the first portion comprises a
first woven portion separated from a second woven portion by
multiple first struts.
26. The device of claim 25, wherein the first portion has a
generally domed shape.
27. The device of claim 25, wherein the first woven portion has a
generally domed shape and the multiple first struts are bent
slightly so as to increase the self-anchoring capability of the
body in an anatomical structure.
28. The device of claim 25, wherein the first portion further
comprises a third woven portion separated from the second woven
portion by multiple second struts, and wherein the first and third
woven portions have generally domed shapes.
29. The device of claim 20, further comprising a graft material
attached to the body.
30. The device of claim 29, wherein the graft material comprises
woven polyester.
31. The device of claim 29, wherein the graft material comprises
Dacron.
32. The device of claim 29, wherein the graft material comprises
polyurethane.
33. The device of claim 29, wherein the graft material comprises
PTFE.
34. The device of claim 29, wherein the graft material partially
covers the body.
35. The device of claim 20, further comprising: a first tube
configured to accept a guide wire; and a second tube configured to
fit over the first tube.
36. The device of claim 35, wherein the second tube is placed over
the first tube, one end of the body is secured to the first tube
and the other end of the body is secured to the second tube.
37. A device comprising: a plurality of biodegradable filaments
woven together to form a self-expanding body suitable for
implantation into an anatomical structure, the self-expanding body
having first and second ends, the biodegradable filaments crossing
each other to form a plurality of angles, at least one of the
angles being obtuse; wherein the value of the at least one obtuse
angle may be increased by axially compressing the self-expanding
body.
38. A method of creating a body suitable for implantation into an
anatomical structure, the body having two ends, the method
comprising: bending the shape memory wires in a plurality of shape
memory wires to create bent portions in the shape memory wires, the
bent portions being arranged to define one end of the body, each
shape memory wire having two ends; and weaving the ends of the
shape memory wires to create the body such that the shape memory
wires cross each other to form a plurality of angles, at least one
of the angles being obtuse; wherein the value of the at least one
obtuse angle may be increased by axially compressing the body.
39. The method of claim 38, wherein the bent portions are
bends.
40. The method of claim 38, wherein the bent portions are
loops.
41. The method of claim 38, wherein the shape memory wires comprise
nitinol.
42. The method of claim 38, wherein the shape memory wires comprise
FePt, FePd or FeNiCoTi.
43. The method of claim 38, wherein the shape memory wires comprise
FeNiC, FeMnSi or FeMnSiCrNi.
44. The method of claim 38, wherein the shape memory wires each
have a diameter ranging in size from about 0.006 inches to about
0.012 inches.
45. The method of claim 38, wherein the plurality of shape memory
wires includes at least 6 shape memory wires.
46. The method of claim 38, wherein the body has a tubular shape
with a substantially uniform diameter.
47. The method of claim 38, wherein the body has a tapered shape
with a diameter that decreases from one end of the body to the
other end of the body.
48. The method of claim 38, wherein the body has a generally
hourglass shape.
49. The method of claim 38, wherein the weaving is by hand.
50. The method of claim 38, wherein the weaving is by machine.
51. A method of creating a body suitable for implantation into an
anatomical structure, the body having two ends, the method
comprising: providing a weaving system comprising: a template
having first template projections; bending shape memory wires
around the first template projections to create bent portions in
the shape memory wires, the bent portions being arranged to define
one end of the body, each shape memory wire having two ends; and
weaving the ends of the shape memory wires around the template to
create the body such that the shape memory wires cross each other
to form a plurality of angles, at least one of the angles being
obtuse; wherein the value of the at least one obtuse angle may be
increased by axially compressing the body.
52. The method of claim 51, wherein the first template projections
comprise tabs.
53. The method of claim 51, wherein the first template projections
comprise pins.
54. The method of claim 53, wherein the pins are attached to a ring
engaged with the template.
55. The method of claim 51, wherein the weaving system further
comprises a first weaving plate configured to rotate in a first
direction during the weaving.
56. The method of claim 55, wherein the weaving system further
comprises first bobbins arranged on the first weaving plate, one
end of each shape memory wire being attached to each first bobbin
prior to the weaving.
57. The method of claim 55, wherein the weaving system further
comprises a second weaving plate configured to rotate in a second
direction during the weaving, the second weaving plate being spaced
apart from the first weaving plate.
58. The method of claim 57, wherein the weaving system further
comprises second bobbins arranged on the second weaving plate, one
end of each shape memory wire being attached to each second bobbin
prior to the weaving.
59. The method of claim 51, further comprising securing the shape
memory wires to the template.
60. The method of claim 51, further comprising forming closed
structures with the ends of the shape memory wires, the closed
structures being arranged to define the other end of the body.
61. The method of claim 51, further comprising heating the body and
the template.
62. A device for delivering an axially and radially expandable
woven body having two ends into an anatomical structure,
comprising: a first tube configured to accept a guide wire; and a
second tube configured to fit over the first tube; wherein when the
tubes are used for delivering the axially and radially expandable
woven body, one end of the axially and radially expandable woven
body is secured to the outside of the first tube and the other end
of the axially and radially expandable woven body is secured to the
outside of the second tube.
63. The device of claim 62, further comprising a guide wire
configured to be placed within the first tube.
64. The device of claim 62, further comprising a push-button
release/lock mechanism configured to secure the first tube to the
second tube.
65. The device of claim 62, further comprising an end fitting
having a side arm, the end fitting being configured to be secured
to the first tube.
66. A device for delivering an axially and radially expandable
woven body having two ends into an anatomical structure,
comprising: a first tube configured to accept a guide wire, the
first tube having at least one pair of first tube holes positioned
proximate one end of the first tube; a second tube configured to
fit over the first tube, the second tube having at least one pair
of second tube holes positioned proximate one end of the second
tube; a first securing wire configured to be threaded through the
at least one pair of first tube holes; and a second securing wire
configured to be threaded through the at least one pair of second
tube holes; wherein when the tubes are used for delivering the
axially and radially expandable woven body, one end of the axially
and radially expandable woven body is secured to the outside of the
first tube with the first securing wire and the other end of the
axially and radially expandable woven body is secured to the
outside of the second tube with the second securing wire.
67. An occluding system comprising: a plurality of shape memory
wires woven together to form a body useful for occluding an
anatomical structure, the body having first and second ends, both
ends of at least one shape memory wire being located proximate one
end of the body, the shape memory wires crossing each other to form
a plurality of angles, at least one of the angles being obtuse;
wherein the value of the at least one obtuse angle may be increased
by axially compressing the body.
68. A device comprising: a body suitable for implantation into an
anatomical structure, the body having an axis, a first end and a
second end, wherein the body comprises a shape memory wire having a
first segment and a second segment, the segments being separated by
a bend in the shape memory wire located proximate one end of the
body, the first segment extending helically in a first direction
around the axis toward the other end of the body, the second
segment extending helically in a second direction around the axis
toward the other end of the body, and the first and second segments
crossing each other in a plurality of locations.
69. A device comprising: a body suitable for implantation into an
anatomical structure, the body having a first end and a second end,
wherein the body comprises a shape memory wire having a first
segment and a second segment, the segments being separated by a
bend in the wire located proximate one end of the body, the first
segment and second segments being arranged to form loops and
twisted segments such that at least two contiguous loops are
separated from another loop by a twisted segment.
70. A device comprising: a body suitable for implantation into an
anatomical structure, the body having two ends and comprising a
shape memory wire having a first segment and a second segment, the
segments being separated by a bend in the wire located proximate
one end of the body, the segments being positioned adjacent to each
other in loop-defining locations, the segments also extending
between the loop-defining locations in spaced relation to each
other so as form at least two loops, at least one of the at least
two loops having a compressed shape.
Description
[0001] The present application claims priority to U.S. Provisional
Patent Application Serial No. 60/118,211 filed Feb. 1, 1999 and
U.S. Provisional Patent Application Serial No. 60/125,191 filed
Mar. 18, 1999. The entire texts of the above-referenced disclosures
are specifically incorporated by reference herein without
disclaimer.
BACKGROUND OF THE INVENTION
[0002] 1. Field of the Invention
[0003] The present invention relates generally to intravascular
devices. More particularly, it concerns self-expandable woven
intravascular devices for use as stents, occluders or filters, the
methods of making the same, and the apparatus and methods for
delivery of the same into a living creature.
[0004] 2. Description of Related Art
[0005] Intravascular devices that serve as stents or filters
constructed using a plain weave, such as the stent disclosed in
U.S. Pat. No. 4,655,771 to Wallsten (hereinafter, the WALLSTENT),
have a propensity to show a high-degree of elongation axially with
diameter reduction. This is especially significant, when the angle
of the crossing wires is close to the largest possible. The closer
that the angle between the wires is to 180.degree., the more the
corresponding elongation of the stent is at a given percentage of
decrease in diameter. Any discrepancy between the diameters of the
stent and the vessel can result in a considerable elongation of the
stent. Simultaneously, the woven type stent has the largest
expansile force and hence the biggest resistance to outer
compression when the angle between the crossing wires is close to
180.degree.. In some applications, such as outer compression by a
space occupying lesion, the increased radial force may be
advantageous. The disadvantage of a propensity for elongation is
that great care must be taken when delivering such a stent in a
vessel or non-vascular tubular structure in order to properly
position it.
[0006] A further disadvantage of intravascular devices formed using
a plain weave, is that they are often incapable of maintaining
their shape when bent. For example, when such a stent is being
delivered through a tortuous passageway with many turns, upon being
bent, the weave of the stent tightens (e.g., the angle of the
crossing wires approaches 180.degree.). As a result of this
tightening, the diameter of the stent increases and the length of
the stent decreases. Consequently, the diameter of the stent may
exceed the diameter of the vessel or structure through which it is
traveling, impeding the delivery of the stent or causing the stent
to lodge in the vessel. This problem may be due in part to the use
of weave materials such as stainless steel, which exhibit poor
shape memory. This problem may also be due to the free, unclosed
wires used to form the stent. The free sharp ends can create
potential complications by penetrating, or perforating the wall of
the tubular structure where such a stent is placed. Further, steps
that have been taken to eliminate the free, sharp ends, such as
connection with U-shaped members using welding, glue or the like
(Wallsten, 1987) are time-consuming and expensive. The delivery
systems for such devices have also suffered from problems relating
to the repositionability of the devices as they are delivered into
position in the living creature.
[0007] In stenting long arterial segments, the contiguously
decreasing diameter of the arterial system from the center to the
periphery may pose problems. Woven stents with a uniform diameter
will exert a substantial expansile force to the vessel wall along
the tapered portion. Additionally, the stent may remain more
elongated in the tapered portion. In a study where WALLSTENTs with
a uniform diameter were used to bridge central venous obstruction
in hemodialysis patients, it was found that the stents which were
selected according to the size of the larger diameter central vein
exerted considerably higher force to the wall of the smaller
caliber subclavian vein (Vesely, 1997). Simultaneously, the length
of the stents in the smaller caliber vein was longer than
expected.
[0008] In the prior art, most of the filter designs except for the
Bird's Nest filter (Cook Inc., Bloomington, Ind.) have a conical
shape and are anchored with multiple legs in the wall of the cava.
The conical design is used because the main stream of the blood
carries the thrombi from the lower part of the body through the
center of the inferior vena cava. Therefore, all these devices are
designed to have good filtration capacity at the center of the
cava. The situation is quite different after some thrombi have been
successfully captured. The center of the cava will no longer be
patent and as a result, the blood will be diverted from the center
to the periphery of the cava. The aforementioned designs, however,
are not capable of catching thrombi effectively at the periphery of
the lumen so the patients will practically be unprotected against
subsequent peripheral embolization (Xian, 1995; Jaeger, 1998).
Further, most of filters tend to be tilted in the cava which can
deter their thrombus-capturing efficacy. Additionally, except for
the Simon nitinol filter (C. R. Bard, New Jersey, N.J.) the
aforementioned designs require a fairly large invasive delivery
system of 10-F or larger.
[0009] The uniform caliber of cylindrical stents in the prior art
used in the ureter, as well as the peristalsis arrested at the
proximal end of the stent, has resulted in severe hyperlasia of the
urothelium and eventually occlusion of the ureter.
[0010] Turning to occluders, percutaneous occlusion techniques have
become indispensable tools in minimally invasive management of a
wide range of pathological conditions. Use of permanent mechanical
occlusion devices has been shown to be equivalent to that of
surgical ligation. The Gianturco-Wallace stainless steel coil (Cook
Inc., Bloomington, Ind.) has been the most widely used permanent,
expandable intravascular occlusion device for transcatheter
delivery (Gianturco et al., 1975).
[0011] Percutaneous coil embolization has been shown to be
advantageous over traditional surgical procedures in treatment of
life threatening hemorrhage due to trauma or obstetric emergencies
(Schwartz et al., 1993; Teitelbaum et al., 1993; Selby Jr., 1992;
Levey et al., 1991; Ben-Menachem et al., 1991; Vedantham et al.,
1997). Furthermore, coils have been used alone or in combination
with microvascular embolic agents for the treatment of vascular
fistulas and malformations, tumors, and varices (Wallace et al.,
1979; Hendrickx et al., 1995; Furuse et al., 1997; White et al.,
1996; Sagara et al., 1998; Punekar et al., 1996). During the last
few years, the transcatheter closure of the patent ductus
arteriosus (PDA) with coils has become a frequently used technique
(Hijazi and Geggel, 1994; Hijazi and Geggl, 1997).
[0012] Although coil type occlusion devices have shown at least a
degree of utility, they have a number of drawbacks that could be
significant in some applications. Intravascular stability of the
coils has been shown to be highly dependent on proper matching of
coil diameter with the diameter of the target vessel (Nancarrow et
al., 1987), and with the exception of small vessels, a single coil
rarely results in a stable occlusive thrombus (Hijazi and Geggel,
1994). Moreover, a long vascular segment is often obliterated
because of the frequent need for multiple coils and the coils often
remain elongated within the vessel because their unconstrained
diameter is larger than the vascular lumen. Furthermore, delayed
recanalization rates of 37%-57% have been reported in humans within
1-3 months after initially successful coil embolization (Sagara et
al., 1998; 11 O'Halpin et al., 1984; Schild et al., 1994).
[0013] These and other drawbacks have inspired modifications in the
design and technique of coil embolization. Recently, detachable
microcoils and macrocoils with controlled delivery have been
designed to achieve a more compact conglomerate of the coil and to
prevent migration by allowing optimal positioning of the coil
before release (Zubillaga et al., 1994; Guglielmi et al., 1995;
Marks et al., 1994; Reidy and Qureshi, 1996; Uzun et al., 1996;
Tometzki et al., 1996; Dutton et al., 1995). However, since optimal
arrangement of the coil alone may not prevent migration in some
cases, such as high flow conditions or venous placement, a coil
anchoring system has been devised (Knya et al., 1998). Although an
anchoring system may stabilize a coil conglomerate within the
vasculature, significantly reducing or eliminating the possibility
of coil migration, such a system may render the coil
non-repositionable.
[0014] Several different non-coil devices have been designed to
achieve a more stable, limited size plug with higher hemostatic
efficiency particularly for transcatheter closure of larger vessels
(Schmitz-Rode et al., 1993; Kato et al., 1997; Knya et al., 1999)
and PDAs (Pozza et al., 1995; Magal et al., 1989; Grifka et al.,
1996). Recently, initial clinical experiences with a new
self-expanding nitinol-mesh PDA occluder have been reported
(Sharafuddin et al., 1996; Masura et al., 1998). A similar
self-expanding, repositionable quadruple-disc device constructed of
a braided nitinol mesh and polyester fibers has been reported to be
superior to standard Gianturco coils in experimental occlusion of
mid-size arteries (Sharaffuddin et al., 1996).
[0015] Although such non-coil devices may be repositionable, they
too exhibit drawbacks. For instance, the quadruple-disc device is
several centimeters long in an elongated fashion, making difficult
to keep the superselective position of the catheter tip during
deployment. The multiple rigid connections between the layers and
the relative long and rigid connection between the occluder and the
delivery cable further increase this drawback. Although the nitinol
mesh-PDA occluder has demonstrated utility, its proper placement
requires a proper match both in size and shape between the occluder
and the lesion to be occluded. The type and quality of the
connection between the occluder and the delivery cable is the same
as in the quadruple-disc design. A common disadvantage of both
designs is that they lack guidewire compatibility. As a result, a
delivery catheter must often be navigated to the site of occlusion
first before an occluder may be loaded into the catheter and
delivered through it. Another relative disadvantage of both devices
is their cost of manufacturing.
[0016] Percutaneous catheter technique for permanent closure of
isolated persistently patent ductus arteriosus (PDA) is now a
treatment of choice among doctors, obviating open surgery. The
configuration of the PDA varies considerably. A majority of PDAs
tend to have a funnel or conical shape due to ductal smooth muscle
constriction at the pulmonary artery insertion, although narrowings
in the middle or aortic ends can be observed (Krichenko, 1989).
That is the reason why not only the size, but also the
configuration, of the lesion plays a significant role in selecting
an appropriate occluding device. Except from the small caliber
lesions (with a maximum diameter of 2.5 mm or 3.3 mm,
respectively), where some authors have achieved successful closure
of the PDA with Gianturco coils (Cambier, 1992; Lloyd, 1993;
Sommer, 1994), Rashkind's "double umbrella" occluder is the most
often used device for this purpose (Rashkind, 1987; Hosking, 1991;
Latson, 1991; Wessel, 1988; Report of the European Registry, 1992).
It is available in two sizes (with a diameter of 12 mm and 17 mm)
which require a 8-F and 11-F delivery system, respectively.
[0017] In the majority of cases, the deployment of the traditional
PDA device is performed from a femoral vein access (Report of the
European Registry, 1992). Because of the size of the delivery
sheath, such a device is not suitable for the treatment of patients
with a body weight of less than 8 kg. Using even a larger umbrella,
this procedure is not recommended for the treatment of the lesions
with a diameter of 8 mm or above (Latson, 1991). About 80% of
unselected patients with isolated PDA are candidates for the
Rashkind device using the aforementioned criteria (Latson, 1991).
With the Rashkind device, the proportion of patients with residual
flow through the lesion fell from 76% immediately after
implantation to 47% by the day after implantation and to 17% by a
year after implantation (Report of the European Registry, 1992).
According to some authors the residual flow carries a potential
risk of infective endocarditis and should be avoided if possible.
Its abolishment can be achieved by implantation of another device
or surgery.
[0018] One of the main drawbacks of the Rashkind umbrella is that
it is not suitable for occlusion of all types of PDA. Preferably,
it is used to occlude short PDAs with relatively wide end-openings.
Its two discs cover both the pulmonary and the aortic opening of
the PDA. Longer PDA may hinder the discs to be positioned in the
proper way, that is, parallel to each other, thereby deteriorating
its self-anchoring. Another disadvantage of the umbrella is that
the occluding capacity of the design depends exclusively on the
thrombogenicity of the porous Dacron material, frequently resulting
in partial and lengthy occlusion.
[0019] For the majority of patients with urinary leakage and/or
fistulas (mainly due to tumor propagation to their ureters), the
diversion of urine is currently performed by a percutaneous
transrenal approach together with ureteral occlusion. Formerly,
detachable and non detachable balloons were used for this purpose,
but they did not cause satisfactory ureteral occlusion. Migration
as well as deflation of the balloons occurred relatively frequently
(Gunter, 1984; Papanicolau, 1985) leading to recurrence of the
urine leakage. A silicone ureteral occluder was developed and used
with only limited success because of device migration (Sanchez,
1988). This resulted in repositioning and consequent incomplete
ureteral occlusion. It appears that the best results have been
accomplished with Gianturco coils and Gelfoam embolization
(Gaylord, 1989; Bing, 1992 a; Farrel, 1996). Even with multiple
coil placements, together with Gelfoam plugs, the ureteral
occlusion may sometimes be achieved for only weeks or months, and
was attributed mostly to the induced urothelial hyperplasia (Bing,
1992 b). Coil migration was frequently encountered in these
studies. The lack of appropriate self-anchoring results in coil
migration which eventually deteriorates the occlusive effect.
[0020] Problems pointed out in the foregoing are not intended to be
exhaustive but rather are among many that tend to impair the
effectiveness of previously known stents, occluders and filters.
Other noteworthy problems may also exist; however, those presented
above should be sufficient to demonstrate that previous techniques
appearing in the art have not been altogether satisfactory,
particularly in providing flexible, self-expanding, repositionable
stents, occluders and filters.
SUMMARY OF THE INVENTION
[0021] The present invention overcomes the problems inherent in the
prior art by providing a self-expandable, repositionable device for
use as a stent, an occluder, or a filter which may be formed using
a plain weave, and may have closed structures at both its ends.
[0022] In one respect, the invention is a device that includes, but
is not limited to, a plurality of shape memory wires woven together
to form a body suitable for implantation into an anatomical
structure. The body has first and second ends. The shape memory
wires cross each other to form a plurality of angles, at least one
of the angles being obtuse. Both ends of at least one shape memory
wire are located proximate one end of the body. The value of the
obtuse angle is increased when the body is axially compressed.
[0023] The shape memory wires may be made of nitinol. The shape
memory wires may be made of FePt, FePd or FeNiCoTi. The shape
memory wires may be made of FeNiC, FeMnSi or FeMnSiCrNi. The shape
memory wires may each have a diameter ranging in size from about
0.006 inches to about 0.012 inches. The plurality of shape memory
wires may include at least 6 shape memory wires. The body may have
a tubular shape with a substantially uniform diameter. The body may
have a tapered shape with a diameter that decreases from one end of
the body to the other end of the body. The body may have a
generally hourglass shape. As used herein, "a generally hourglass"
shape is a shape that resembles a body having two ends that are
larger in terms of cross-sectional area than a mid-portion located
therebetween. Such shapes include those resembling traditional
hourglasses or dumbbells, for example. The body may be woven by
hand. The body may be woven by a machine, such as a braiding
machine.
[0024] The device may also include, but is not limited to, a graft
material attached to the body. The graft material may be made from
woven polyester. The graft material may be made from Dacron. The
graft material may be made from polyurethane. The graft material
may be made from PTFE. The graft material may partially cover the
body. As used herein, a graft material that "partially covers" a
body is attached to the body such that a portion of the wire or
wires forming the body are left bare or exposed. As a result of
only partially covering a body, blood or other bodily fluids may
flow through the bare portion of the body relatively unimpeded by
the graft material.
[0025] The device may also include, but is not limited to, a first
tube that is configured to accept a guide wire and a second tube
that is configured to fit over the first tube. Prior to delivering
the body into an anatomical structure, the second tube is placed
over the first tube, one end of the body is secured to the first
tube and the other end of the body is secured to the second
tube.
[0026] In another respect, the invention is a device that includes,
but is not limited to, a body suitable for implantation into an
anatomical structure. The body has a first end, a second end and is
defined by at least n shape memory wires, wherein n is greater than
one. The n shape memory wires are arranged such that the body
includes a first portion. The first portion includes a first woven
portion and at least one strut. The shape memory wires of the first
woven portion cross each other to form a plurality of angles, at
least one of the angles being obtuse. Both ends of at least one
shape memory wire are located proximate one end of the body. The
value of the obtuse angle is increased when the body is axially
compressed.
[0027] The shape memory wires may be made from nitinol. The shape
memory wires may be made from FePt, FePd or FeNiCoTi. The shape
memory wires may be made of FeNiC, FeMnSi or FeMnSiCrNi. The first
portion may include a first woven portion separated from a second
woven portion by multiple first struts.
[0028] The body may also include, but is not limited to, a second
portion located adjacent to the first portion. The second portion
includes a second woven portion. The second portion has n+x shape
memory wires, and x is at least one. The first portion may have a
generally domed shape. The first woven portion may have a generally
domed shape and the multiple first struts may be bent slightly so
as to increase the self-anchoring capability of the body in an
anatomical structure. The first portion may also include a third
woven portion separated from the second woven portion by multiple
second struts. The first and third woven portions may have
generally domed shapes.
[0029] The device may also include, but is not limited to, a graft
material attached to the body. The graft material comprises may be
made from woven polyester. The graft material may be made from
Dacron. The graft material may be made from polyurethane. The graft
material may be made from PTFE. The graft material may partially
cover the body.
[0030] The device may also include, but is not limited to, a first
tube that is configured to accept a guide wire and a second tube
that is configured to fit over the first tube. Prior to delivering
the body into an anatomical structure, the second tube is placed
over the first tube, one end of the body is secured to the first
tube and the other end of the body is secured to the second
tube.
[0031] In another respect, the invention is a device that includes,
but is not limited to, a plurality of biodegradable filaments woven
together to form a self-expanding body suitable for implantation
into an anatomical structure. The self-expanding body has a first
end and a second end. The biodegradable filaments cross each other
to form a plurality of angles, at least one which is obtuse. The
value of the obtuse angle is increased when the body is axially
compressed.
[0032] The biodegradable filaments may be made from polyglycolic
acid. The biodegradable filaments may be made from poly-L-lactic
acid. The biodegradable filaments may be made from a
polyorthoester. The biodegradable filaments may be made from a
polyanhydride. The biodegradable filaments may be made from a
polyiminocarbonate. The biodegradable filaments may be made from an
inorganic calcium phosphate. The biodegradable filaments may
include about 0.05 to 0.25 percent by weight of calcium oxide,
calcium hydroxide, calcium carbonate, calcium phosphate, magnesium
oxide, magnesium hydroxide, magnesium carbonate, magnesium
phosphate, sodium phosphate or potassium sulfate. The biodegradable
filaments may be made from a polymer having about 15 to about 30
mole percent glycolide. At least one of the biodegradable filaments
may be made from paclitaxel, docetaxel or heparin. Both ends of at
least one biodegradable filament may be located proximate the first
end of the self-expanding body. Each end of the self-expanding body
may include at least one closed structure.
[0033] The device may also include, but is not limited to, at least
one shape memory wire secured to the self-expanding body. Both ends
of the one shape memory wire may be located proximate one end of
the self-expanding body.
[0034] In another respect, the invention is a method of creating a
body suitable for implantation into an anatomical structure. The
body has two end ends. The method includes, but is not limited to,
bending the shape memory wires in a plurality of shape memory wires
to create bent portions in the shape memory wires. The bent
portions are arranged to define one end of the body. Each shape
memory wire has two ends. The method also includes, but is not
limited to, weaving the ends of the shape memory wires to create
the body such that the shape memory wires cross each other to form
a plurality of angles, at least one of the angles being obtuse. The
value of the obtuse angle is increased when the body is axially
compressed.
[0035] The bent portions may be bends or loops. The shape memory
wires may be made from nitinol. The shape memory wires may be made
of FePt, FePd or FeNiCoTi. The shape memory wires may be made of
FeNiC, FeMnSi or FeMnSiCrNi. The shape memory wires may each have a
diameter ranging in size from about 0.006 inches to about 0.012
inches. The plurality of shape memory wires may include at least 6
shape memory wires. The body may have a tubular shape with a
substantially uniform diameter. The body may have a tapered shape
with a diameter that decreases from one end of the body to the
other end of the body. The body may have a generally hourglass
shape. The body may be woven by hand. The body may be woven by a
machine, such as a braiding machine.
[0036] In another respect, the invention is a method of creating a
body suitable for implantation into an anatomical structure. The
body has two ends. The method includes, but is not limited to,
providing a weaving system that includes a template having first
template projections. The method also includes, but is not limited
to, bending shape memory wires around the first template
projections to create bent portions in the shape memory wires. The
bent portions are arranged to define one end of the body. Each
shape memory wire has two ends. The method also includes, but is
not limited to, weaving the ends of the shape memory wires around
the template to create the body such that the shape memory wires
cross each other to form a plurality of angles, at least one of the
angles being obtuse. The value of the obtuse angle is increased
when the body is axially compressed.
[0037] The first template projections may be tabs. The first
template projections may be pins. The pins may be attached to a
ring engaged with the template. The weaving system may also
include, but is not limited to, a first weaving plate configured to
rotate in a first direction during the weaving. The weaving system
may also include, but is not limited to, first bobbins arranged on
the first weaving plate, and one end of each shape memory wire is
attached to each first bobbin prior to the weaving. The weaving
system may also include, but is not limited to, a second weaving
plate configured to rotate in a second direction during the
weaving, and the second weaving plate is spaced apart from the
first weaving plate. The weaving system may also include, but is
not limited to, second bobbins arranged on the second weaving
plate, and one end of each shape memory wire is attached to each
second bobbin prior to the weaving. The method may also include,
but is not limited to, securing the shape memory wires to the
template. The method may also include, but is not limited to,
forming closed structures with the ends of the shape memory wires.
The closed structures may be arranged to define the other end of
the body. The method may also include, but is not limited to,
heating the body and the template.
[0038] In another respect, the invention is a device for delivering
an axially and radially expandable woven body having two ends into
an anatomical structure. The device includes, but is not limited
to, a first tube configured to accept a guide wire, and a second
tube configured to fit over the first tube. When the tubes are used
for delivering the axially and radially expandable woven body, one
end of the axially and radially expandable woven body is secured to
the outside of the first tube and the other end of the axially and
radially expandable woven body is secured to the outside of the
second tube.
[0039] The first tube may be made from NYLON or TEFLON. The second
tube may be made from NYLON or TEFLON. The device may also include,
but is not limited to, a guide wire configured to be placed within
the first tube. The outer diameter of the first tube may range in
size from 3 French to 7 French. The outer diameter of the second
tube may range in size from 5 French to 9 French. The device may
also include, but is not limited to, a push-button release/lock
mechanism configured to secure the first tube to the second tube.
The device may also include, but is not limited to, an end fitting
having a side arm. The end fitting is configured to be secured to
the first tube. The first tube may be provided with at least one
pair of first tube holes through which a first securing wire may be
threaded. The pair of first tube holes may be positioned proximate
one end of the first tube. The second tube may be provided with at
least one pair of second tube holes through which a second securing
wire may be threaded. The pair of second tube holes may be
positioned proximate one end of the second tube.
[0040] In another respect, the invention is a device for delivering
an axially and radially expandable woven body having two ends into
an anatomical structure. The device includes, but is not limited
to, a first tube configured to accept a guide wire. The first tube
has at least one pair of first tube holes that are positioned
proximate one end of the first tube. The device also includes, but
is not limited to, a second tube configured to fit over the first
tube. The second tube has at least one pair of second tube holes
that are positioned proximate one end of the second tube. The
device also includes, but is not limited to, a first securing wire
configured to be threaded through the pair of first tube holes. The
device also includes, but is not limited to, a second securing wire
configured to be threaded through the pair of second tube holes.
When the tubes are used for delivering the axially and radially
expandable woven body, one end of the axially and radially
expandable woven body is secured to the outside of the first tube
with the first securing wire and the other end of the axially and
radially expandable woven body is secured to the outside of the
second tube with the second securing wire.
[0041] In another respect, the invention is an occluding system
that includes, but is not limited to, a plurality of shape memory
wires woven together to form a body useful for occluding an
anatomical structure. The body has first and second ends. Both ends
of at least one shape memory wire are located proximate one end of
the body. The shape memory wires cross each other to form a
plurality of angles, at least one of the angles being obtuse. The
value of the obtuse angle is increased when the body is axially
compressed.
[0042] The shape memory wires may be made from nitinol. The
occluding system may also include, but is not limited to, an
occluding agent enclosed within the body. The occluding agent may
include one or more threads of polyester. The occluding agent may
also include, but is not limited to, one or more threads of DACRON.
The occluding system may also include a jacket coupled to the body.
The jacket may be made from silicone. The jacket may be made from
polyurethane. The occluding system may also include, but is not
limited to, a first tube configured to accept a guide wire, and a
second tube configured to fit over the first tube. Prior to
delivering the body into an anatomical structure, one end of the
body is secured to the outside of the first tube and the other end
of the body is secured to the outside of the second tube.
[0043] In another respect, the invention is a device that includes,
but is not limited to, a body suitable for implantation into an
anatomical structure. The body has an axis, a first end and a
second end. The body is made from a shape memory wire that has a
first segment and a second segment. The segments are separated by a
bend in the shape memory wire that is located proximate one end of
the body. The first segment extends helically in a first direction
around the axis toward the other end of the body. The second
segment extends helically in a second direction around the axis
toward the other end of the body. The first and second segments
cross each other in a plurality of locations.
[0044] The first segment may be positioned farther from the axis
than the second segment at at least one location. The first segment
may be positioned farther from the axis than the second segment at
each location. The shape memory wire may be made from nitinol. The
device may also include a first tube configured to accept a guide
wire, and a second tube configured to fit over the first tube.
Prior to delivering the body into an anatomical structure, one end
of the body is secured to the outside of the first tube and the
other end of the body is secured to the outside of the second
tube.
[0045] In another respect, the invention is a device that includes,
but is not limited to, a body suitable for implantation into an
anatomical structure. The body has a first end and a second end.
The body is formed from a shape memory wire that has a first
segment and a second segment. The segments are separated by a bend
in the wire that is located proximate one end of the body. The
first segment and second segments are arranged to form loops and
twisted segments such that at least two contiguous loops are
separated from another loop by a twisted segment. The definition of
"contiguous" is set forth below with reference to the figures
herein for the sake of clarity.
[0046] At least three contiguous loops may be separated from
another loop by a twisted segment. At least four contiguous loops
may be separated from another loop by a twisted segment. At least
two contiguous loops may be separated from two other contiguous
loops by a twisted segment. The shape memory wire may be made from
nitinol. The device may also include, but is not limited to, a
first tube configured to accept a guide wire, and a second tube
configured to fit over the first tube. Prior to delivering the body
into an anatomical structure, one end of the body is secured to the
outside of the first tube and the other end of the body is secured
to the outside of the second tube.
[0047] In another respect, the invention is a device that includes
a body suitable for implantation into an anatomical structure. The
body has, but is not limited to, two ends and is formed from a
shape memory wire that has a first segment and a second segment.
The segments are separated by a bend in the wire that is located
proximate one end of the body. The segments are positioned adjacent
to each other in loop-defining locations. The segments also extend
between the loop-defining locations in spaced relation to each
other so as form at least two loops. At least one of the at least
two loops has a compressed shape. The definition of a "compressed"
shape is set forth below with reference to the figures herein for
the sake of clarity.
[0048] The shape memory wire may be made from nitinol. The segments
may be secured together using welds at the loop-defining locations.
The segments may be secured together with collars at the
loop-defining locations. The body may also include, but is not
limited to, at least one coil placed over at least a portion of one
of the segments, and, as a result, the body may be used as an
occluder. The body may also include at least one fiber attached to
the coil. The device may also include, but is not limited to, a
first tube configured to accept a guide wire, and a second tube
configured to fit over the first tube. Prior to delivering the body
into an anatomical structure, one end of the body is secured to the
outside of the first tube and the other end of the body is secured
to the outside of the second tube.
[0049] The present invention also provides a delivery system that
may secure both the proximal and distal ends of the stent, occluder
or filter. Advantageously, this delivery system allows the stent,
occluder or filter to be easily repositioned as it is being
delivered into place. As a result, the stent, occluder or filter
may be more precisely positioned within the living creature.
[0050] One advantage of the present invention is the unique
fixation method of the tapered stent. The tapered shape of the
stent allows the stent to be fixed in a tapered vessel or tubular
structure with less radial or expansile force than a straight stent
might exhibit, thus potentially resulting in a less hyperplastic
intimal reaction.
[0051] The straight stent of the present invention exhibits a high
expansile force and thus a large capability of withstanding outer
compression. This may be especially advantageous in tumorous
stenoses, or fibrous strictures (including radiation-induced
stenoses) where stents with inadequate expansile forces can be
easily compressed and/or are incapable of assuming their nominal
shape and diameter. In some cases, even the stenoses of
arteriosclerotic origin can be so calcified (e.g., iliac or renal
artery stenoses) that extra radial force is required from the stent
to hold the patency of the vessel. Furthermore, the woven
intravascular devices of the present invention are also able to
return to their original, unconstrained shape after being bent,
even maximally.
[0052] Advantageously, the stents, occluders and filters of the
present invention do not possess free, sharp wire ends. Thus, many
potential complications are eliminated (Prahlow, 1997).
Additionally, the tight mesh of the stents of the present invention
coupled with the use of nitinol wires, for example, makes them easy
to monitor under fluoroscopy.
[0053] The present invention also includes a group of
self-expanding, self-centering cava filters woven from materials as
described above such that a coherent element is formed that without
the use of a joint or attachment between the portions of the
filters. The cava filters of the present invention provide
increased filtrating efficiency not only at the center but also at
the periphery of the cava. Additionally, the hourglass filter of
the present invention utilizes multiple filtration levels. The cava
filters of the present invention are able to self-center due to the
symmetrical nature of their design and their potentially flared
base.
[0054] The cava filters of the present invention may utilize a
relatively small, 7 French delivery catheter or sheath.
Additionally, the superb flexibility of the cava filters makes it
possible to deliver them via any of the possible access sites of
the human body (femoral, jugular, antecubital veins).
[0055] The present invention also includes a bi-iliac filter ("BI
filter") that is a low-profile, self-expanding, flexible, temporary
filter which may be woven from a number of superelastic or shape
memory alloys. The BI filter is a type of temporary filter that can
be deployed from either femoral vein, and it can filtrate the blood
at the iliac veins/inferior cava junction. The BI filter of the
present invention typically works at a low level of venous
circulation. Advantageously, the BI filter simultaneously filters
all the blood coming from both iliac veins, achieving almost 100%
filtration. Further, the use of the BI filter is particularly
beneficial in perioperative and posttraumatic cases.
[0056] The inverse U-shape of the BI filter together with the
expansile force of the tubular weave ensures firm position along
the iliac/cava junction. A further advantage of the present
invention is that the BI filter may utilize a relatively small, 7
French delivery catheter or sheath. Further, due to the flexibility
of the mesh of the BI filter, the delivery system thereof may be
advanced from ipsi- to contralateral iliac vein. As with the cava
filters, the BI filter may possess a non-ferromagnetic character
making it MRI compatible.
[0057] The BI filter is suitable for temporary filtration. The BI
filter allows for removal of the entrapped thrombi safely and
successfully before removal of the filter. Using an adequately
sized sheath, the small thrombus fragments entrapped within the
mesh could also be removed together with the filter.
[0058] The stents of the present invention can be advantageously
covered with materials such as silicone, polyurethane, and/or an
anticancer coating agent that allow the stents to reduce the
possibility of restenosis after delivery, and which also allow the
stents to be used in stenting malignant stenoses, for example. The
filters of the present invention may also be covered with
anticoagulant coating agents.
[0059] Ureter strictures/compression/occlusion may be stented with
these uncovered and/or covered stents; in particular, the use of a
long tapered stent may advantageously match the special conditions
posed by the different caliber and distensibility of the different
segments of the ureter as well as the constant peristalsis.
[0060] The stents of the present invention can also be used in some
non-vascular applications including biliary tree and
tracheo-bronchial system if the lesion does not require a
bifurcated stent.
[0061] The stents, occluders and filters of the present invention
may be used in many different applications. They provide the
advantages of superb flexibility, repositionability/removability,
and precise positionability.
BRIEF DESCRIPTION OF THE DRAWINGS
[0062] The following drawings form part of the present
specification and are included to further demonstrate certain
aspects of the present invention. The invention may be better
understood by reference to one or more of these drawings in
combination with the description of illustrative embodiments
presented herein.
[0063] FIG. 1A is a perspective view of a stent according to one
embodiment of the present invention.
[0064] FIG. 1B is a front view of a stent end defined by bends
according to one embodiment of the present invention.
[0065] FIG. 1C is a perspective view of one wire of a stent
according to one embodiment of the present invention.
[0066] FIG. 2 is a side view of the arrangement of wires in a plain
weave according to one embodiment of the present invention.
[0067] FIG. 3 is a perspective view of a delivery system according
to one embodiment of the present invention.
[0068] FIG. 4 is a side view of a delivery system according to one
embodiment of the present invention.
[0069] FIGS. 5A-E sequentially illustrative steps in a delivery
method according to one embodiment of the present invention.
[0070] FIG. 6 is a front view of a conical filter having bends or
loops in the proximal (rear) end thereof according to one
embodiment of the present invention.
[0071] FIG. 7 is a front view of a conical filter having bends or
loops in the distal (front) end thereof according to one embodiment
of the present invention.
[0072] FIG. 8 is a front view of a dome filter having bends or
loops in the distal end thereof according to one embodiment of the
present invention.
[0073] FIG. 9 is a front view of an hourglass filter according to
one embodiment of the present invention.
[0074] FIG. 10 is a front view of an hourglass filter according to
one embodiment of the present invention placed in the Inferior Vena
Cava.
[0075] FIG. 11 is a front view of a bi-iliac filter according to
one embodiment of the present invention placed in the iliac
veins.
[0076] FIG. 12 is a front view of a bi-iliac filter having a
retrieval loop according to one embodiment of the present invention
placed in the iliac veins.
[0077] FIG. 13 is a front view of a bi-iliac filter having a
retrieval loop and a stabilizing wire according to one embodiment
of the present invention placed in the iliac veins.
[0078] FIG. 14 is a is a perspective view of a tapered stent
according to one embodiment of the present invention.
[0079] FIG. 15 is a perspective view of a single wire embodiment
filter according to one embodiment of the present invention.
[0080] FIGS. 16-24 show stages in a hand weaving method according
to one embodiment of the present invention.
[0081] FIG. 25 is a front view of the proximal portion of a
delivery system according to one embodiment of the present
invention.
[0082] FIG. 26 is a front view of a delivery system for a temporary
filter according to one embodiment of the present invention.
[0083] FIGS. 27A and B illustrate stages in the removal of a filter
from a vessel according to one embodiment of the present
invention.
[0084] FIG. 28 is a front view of a conical filter in a fully
stretched position according to one embodiment of the present
invention.
[0085] FIG. 29 is a projected cross section of an hourglass filters
taken across the middle portion of the filter according to one
embodiment of the present invention.
[0086] FIG. 30A is a front view of two wires coupled together for
use in a hand weaving method according to one embodiment of the
present invention.
[0087] FIG. 30B is a perspective view of the placement of two wires
each coupled to a pin for use in a hand weaving method according to
one embodiment of the present invention.
[0088] FIG. 31 is a perspective view of a biodegradable stent with
a reinforcing wire according to one embodiment of the present
invention.
[0089] FIG. 32 is a perspective view of a biodegradable stent with
a reinforcing wire according to a second embodiment of the present
invention.
[0090] FIGS. 33A-G are front views of various configurations of an
occluder according to the present invention.
[0091] FIG. 34 is a front view of an occluder having a jacket
according to one embodiment of the present invention.
[0092] FIG. 35 is a front view of an occluder having clips
according to one embodiment of the present invention.
[0093] FIG. 36 is a front view of an aneurysm being treated by
transcatheter embolization according to one embodiment of the
present invention.
[0094] FIG. 37 is perspective view of a template with longitudinal
tabs around which wires are bent according to one embodiment of the
present invention.
[0095] FIG. 38A is an enlarged perspective view of the longitudinal
tab and bent wire depicted in FIG. 37 according to one embodiment
of the present invention.
[0096] FIG. 38B is an enlarged perspective view of a longitudinal
tab depicted in FIG. 37 around which a wire is bent to form a loop
according to one embodiment of the present invention.
[0097] FIG. 39 is a perspective view of a wire bent around a
longitudinal tab and wrapped around a pair of bobbins according to
one embodiment of the present invention.
[0098] FIG. 40 is a top view of inner and outer weaving plates
provided with bobbins according to one embodiment of the present
invention.
[0099] FIG. 41 is a perspective view depicting an upper weaving
plate provided with bobbins and wires, a partial cross-sectional
view of a lower weaving plate provided with bobbins and wires, and
a partial cross-sectional view of a template around which both
plates are arranged according to one embodiment of the present
invention.
[0100] FIG. 42A is a top view of upper and lower weaving plates
provided with bobbins and wires and arranged around a template, and
illustrates the first crossing of the wires according to one
embodiment of the present invention.
[0101] FIG. 42B is a front view of a small caliber loop formed by
bending a wire according to one embodiment of the present
invention.
[0102] FIG. 43A is a top view of upper and lower weaving plates
provided with bobbins and wires and arranged around a template, and
illustrates the first crossing of the wires according to another
embodiment of the present invention.
[0103] FIG. 43B is a front view of a bend formed by bending a wire
according to one embodiment of the present invention.
[0104] FIG. 44 is a perspective view of upper and lower weaving
plates provided with bobbins and arranged around a template such
that the surfaces of the weaving plates from which the bobbin rods
extend face each other according to one embodiment of the present
invention.
[0105] FIG. 45 is a perspective view of upper and lower weaving
plates provided with bobbins and wires and arranged around a
template such that the surfaces of the weaving plates from which
the bobbin rods extend face each other according to one embodiment
of the present invention.
[0106] FIG. 46A is a perspective, partial cross-sectional view of a
tool for twisting the wire ends of a woven body according to one
embodiment of the present invention.
[0107] FIG. 46B is a cross-sectional view of the jaws and outer
housing of the tool illustrated in FIG. 46A.
[0108] FIG. 47A is a perspective view of a body woven around a
template having longitudinal and transverse tabs according to one
embodiment of the present invention.
[0109] FIG. 47B is an enlarged perspective view of one of the
transverse tabs and twisted wire ends depicted in FIG. 47A
according to one embodiment of the present invention.
[0110] FIG. 48 is a perspective view of a template around which a
ring having finish pins has been threadably engaged according to
one embodiment of the present invention.
[0111] FIG. 49 is a perspective view of a template having finish
holes through which finish pins may be placed according to one
embodiment of the present invention.
[0112] FIG. 50A is a front view of a stent formed from a single
wire according to one embodiment of the present invention.
[0113] FIG. 50B is a front view of a stent formed from a single
wire according to a second embodiment of the present invention.
[0114] FIG. 50C is a front view of a stent formed from a single
wire according to a third embodiment of the present invention.
[0115] FIG. 50D is a perspective view of the stent depicted in FIG.
50B positioned on a template according to one embodiment of the
present invention.
[0116] FIG. 51 is a perspective view of a barbless stent filter
according to one embodiment of the present invention.
[0117] FIG. 52 is a perspective view of a barbless stent filter
having bent longitudinal segments according to one embodiment of
the present invention.
[0118] FIG. 53 is a perspective view of a barbless stent filter
having two filtrating levels according to one embodiment of the
present invention.
[0119] FIG. 54 is a front view of two stents placed in side-by-side
relationship with each other in the aorta according to one
embodiment of the present invention.
[0120] FIG. 55 is a perspective view of two partially-covered
stents placed in side-by-side relationship with each other in the
aorta according to one embodiment of the present invention.
[0121] FIG. 56 is a perspective view of a stent having struts
placed in side-by-side relationship with another stent in the aorta
according to one embodiment of the present invention.
[0122] FIG. 57A is a front view of an occluder formed from a single
wire around a template according to one embodiment of the present
invention.
[0123] FIG. 57B is a perspective view of an occluder formed from a
single wire that includes collars placed around the wire segments
at loop-defining locations according to one embodiment of the
present invention.
[0124] FIG. 57C is a top view of an occluder formed from a single
wire that has coil pieces placed over portions of the wire segments
located between collars according to one embodiment of the present
invention.
[0125] FIG. 57D is a top view of an occluder formed from a single
wire that has coil pieces placed over portions of the wire segments
located between collars and also has thrombogenic filaments
attached to the coil pieces according to one embodiment of the
present invention.
[0126] FIGS. 58A-D show stages in the delivery of one stent of a
pair of stents in the aorto-renal junction according to one
embodiment of the present invention.
[0127] FIG. 59 is a front view of a barb (of a filter) that is
penetrating a vessel wall according to one embodiment of the
present invention.
[0128] FIG. 60 is a perspective view of a single wire embodiment
filter according to another embodiment of the present
invention.
[0129] FIG. 61 is a front view of upper and lower weaving plates
supported by a weaving plate supporter according to one embodiment
of the present invention.
DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0130] 1. Stents
Straight Stents
[0131] With reference to the illustrative embodiment shown in FIG.
1A, there is shown a stent for insertion and delivery into an
anatomical structure. The stent includes a plurality of wires 5
which may be arranged in a plain weave so as to define an
elastically deformable body 10. As used herein, "elastically
deformable" means that the deformation of such a body is
non-permanent and an original or initial shape may be substantially
recovered, or regained, upon the release of a force (which may be
mechanical, electromagnetic, or any other type of force). As used
herein, "substantially recovered" means that recovery need not be
such that the exact, original shape be regained. Rather, it means
that some degree of plastic deformation may occur. In other words,
recovery need not be total. Such elastic deformability may be
achieved by utilizing the superelastic properties of suitable shape
memory wires, which are discussed below.
[0132] U.S. Pat. No. 4,655,771 to Wallsten (1987), which is hereby
expressly incorporated by reference, displays the manner in which
wires cross each other using plain weave as shown in FIG. 1a
therein. FIG. 2 also illustrates the manner in which the wires 5 of
the present intravascular devices may be arranged utilizing a plain
weave.
[0133] Body 10 is both radially and axially expandable. Body 10
includes front or distal end 12 and rear or proximal end 2. As
shown in FIG. 1A, end 12 has a plurality of closed structures.
These closed structures may be small closed loops 6 or bends 8
(FIG. 1B). Both bends 8 and small closed loops 6 may be formed by
bending a wire 5 at a selected point located between the ends 7 of
wire 5 (FIG. 1C shows small closed loops 6). For most applications,
the selected point of the bend or small closed loop may be close to
the midpoint of wire 5, as shown in FIG. 1C with respect to small
closed loop 6. FIG. 1C also shows both ends of wire 5 being located
proximate end 2 of body 10 (although the remainder of body 10 is
not shown). Body 10 is formed by plain weaving wires 5, as will be
discussed below in greater detail.
[0134] Loops 6 and bends 8 provide significant advantages, some of
which are unexpected, over woven devices such as the WALLSTENT that
have free wire ends. For instance, the Wallsten patent recognizes
that the free wire ends of the WALLSTENT should be protected,
implicitly acknowledging the potential tissue-damaging dangers such
free, sharp wire ends pose. The Wallsten patent suggests methods by
which one can attempt to lessen these dangers, such as connecting
the free wire ends to each other by attaching U-shaped members to
them through heat welding, gluing or the like. These suggested
methods can be time-consuming and, as a result, expensive. No such
steps need to be taken in creating either loops 6 or bends 8 of the
present woven devices as will be discussed below in greater
detail.
[0135] Further, the connections resulting from the methods
disclosed in the Wallsten patent are likely more prone to
mechanical failure than are loops 6 or bends 8 of the present woven
devices. For example, welding can introduce anomalies such as
cracks (which may result from the non-uniform solidification,
uneven boundaries, etc.); voids or other irregularities resulting
from porosity; inclusions (which include slag, oxides, etc.); etc.,
into the welded metal that create stress concentrations and
dramatically increases the propensity for the welded connection to
fail at those locations. In contrast, the gentle curves and bends
resulting in loops 6 and bends 8 are virtually free of any such
induced stresses and, as a result, are much less likely to
fail.
[0136] The Wallsten patent also suggests gluing the free wire ends,
a method that provides even less structural integrity than can
welding, because the resulting bond between the joined wire ends is
only as strong as the surface tension between the glue and the
metal used. Consequently, the joint created is more prone to
failure than a welded joint suffering from the anomalies just
discussed.
[0137] Similarly, the Wallsten patent discloses first utilizing
electric resistance heating to weld together the points of crossing
of the free wire ends in a ring around the stent and then folding
the free wire ends extending beyond the welded ring inwardly with
light plastic deformation through controlled heating. This method
involves not only the likely introduction of the anomalies
discussed above that can result from welding, it also involves an
additional stress on the joints created as the free wire ends are
folded inwardly while being heated. Thus, this proferred joint is
similar to the glued joint in that it is likely even more prone to
failure than one involving only welding.
[0138] In sum, the gentle curves and bends that may be used to
create loops 6 and bends 8 of the present woven devices provide
devices with safer ends: no free wire ends exist that may
unintentionally penetrate and damage the wall of the structure into
which they are delivered; the bends 8 or loops 6 are much less
likely to mechanically fail than are the free wire ends that are
connected together using welding or glue; and the likely
time-consuming task of creating multiple welded or glued joints
does not exist. Further, while the closed structures 4 (discussed
below in greater detail) may be reinforced using methods similar to
those suggested by the Wallsten patent (i.e., such as by welding),
the present woven devices have, at most, only half as many
potential locations for using such methods (and most likely less
than half considering fewer wires are generally needed for making
the present stents than are needed for making comparably-sized
WALLSTENTS, even equating one of the present wires to two wires as
those are used in the WALLSTENT). As a result, the potential for
mechanical failure of the present woven devices is reduced
accordingly.
[0139] In addition to the foregoing benefits, loops 6 and bends 8
also provide advantages over the modified free wire ends disclosed
in the Wallsten patent discussed above that are unexpected. For
example, the inventors have found that the mesh of one of the
present woven stents may be formed from fewer wires than can the
mesh of a comparably-sized WALLSTENT (even equating one of the
present wires to two wires as those are used in the WALLSTENT).
Accordingly, the expansile force of one of the present woven stents
of a given size may be maintained with fewer wires than would be
needed to maintain the same expansile force of a WALLSTENT of the
same size by simply increasing the mesh tightness (i.e., by
increasing angle a--FIG. 1A--discussed below in greater detail).
Similarly, the inventors have found that the same result may be
achieved by increasing the diameter of the present wires with or
without adjusting the mesh tightness. As a result, the amount of
metal needed for the present woven stents may be less than what is
needed in another comparably-sized woven stent, such as the
WALLSTENT. This reduction in necessary metal translates to a cost
savings, and, as described above, also means that patients are less
likely to experience thrombosis and/or restenosis. As a further
result, the variety of sizes that may be created for the present
stents and the variety in the tightness of the weave of each is
virtually unlimited, thereby facilitating virtually all potential
applications.
[0140] Further, the inventors also discovered that virtually no
shortening occurs while bending the present woven stents, nor do
the diameters of the present woven stents increase during bending.
Thus, it is easier to accurately and predictably position the
present stents in a tortuous anatomy than it is to position other
woven stents that shorten more or suffer larger increases in
diameter when bent, such as the WALLSTENT. For example, a
tightly-woven present stent, 2.5 cm long, 10 mm in diameter, formed
from 10 0.006-inch wires may be maximally bent by simply holding
the two ends thereof between two fingers and bringing those ends
together, and no shortening or diameter increase occurs during
maximal bending. In contrast, for a WALLSTENT formed from 24
0.005-inch wires to behave similarly, the inventors found that it
should be 6 cm long and 9 mm in diameter; although, when
manipulated in a similar manner, the WALLSTENT experienced a 10%
increase in diameter and some shortening. Thus, the
length-to-diameter ratios of the foregoing stents were 2.5 and 6.6,
respectively.
[0141] As few as five wires, and an unlimited maximum number of
wires may be used to form body 10 for any given application. As
used herein, "wires" will mean a strand formed of any material,
such as metal, plastic, fiber, etc. In an exemplary embodiment of
the present invention, 6 to 12 wires are typically used to form
body 10 in most applications.
[0142] The number of wires that may be used depends on the
application, and specifically on the desired expansile force of the
stent. The expansile force of the stent is the radial force
necessary to reduce the diameter of the stent. Factors affecting
the expansile force of the stent include: the tightness of the
weave (which is determined by the number of wires used and the
angle formed by the crossed wires--the more wires or the closer the
angle is to 180.degree., the tighter the weave), the number of
wires used to form the woven stent, and the diameter of the wires
used. When body 10 is used in the coronary artery, for example, it
may be desirable to use the smallest possible amount of wire
material to prevent thrombosis and reduce the possibility of
restenosis in the vessel with a relatively slow circulation.
[0143] In FIG. 1A, when body 10 is in its initial, unconstrained
shape, angle a may range from about 90.degree. up to, but not
including, 180.degree.. The expansile force of body 10 increases as
angle a approaches 180.degree.. It is to be understood that angles
less than 90.degree. may be utilized for angle a. In an exemplary
embodiment, angle a is preferably obtuse, i.e., more than
90.degree., and most preferably about 150.degree.. In certain
applications, however, a larger expansile force may be desirable,
and, thus, angle a may be closer to 180.degree., such as in the
case of a tumorous stricture or the like. In this regard, in an in
vitro comparative study, a stent according to the present invention
exhibited a higher expansile force and thus a larger capability of
withstanding outer compression than both a Z-stent and a WALLSTENT
of the same diameter, as revealed in Table 1, below. In Table 1,
the designation .DELTA. in the leftmost column represents the
circumferential displacement (in mm) of the stent in question. For
example, a .DELTA. of 2 mm indicates that the circumference of the
stent in question was reduced by 2 mm, and the force necessary to
effect that displacement was then recorded. The designation "W"
refers to the WALLSTENT.
1TABLE 1 Comparison of Expansile Forces of a Z-Stent, a WALLSTENT
and a Nitinol Woven Stent Z Z W .DELTA. Z Be- Side by W W Side by
Woven (mm) Center tween Side Center Overlap Side Stent 2 16 13 19
15 35 18 44 4 36 28 31 25 59 22 91 6 51 44 42 42 80 35 126 8 63 61
56 50 108 42 158 10 81 79 62 60 126 48 167 12 100 98 76 74 149 54
175 14 115 119 90 84 170 63 184 16 127 133 101 100 197 73 202 18
146 192 122 111 220 84 20 165 unmea- 142 129 248 96 sur.
[0144] With respect to Table 1, the unit "g" for "grams" is used as
a measure of force. Although the correct unit of force is the
"dyne", which is equal to the mass in grams multiplied by the
gravitational constant, the inventors believe that the average
reader will have a better idea about the size of force when the
associated mass unit (grams) is specified.
[0145] When one uses, e.g., a WALLSTENT or other commercially
available stent for stenting, the manufacturer usually recommends
to use a stent one mm larger than the diameter of the vessel, after
precise determination of the size of the vessel, to eliminate the
magnification factor caused by the fluoroscopy/radiography. This
minimal "overstenting" is used to achieve good contact between the
stent and the vessel wall. The manufacturer also typically provides
exact data regarding the relationship between the stent's diameter
and length to facilitate precise positioning thereof. The woven
nitinol design of the present invention has significantly greater
expansile force than that of the WALLSTENT if a comparable number
of wires are used to form the same caliber stent (understanding
that one wire as used herein and shown in FIG. 1C would require the
use of two wires in the WALLSTENT, given the free, unclosed wires
thereof). Compared to the WALLSTENT, the closed structures of the
stents of the present invention and the better shape memory of the
wires that may be used may result in a considerable reduction in
the size of the wires used, in the number of wires used, as well as
in the angles between the wires. For instance, in small vessel
applications (e.g., coronary artery) it is advantageous to use the
minimum amount of wire (metal) to reduce the possibility of
thrombosis and/or restenosis. Furthermore, in preferred
embodiments, angle a may be reduced below 90 degrees without losing
the necessary expansile force for self anchoring. For the same
vascular application, the same or even greater expansile force can
be achieved with a loosely-woven nitinol design of the present
invention compared to the WALLSTENT and other available stents. A
stent of the present invention may also be chosen so as to have a
diameter approximately ten percent larger than the diameter of the
tubular structure to be stented.
[0146] Body 10 may also be formed from a single wire ("the single
wire embodiment"). The single wire embodiment is illustrated in
FIG. 1C, wherein wire ends 7 have not yet been twisted or coupled
together to form a closed structure 4, as described below in
greater detail. One version of the single wire embodiment is
illustrated in FIG. 50A. As illustrated in FIG. 50A, body 10 of the
stent has an axis 810, distal end 12 and proximal end 2. First
segment 812 of wire 5 is separated from second segment 814 by
either bend 8 (not shown) or closed loop 6. As shown in FIG. 50A,
first segment 812 extends helically in a first direction around
axis 810 toward end 2, and second segment 814 extends helically in
a second direction around axis 810 toward end 2. First segment 812
crosses second segment 814 in a number of locations 816. As shown
in FIG. 50A, locations 816 define loops 818, which touch each other
such that the loops are contiguous. Loops 818 are "contiguous"
because, with the exception of the first and last loops, each loop
shares a point--location 816--with two other loops.
[0147] Segments 812 and 814 may be arranged in two different ways
with respect to each other. As shown in FIG. 50A, segment 812 is
positioned farther from axis 810 than segment 814 at each location
816, while in FIG. 50B, segments 812 and 814 alternate being
further from axis 810 at each location 816. It will be understood
to those of skill in the art, with the benefit of this disclosure,
that segment 812 may be positioned farther from axis 810 than
segment 814 at one or more locations 816.
[0148] In the single wire embodiment of the stents in FIGS. 50A and
50B, loops 818 reside in a series of planes that includes two
groups of planes (not shown), one of which includes the planes
passing through the first, third, fifth, etc. loops 818, and the
other of which includes the planes passing through the second,
fourth, sixth, etc. loops 818. The planes in each group are roughly
parallel to each other. When body 10 is in its unconstrained state,
the planes in one of the groups intersect the planes in the other
group at acute angles falling within the range of slightly greater
than 0.degree. to about 45.degree.. Axis 810 passes generally
through the center of each of loops 818.
[0149] As shown in FIG. 50C, certain of loops 818 of the single
wire embodiment of body 10 of the stent may be separated by
longitudinal segments in which segments 812 and 814 are twisted
together. As shown, pairs of contiguous loops 818--with the
exception of the loop located after closed loop 6--are separated by
twisted segments 820. Although not shown, it will be understood to
those of skill in the art, with the benefit of this disclosure,
that as many contiguous loops as are desired may be separated by a
twisted segment 820 from another loop or any other number of
contiguous loops to suit a particular application. For example,
three contiguous loops may be separated from another loop or two or
more other contiguous loops by a twisted segment in the same manner
that the pairs of contiguous loops are separated by twisted
segments as illustrated in FIG. 50C. Similarly, four contiguous
loops may be separated from another loop or two or more other
contiguous loops by a twisted segment. As yet another example, a
single wire embodiment stent may have only one twisted segment
separating two groups of five contiguous loops.
[0150] In contrast to the "hoop stent" disclosed in U.S. Pat. No.
5,830,229 to Konya et al. ("the hoop stent"), which is incorporated
herein by reference, the single wire embodiment of the stent that
has twisted segments 820, depicted in FIG. 50C for example,
possesses multiple contiguous loops 818. As a result, the single
wire embodiment stents with such twisted segments are more
resistant to forces compressing loops 818 in a lateral manner. The
directions of such lateral forces are indicated by the large arrows
in FIG. 50C. As a result, if the single wire embodiment of the
stent having multiple contiguous loops, such as the stent depicted
in FIG. 50C, is placed in a vessel or other structure that is
sometimes bent or flexed, that vessel or structure will more likely
remain patent when bent or flexed than it would were it supported
by the hoop stent.
[0151] Body 10 of a stent according to the present invention may be
formed by various methods of plain weave including hand weaving and
machine weaving. The following process is an exemplary embodiment
of plain weaving according to the present invention. As shown in
FIG. 16, a template 300 having a diameter corresponding to the
chosen diameter of body 10 is provided. The top of the template is
equipped with holes 302 around its circumference. Pins 304 are
placed through the holes such that they extend beyond the outer
surface of the template on opposing sides. As shown in FIG. 16,
wires 5 are bent at about their midpoint around the pins. This
bending may result in the formation of bend 8 as shown, or wires 5
may be wrapped around the pins to form small loops 6 (not shown).
In one embodiment of body 10, angle b of small closed loop 6 or
bend 8 (FIG. 1A) may be less than 90.degree.. In a more typical
embodiment of body 10, angle b may be equal to or greater than
90.degree., and may approach, but not include, 180.degree.. In an
even more typical embodiment, angle b may be about 140-160.degree..
As discussed above, bends 8 and loops 6 are created in a manner
that makes them likely more mechanically sound than the joints
disclosed in the Wallsten patent created by connecting two wire
ends together through welding or gluing.
[0152] In one embodiment of the present plain weaving process, the
ends of two wires 5 may be coupled together and placed around pin
304, instead of bending a single wire 5 as above described. This
coupling may be achieved by using any suitable means capable of
preventing the wires from returning to their straight, unbent
configuration. As shown in FIG. 30A, such means include bending and
crimping a metal clip around the wires. In another embodiment of
the present plain weaving process, as shown in FIG. 30B, two wires
5 may each be wrapped around pin 304 separately and secured using
any suitable means, such as those just described, in further
contrast to bending one wire around pin 304. After annealing (i.e.,
heating and cooling) wires 5 shown in FIG. 30B as described below,
the two wires may be coupled to each other using any suitable means
such as twisting, crimping or tying as further below described.
[0153] Although only two pins are shown in FIG. 16, it is to be
understood that this is done for illustrative purposes only, and
not to indicate the appropriate number of wires to use in any given
application. In an exemplary embodiment, template 300 is typically
formed of brass or copper, but may be formed of any suitable
material capable of withstanding the cure temperature below
discussed, such as stainless steel. Similarly, in an exemplary
embodiment, pins 304 are typically formed of stainless steel, but
may be formed of any similarly suitable material. It is to be
understood that the pins may be supported by the template by any
suitable means capable of withstanding the cure temperature,
including preforming, attachment by welding, threading, or the
like.
[0154] As shown in FIG. 17, after the wires have been bent around
the pins, the wires are secured to the template to prevent them
from returning to their original, straight, unbent position. This
may be necessary given the superelastic nature of wires such as
nitinol and the like (discussed below). As shown in FIG. 17, wires
5 are secured by securing wire 306 around the outside of wires 5 so
as to secure wires 5 against the outside of the template. In an
exemplary embodiment, copper is typically used for securing wire
306, but it is to be understood that any suitable wire capable of
withstanding the annealing temperature of about 500.degree. C.
discussed below may be used. After the wires are secured, small
weights 360 (shown in FIG. 20) are attached to the free ends of the
wires using any suitable means such as tying, or the like. In an
exemplary embodiment, weights with masses of approximately 50-100
grams may typically be used with wires having diameters of between
about 0.005 inches and about 0.011 inches. However, it is to be
understood that weights of different masses may be chosen so long
as the wires are kept under tension (i.e. straight) during plain
weaving (as described below), and properly balance the central
weight (described below).
[0155] As shown in FIG. 18, a stand 330 with a circular plate 320
is provided with an opening 325. The diameter of the opening may
depend on the diameter of the template. In an exemplary embodiment,
an opening with a diameter of about 4.5 cm may be typically
utilized in conjunction with a template of about 1.0 cm. It is to
be understood, however, that an opening with a diameter more
closely corresponding to the diameter of the template may be
utilized.
[0156] As shown in FIG. 19, before or after the weights are
attached to the ends of wires 5, the template is inverted. In an
exemplary embodiment, the weights may be typically attached to the
free ends of the wires prior to inversion of the template such that
the wires are kept under tension and may be prevented from
returning to their unbent, nominal state. A central weight 340 may
then be attached to the end of the template. In an exemplary
embodiment, the central weight may be typically hung from the pins.
However, it is to be understood that the central weight may be
attached to the template's end in any suitable manner, such as
hanging from holes in the template itself, etc.
[0157] Before or after central weight 340 is attached to the end of
the template, the inverted template is placed through opening 325,
as shown in FIG. 20. In an exemplary embodiment, the central weight
may typically be attached to the inverted template after the
inverted template is placed through opening 325. As shown in FIG.
20, the wires 5 may be arranged fairly evenly around the
circumference of the circular plate. As shown in FIG. 21, in an
exemplary embodiment of the present invention, 6 wires having 12
ends numbered 1-12 (each wire having 2 ends) are shown as being
arranged in a substantially symmetrical fashion around circular
plate 320. The weights 340 and 360 typically serve to keep the
wires under tension and in balance. Next, the plain weaving may
take place.
[0158] In the manner shown in FIG. 22, the weave may be started by
crossing one wire end over the adjacent wire end. This crossing may
be made in either a clockwise or counterclockwise fashion. This
crossing may be carried out as directed by the arrows shown in FIG.
22. After a complete set of crosses (or one "turn") has been
carried out, the location of the crossed wire ends is as shown in
FIG. 23. In an exemplary embodiment, the resulting location of the
wire ends may be achieved by crossing one wire end over another in
one direction while slightly shifting the wire end not crossed in
the opposite direction. In an exemplary embodiment, this shifting
may be about 15.degree.. Thus, wire end 1 may be crossed in a
clockwise direction over wire end 2, while shifting wire end 2
about 15.degree. counterclockwise. Once one turn has taken place,
crossing may begin in the same fashion, but in the opposite
direction, as shown in FIG. 24. This process may be repeated until
the plain weave is complete.
[0159] The tightness of the plain weave (i.e., the angle a between
the wires--FIG. 1A) may be adjusted by changing the central weight.
An increase in the central weight results in a looser weave
(decreased angle a between the wires) and vice versa. Upon
completion of the plain weave, the adjacent wire ends may be closed
as below described.
[0160] In an exemplary embodiment according to the present
invention, a conventional braiding machine may be utilized to
arrange wires 5 in a plain weave to form body 10 of a stent or any
other device described herein. Such a braiding machine may be
obtained, for example, from Wardwell Braiding Machine Company in
Central Falls, R.I. The manner in which a plain weave may be
achieved using a conventional braiding machine is displayed in FIG.
7 of U.S. Pat. No. 5,419,231 to Earle, III et al. (1995), which is
hereby expressly incorporated by reference, as well as in FIG. 1 of
U.S. Pat. No. 5,485,774 to Osborne (1996), which is hereby
expressly incorporated by reference.
[0161] After the plain weave process is complete, as shown in FIG.
1A, at the rear or proximal end 2 (the end closest to the
surgeon/operator) of body 10, wire ends 7 may be twisted together
using multiple twists so as to form closed structures 4. In an
exemplary embodiment, as few as 2 twists may be used, and as many
as about 6. In an exemplary embodiment, it is preferable to keep
the twisted wire ends as short as possible. The shorter the twisted
wire ends are kept, the more resistant to bending the twisted wire
ends are. As a result, the twisted wire ends are less likely to be
inadvertently displaced during placement, repositioning, or
retrieval, thus reducing the potential for causing tissue damage.
Although not shown, it will be understood to those of ordinary
skill in the art with the benefit of the present disclosure that
the wire ends may be coupled together, instead of by twisting,
using any suitable means capable of withstanding the heating
described below, such as bending and crimping a metal clip around
the wires, tying them together with suitable material such as
stainless steel wire, welding, etc.
[0162] Other configurations of template 300 may also be utilized
consistently with the present disclosure. For example, template 300
may be provided not only with pins 304 or tabs 600 (described
below), around which wires 5 are bent, wrapped, tied, twisted,
etc., prior to weaving the body of the stent (or the bodies of any
of the woven structures disclosed herein), but may also be provided
with pins around which the wire ends may be twisted in fashioning
closed structures 4. Finish pins 800 may be supplied on a ring,
such as ring 802 depicted in FIG. 48, in any suitable fashion,
including, for example, through removable or permanent attachment.
Ring 802 may be configured to threadably engage template 300 as
depicted in FIG. 48. In other embodiments, ring 802 may be
configured to engage template 300 by virtue of frictional forces
(not shown) or may be configured to be secured to template 300 as
would a clamp (not shown). Finish pins 800 may also be engaged with
template 300 in the same manner as pins 304. As shown in FIG. 49,
in such an embodiment, template 300 may be provided with finish
holes 804 similar to holes 302, and finish pins 800 may be placed
through finish holes 804. Ring 802 may also be utilized in place of
holes 302 and pins 304.
[0163] In an embodiment in which finish pins 800 are engaged with
template 300 through the utilization of ring 802, the number of
finish pins utilized may be equal to the number of wires 5 that are
used. Template 300 may be threaded along any portion of its length
so as to best accommodate a variety of woven body sizes. For
example, only a portion of template 300 may be threaded, as
depicted in FIG. 49. Threads need not be utilized with a ring that
engages template 300 by virtue of frictional forces.
[0164] Advantageously, the use of ring 802 allows for the easy and
precise alignment of pins 304 or tabs 600 with finish pins 800.
Another advantage afforded by the use of ring 802 is the ease with
which the precise length of the woven body may be achieved. The
length of the woven body may be achieved by adjusting and fixing
the distance along the length of template 300 between pins 304 or
tabs 600 and finish pins 800. In an embodiment in which finish pins
800 are placed through finish holes 804, the number of finish pins
utilized may be equal to one-half of the number of wires 5 that are
used, since both ends of the finish pins will be utilized. Template
300 may be provided with finish holes 804 along any portion of its
length so as to best accommodate a variety of woven body sizes. For
example, only a portion of template 300 may be provided with finish
holes 804, as depicted in FIG. 49.
[0165] As with ring 802, the use of finish holes 804 advantageously
allows for the easy and precise alignment of pins 304 or tabs 600
with finish pins 800. Additionally, the precise length of the woven
body may advantageously be achieved by virtue of the distance along
the length of template 300 between pins 304 or tabs 600 and finish
holes 804 (and, therefore, finish pins 800.)
[0166] With finish pins 800 in place, once the wire ends of wire(s)
5 have been woven around template 300, the wire ends may be secured
around finish pins 800 in any suitable manner to form closed
structures 4, including by twisting, bending, wrapping and the
like. In one embodiment, the wire ends may be crossed, then bent
around finish pins 800 and then secured together using a short
piece of a thin-walled metal tubing. Such a joint may then be
reinforced by soldering, welding, or the like. A suitable number of
additional twists may be utilized after securing the wire ends
around finish pins 800 in forming closed structures 4. Securing
wire 306 (not shown) may be utilized to secure closed structures 4
to template 300 during annealing.
[0167] As a result of securing the wire ends around finish pins
800, the angle created between the crossed wire ends may be
similar, if not identical to, angle b described above.
Advantageously, by using finish pins 800, this angle between the
crossed wire ends may be maintained, preventing the weave of the
woven body from loosening. Were loosening to occur, the expansile
or radial force of the portion of the body with the loosened weave
could decrease, causing that portion of the woven body to remain
elongated within the structure in which it is placed. Therefore,
through the use of finish pins 800 and as a result of the
correlating maintenance of the angle between the crossed wire ends
that are wrapped or twisted around the finish pins, the tightness
of the weave along the length of the woven body--from end to
end--may be consistent and resistant to loosening, and the
expansile force of the end of the woven body having closed
structures 4 may be comparable to the expansile force of the other
portions of the woven body.
[0168] Another method of creating body 10 of a stent according to
the present invention is illustrated in FIGS. 37-47B. As shown in
FIG. 37, the base of template 300 may be equipped with longitudinal
tabs 600 formed by two longitudinal cuts connected by a transverse
cut. The length of the cuts may be determined based upon the size
of the template chosen. For example, a template that is about 10 mm
in diameter may have longitudinal tabs with longitudinal cuts about
4 to 5 mm long, and the connecting transverse cuts may be about 2
mm long. As illustrated in FIG. 37, tabs 600 may be slightly
elevated from the surface of template 300 and may be positioned
equally around template 300.
[0169] FIGS. 37 and 38A and B also illustrate that wires 5 may be
bent around tabs 600 at selected points located between the ends of
the wires to form bent portions along wires 5. The bent portions
may take the form of bends 8, as shown in FIG. 38A, or may be
further wrapped around tabs 600 to form loops 6, as shown in FIG.
38B. Angle b of bends 8 or loops 6 may be less than 90.degree.. In
a more typical embodiment of body 10, angle b may be equal to or
greater than 90.degree., and may approach but not include,
180.degree.. The bent portions may be arranged to define end 12 of
body 10. Wire ends 7 of wires 5 may then be weaved to create body
10 using, for example, the following machine weave method.
[0170] As shown in FIG. 39, ends 7 of each wire 5 may be arranged
around a pair of bobbins 602. The length of the wire wound around
each bobbin may be determined by considering the total length of
the wire needed to form body 10 as well as the wire length needed
to arrange the bobbins around weaving plates (shown in FIG. 40),
which are discussed below in greater detail.
[0171] As shown in FIG. 40, in one embodiment in which bobbins 602
are utilized, two coaxially arranged weaving plates may be
utilized. As shown in FIG. 41, upper weaving plate 604 and lower
weaving plate 606 may be positioned in different horizontal planes.
FIG. 41 illustrates that the weaving plates may be equipped with
multiple bobbin rods 608, the axes of which are substantially
perpendicular to the weaving plates, on which bobbins 602 may be
slidably secured. (FIG. 41 depicts only 4 bobbins for the sake of
simplicity.) The weaving plates may be provided with holes therein
through which template 300 and/or wires 5 may pass, as shown in
FIG. 41. Template 300 may be secured to the base of the weaving
machine chosen using any suitable means such as template rod 610,
around which template 300 may pass, as shown in FIG. 41. Template
300 may be secured to the base of the weaving machine chosen using
any suitable means such as template rod 610, around which template
300 may be slidably placed (FIG. 35). Template rod 610 may be
configured to firmly engage template 300 through frictional forces
(e.g., by tapering template rod 610). Instead of template rod 610,
any appropriate lock mechanism may be used to secure the base of
the weaving machine to template 300.
[0172] As shown in FIGS. 42A and 43A, the pairs of bobbins 602 may
be prepared for weaving by arranging one bobbin on upper weaving
plate 604 and the other bobbin from the pair on lower weaving plate
606. Wires 5 may then be bent around tabs 600, and the ends of the
wires may be attached to bobbins 602 using any suitable means
capable of holding wires 5 under tension throughout the weaving
process. An example of such a mechanism is a one-way brake that
allows bobbin 602 to rotate in a single direction only, such that
the wire 5 may wind off bobbin 602. Simultaneously, such a brake
may be configured so as to continuously maintain tension in wire 5
by virtue of the brake's resistance to the winding off of wire
5.
[0173] As shown in FIG. 42A, with the wire ends in place, the
weaving may begin by crossing the wire ends of the same wire, which
results in the formation of a small caliber loop 6 (FIG. 42B) at
the site of the bent portion. In another manner of weaving
illustrated in FIG. 43, the wire ends of different wires may be
crossed first, resulting in bend 8 at the site of the bent portion
(FIG. 43B).
[0174] As shown in FIGS. 44-45, the two weaving plates may be
arranged such that the surfaces thereof from which the bobbin rods
extend face each other. In this alternative embodiment, the
diameters of the plates may be the same or different. Wires 5 may
be arranged on bobbins 602 in the same manner as described above,
as shown in FIG. 45.
[0175] Despite which of the aforementioned weaving plate
arrangements is utilized, the weaving plates rotate in opposite
directions during the weaving process. The weaving plates may be
operated at any suitable speed. In this regard, a speed as low as 1
to 10 cycles per minute is acceptable. The weaving plates may also
be driven by hand.
[0176] The weaving plates may supported and rotated using any
suitable means. FIG. 61 illustrates one means of supporting and
rotating weaving plates 604 and 606. (FIG. 61 depicts on 4 bobbins
for the sake of simplicity.) As shown, weaving plate supporter 650
may be equipped with lower arm 652 and upper arm 654 for supporting
lower and upper weaving plates 606 and 604, respectively. Weaving
plate drivers 660 may be secured to the upper and lower arms of the
weaving plate supporter and engaged with the weaving plates in
order to operate them. The drivers may be configured to operate in
any suitable fashion. For example, the drivers may be configured
with a power source and provided with gears of any suitable
configuration for causing the weaving plates to rotate. The drivers
may also be configured to utilize magnetism or electromagnetism to
rotate the weaving plates. The drivers may be also be configured
such that the weaving plates may be rotated by hand. Further,
although not shown, it will be understood to those of skill in the
art, with the benefit of this disclosure, that either or both of
the upper and lower arms may be provided with branches to which
drivers may be attached. The drivers on the branches could then be
secured to or engaged with the top surfaces of the weaving plates
in the same fashion that drivers 660 are engaged with the bottom
surfaces of the weaving plates as shown in FIG. 61. Thus, in such
an embodiment, both the top and bottom surfaces of each weaving
plate would be engaged with drivers.
[0177] A braiding machine suitable for carrying the weaving process
just described (i.e., utilizing the weaving plates) may be
obtained, for example, from Wardwell Braiding Machine Company in
Central Falls, R.I.
[0178] After the weaving process is complete, wire ends 7 may be
twisted together or coupled as described above to form closed
structures 4. To make the process of wire twisting faster and
easier, the wires may be twisted with a special hand tool designed
for this purpose. Tool 612 illustrated in FIG. 46A follows the
principle of an automatic pencil. Jaws 614 of tool 612 are
configured so that wire ends 7 may be firmly held between jaws 614.
Jaws 614 may be activated by push button 616 moving against spring
618. After placing wire ends 7 into pre-formed gaps 620 located
between jaws 614 (FIG. 46B), spring 618 expands (or returns to its
unconstrained state) and retracts jaws 614, securing wire ends 7
firmly between jaws 614 due to the pressure of outer housing 622
acting to close jaws 614. Outer housing 622 may then be rotated to
create multiple twists of wire ends 7. As illustrated in FIGS. 47A
and 47B, the twisted ends of body 10 may be secured to template 300
using transverse tabs 624, which may be formed the same way as
longitudinal tabs 600.
[0179] Turning to the single wire embodiment, body 10 may be formed
using either the hand weaving process or the machine weaving
process, both of which are described above. In preparation for the
weaving process, template 300, which may be configured to have any
suitable shape, may be provided with pin 304 or longitudinal tab
600 near the end thereof at which the weaving is to begin. Near its
other end, template 300 may be provided with finish pin 800 or
transverse tab 624, which may be appropriately aligned with pin 304
or longitudinal tab 600. In one embodiment, finish pin 800 may be
provided on ring 802.
[0180] The weave of body 10 may then be started by bending wire 5
around pin 304 or longitudinal tab 600 to form either bend 8 or
closed loop 6. In an exemplary embodiment, securing wire 306 may be
utilized to secure bent wire 5 to template 300 as described above.
The two segments of wire 5 on either side of bend 8 or closed loop
6 may then be woven to create body 10 by helically wrapping the
segments around template 300 in opposite directions toward finish
pin 800 or transverse tab 624. The segments may be crossed over
each other during the process in alternating fashion to result in
the single wire embodiment depicted in FIG. 50B. This weaving may
take place either by hand or using the weaving templates described
above.
[0181] After the weaving is complete, in one embodiment, closed
structure 4 may be created by wrapping the wire ends around finish
pin 800 in the manner described above. In another embodiment, the
wire ends may be twisted or coupled together as described above to
form closed structure 4, which may then be secured to transverse
tab 624. It will be understood that additional pins 304 or
longitudinal tabs 600 may be utilized to create the single wire
embodiment. Such additional pin(s) or tab(s) may be vertically
aligned with the other pin or longitudinal tab such that multiple
closed loops 6 may be formed at the end of body 10 where the weave
begins, as depicted in FIG. 50B. Similarly, additional finish pins
or transverse tabs may be utilized in the same fashion. The use of
pin(s) 304 or longitudinal tab(s) 600 with finish pin 800 or
transverse tab 624 will advantageously ensure that wire 5 remains
in position during annealing. The annealing processes described
below may be utilized for annealing the single wire embodiment.
[0182] After the plain weave of wires 5 is completed on the
template, if the wires are made of a material that can be
programmed with either thermal shape memory or superelasticity such
as nitinol or other shape memory materials described below, body
10/template unit may be heated so as to program body 10 with either
thermal shape memory or superelasticity. If body 10 is programmed
with superelasticity, its initial shape can be deformed by applying
a force thereto. After removal of the force, body 10 may
substantially recover its initial shape. If body 10 is programmed
with thermal shape memory, its initial shape can be deformed upon
application of a force at a first temperature. The force may be
removed, and body 10 may remain deformed until heated to a second
temperature. At the second temperature, body 10 may substantially
recover its initial shape.
[0183] In programming body 10 with superelasticity, the body
10/template unit may be heated to about 500.degree. C. for about 5
to 15 minutes, typically about 12 to 15 minutes, and even more
typically for about 15 minutes, in an oven. After allowing the unit
to cool to room temperature, wires 5 possess superelastic
properties. In an exemplary embodiment, natural cooling is
typically used. It is to be understood, however, that accelerated
cooling using a fluid bath, for example, may be utilized resulting
in slightly different superelastic characteristics than are
achieved with natural cooling. In programming body 10 with thermal
shape memory, the body 10/template unit may be heated to about
500.degree. C. for about 60 to 120 minutes, typically about 120
minutes, in an oven. After allowing the unit to cool to room
temperature, wires 5 possess thermal shape memory. In an exemplary
embodiment, natural cooling is typically used. It is to be
understood, however, that accelerated cooling using a fluid bath,
for example, may be utilized resulting in slightly different
thermal shape memory characteristics than are achieved with natural
cooling.
[0184] In an exemplary embodiment of body 10, it is preferable to
further reinforce the coupled wire ends of closed structures 4
after body 10 has been properly annealed (especially if twisting
was utilized). This reinforcement may be accomplished by any
suitable means such as point welding, soldering, pressure welding,
or the like. The wire ends of closed structures 4 may be soldered
by removing any oxide layer that may have formed over the relevant
portions of the wires used, and applying solder to those portions.
Soldering may be enhanced by first wrapping the coupled wire ends
of the closed structures 4 with thin stainless steel wires. In an
exemplary embodiment, point welding is preferred to soldering,
because point welding is easier to perform than soldering, and may
be more suitable with regard to long-term implantation of the
stent.
[0185] The wires of body 10 may be constructed of any material
compatible with the tissue in which the stent will be placed.
Further, the material may be suitably rigid and elastic and capable
of being programmed with either superelasticity or thermal shape
memory. The materials may, for example, be NiTi alloys like
nitinol. Such alloys can be heated and allowed to cool to room
temperature, resulting in the alloys having either superelastic or
thermal shape memory properties, depending on the heating time as
above described. Other alloys that may be used include FePt, FePd,
and FeNiCoTi. These alloys may be heat treated to exhibit
thermoelastic martensitic transformation, and, therefore, good
thermal shape memory. Other alloys such as FeNiC, FeMnSi, and
FeMnSiCrNi do not possess long-range order and undergo
nonthermoelastic transformation, and, thus, may also be used.
Additionally, some .beta.-Ti alloys and iron-based alloys may also
be used.
[0186] In an exemplary embodiment, nitinol possessing about 55 to
56% Nickel, and 45 to 44% Titanium, may be used for wires 5 of body
10. Such nitinol wires are commercially available from Shape Memory
Applications in Santa Clara, Calif.
[0187] When using nitinol wire, the radiopacity of body 10
advantageously increases over the radiopacity of stents formed
using materials such as stainless steel. The radiopacity depends
primarily on the diameter of the nitinol wires and the tightness of
the plain weave created by the wires. The radiopacity of body 10
can be increased further by using silver solder to reinforce the
coupled wire ends forming closed structures 4.
[0188] The wire sizes that may be used for the stents of the
present invention vary depending on the application of the stent.
In an exemplary embodiment, small stents ranging from about 2 to
about 4 mm in diameter and about 1 to about 2.5 cm in length,
typically for coronary application, may utilize wires from about
0.003 to about 0.006 inches in diameter. In an exemplary
embodiment, medium stents ranging from about 4.5 to about 10 mm in
diameter and about 2 to about 10 cm in length, such as are used in
the iliac artery, femoro-popliteal artery, carotid artery, and the
renal artery, may utilize wires from about 0.006 to about 0.009
inches in diameter. In an exemplary embodiment, large stents above
about 10 mm in diameter may utilize wires from about 0.006 to about
0.012 inches in diameter. Applications for the large stents include
the aorta (typically a vessel diameter in about the 20 to 40 mm
range), the inferior vena cava ("IVC"), which is usually less than
about 28 mm in diameter, the superior vena cava ("SVC"), the
esophageal (20-25 mm in diameter), and the colon, which may be
about 15 to about 25 mm.
Tapered Stents
[0189] With reference to the illustrative embodiment shown in FIG.
14, there is shown a tapered stent for insertion and delivery into
an anatomical structure. Tapered body 100 may be formed using plain
weave by the methods above described. Potential embodiments of
tapered body 100 include the single wire embodiment. The types of
applications for which a tapered stent may be used include the
ilio-femoral, femoro-popliteal arteries, as well as in the carotid
arteries for stenting long lesions.
[0190] The tapered configuration may be achieved different ways. In
a first method using the hand weave method or any of the machine
methods described above, a template may be chosen possessing an
appropriate taper. In an exemplary embodiment, a template with a
smooth, contiguously decreasing diameter without steps is typically
used. The shape of the template may correspond roughly to the inner
shape of the tapered stent. The shape of the tapered stent may be
chosen based on the shape of the vessel or structure into which it
will be placed.
[0191] In an exemplary embodiment, it may be preferable to choose a
shape for the tapered stent (and, thus, for the template) such that
a "wedge-effect" will be achieved between the tapered stent and the
vessel or structure into which it is placed. The wedge-effect may
be used to fix the stent in position and prevent it from distal
migration. It is to be understood, however, that any suitable means
for improving the fixation of the stent in the vessel or structure,
such as flaring the proximal end of the stent, may be used in
addition to or instead of the wedge-effect.
[0192] Using such a template and either hand or machine weave, the
weave may be substantially uniform along the axial length of the
stent. As a result of the substantially uniform weave, the
expansile force of the stent may be substantially uniform along the
axial length of the stent. Although the expansile force may be
substantially uniform as stated, the match between the diameters of
the tapered stent and the vessel into which the stent is placed may
result in the vessel being exposed to a force lesser than would be
exhibited by a straight stent.
[0193] In another embodiment according to the present invention, a
template possessing a uniform diameter as described above may be
chosen for use with either the hand weave method or a machine
method. The diameter of this template may correspond to the
diameter of the largest portion of the stent. Tapered body 100 may
be woven around this template and heated and cooled as above
described. The wire ends of closed structures 104 may then be
reinforced as needed for the application. Tapered body 100 may then
be mounted on a tapered template in a fashion similar to the one
described above (e.g., using a copper wire), and reheated in a
manner similar to the original heating. Forming the stent in this
manner results in a contiguously loosening mesh toward the tapered
end of the stent. That is, angle a is contiguously decreased toward
the distal end 102 of tapered body 100 resulting in a decreasing
expansile force of the tapered stent towards the tapered distal end
102.
[0194] It is to be understood that if a stent (or any other device
disclosed herein) is remodeled a number of times and it is not
intended that the stent be programmed with thermal shape memory,
care should be taken not to exceed a total heating time (which
includes the first heating time and the second heating time, etc.)
of about 60 minutes, because at about 60 minutes, the stent may be
programmed with thermal shape memory.
[0195] As with body 10, one or more of the coupled wire ends of
tapered body 100 may be left slightly longer than the others and
bent inward so as to allow for retrieval of the stent using a
foreign body retrieval device. Further, closed structures 104 of
body 100 may be flared to improve stent fixation.
[0196] In an in vitro study, the expansile force of the tapered
stent of the present invention was found to be proportional to the
weave tightness. The results of this study are set forth below in
Table 2. The tightness of the weave is strongly associated with the
angle between the crossing wires as well as with the number of
wires used for creating the weave. The stents used in the study
were built from 0.011 inch nitinol wires. If the angles between the
crossing wires are wide (closer to 180.degree.), the stent is
better able to withstand any outer compression. An increase in the
diameter of the nitinol wire would increase the expansile force of
the stent.
2TABLE 2 Taper-Shaped Self-Expanding Repositionable Stent
Comparative Study, Using 0.011" Diameter Wires 10 Wires, 8 Wires, 6
Wires, 6 Wires, .DELTA. Tight Moderate Loose Tight (mm) Weave Weave
Weave Weave 2 115 91 26 92 4 176 123 55 103 6 208 141 74 119 8 238
158 92 126 10 273 170 103 136 12 293 186 120 145 14 331 202 129 153
16 371 223 146 171
[0197] With respect to Table 2, the inventors used the unit "g" for
"grams" as the measure of force for the reasons discussed above.
Similarly, the designation .DELTA. in the leftmost column of Table
2 represents the circumferential displacement (in mm) of the stent
in question. For example, a .DELTA. of 2 mm indicates that the
circumference of the stent in question was reduced by 2 mm, and the
force necessary to effect that displacement was then recorded.
[0198] Advantages of the tapered stent of the present invention
include superb flexibility, repositionability and removability,
precise positionability, and better matching than a cylindrical
stent with a uniform diameter between the tapered vessel and the
stent which may result in less intimal reaction and longer vessel
patency.
Covered Stents
[0199] Various material may be suitably used as grafts (including
materials used as covers and those used as liners) that may be
attached to the present woven stents so as to create stent grafts.
One type of covering material that may be utilized for this purpose
is made from material that is stretchable enough to substantially
follow the movement of the stent's mesh. This type of graft
material includes woven polyester, Dacron, polyurethane and the
like. Depending on the application, the graft material may, for
example, be somewhat porous (to facilitate endothelial ingrowth),
highly porous (to leave bridged side branches patent) or non-porous
(e.g., to exclude an aneurysm or fistula from circulation, or in
another application to prevent tumor ingrowth into the stent graft
lumen).
[0200] The graft material may be attached to either the outer or
the inner surface of the stent, so as to serve as a cover or a
liner, respectively. The graft material may be attached to the
stent using monofilament sutures (e.g., polypropylene such as 5-0,
6-0, 7-0 Prolene, which is commercially available from Ethicon),
glue, heat, or any other appropriate means.
[0201] Graft materials that are not stretchable or elastic may also
be utilized to form stent grafts. One such material is PTFE. Such
graft material may be attached to only one of the stent end's,
thereby allowing free movement of the wire mesh. The attachment
between the stent and the graft material may be created at the
proximal end of the resulting stent graft (that is, the end of the
stent that will be closest to the operator).
[0202] Such a stent graft may be pre-loaded into an
appropriately-sized sheath. The graft material may be folded or
arranged so that it occupies as little space within the sheath as
possible.
[0203] Delivering a stent graft having a graft material made from a
relatively non-stretchable material such as PTFE may be performed
in a manner that is different than the manner in which a stent
graft having a stretchable graft material may be delivered. For
example, with a stent graft having a cover made from relatively
non-stretchable graft material, after the stent graft is positioned
as described below in greater detail, the sheath may be retracted
and the graft material may thereby be exposed. Then the stent may
be allowed to assume its unconstrained diameter by using the
coaxial delivery system. The fact, that the coaxial delivery system
enables to achieve a more compressed mesh tightness than that
achievable by allowing the stent to recover, may be advantageous to
create an adequate contact between both the stent and the graft as
well as between the stent graft and the vessel wall. The different
delivery mechanism requires a different approach to stent graft
retrieval. First, the stent is completely restretched over the
delivery tubes and the stent's completely elongated position is
secured by the proximal lock mechanism. Second, the sheath is
advanced preferably using some rotating movement to recapture the
graft material. The creation of the attachment site between the
stent and the graft at the proximal end of the stent is
advantageous for possible repositioning. The stent's proximal end
is secured to the outer delivery tubes, and the graft to the
proximal end of the stent, therefore, the proximal portion of the
graft is formed into a funnel shape facilitating its retrieval into
the sheath.
Side-By-Side Stent Placement in Aorta and Bilateral Renal
Artery
[0204] The present stents may be delivered in a variety of
anatomical structures. Further, they may be used in conjunction
with each other in a variety of manners to best treat the diseased
structure. For example, as shown in FIG. 54, the bilateral
aorto-renal junction 830, consisting of aorta 832, left renal
artery 834 and right renal artery 836, along with the aorto-iliac
junction 840, consisting of left iliac artery 842 and right iliac
artery 844, may be treated using uses two stents positioned in
side-by-side relationship with each other. Alternatively, stent
grafts shorter in length than those shown in FIG. 54 may be
delivered within the aorta or the aorto-iliac junctions with some
overlap therebetween.
[0205] The stents that may be utilized may be woven and annealed as
described above on a variety of templates. In one embodiment,
straight templates may be used. The stents may also be woven and
annealed as described above so as to be relatively tapered, such as
those in FIG. 54. In such a configuration, the portions of the
stents that will occupy the aorta may be larger in caliber than
those portions of the stents that will occupy the renal arteries.
The stents may also be woven on templates that are configured with
a bend that may approximate or match the angle between the
appropriate renal artery and the aorta.
[0206] Stents that may be partially or completely provided (i.e.,
covered or lined) with any of the graft materials described above
using any of the methods of connection described above may be used
in this application. In the embodiment of the pair of stents
illustrated in FIG. 55, the portions of the stents that occupy
aorta 832 and portions of the stents proximate the caudad surfaces
838 of renal arteries 834 and 836 are covered. By only partially
covering the portions of the stents that will occupy renal arteries
834 and 836, the possibility of endoleak from the renal arteries
may be greatly reduced or eliminated.
[0207] In another possible embodiment suitable for this application
illustrated in FIG. 56, the aorto-renal stent may include struts
850 that may be formed by twisting neighboring segments of wires 5
during the weaving process. Struts 850 may also be formed in any
suitable manner such as by encasing neighboring segments of wires 5
in flexible tubes, such as those made of nitinol, or by soldering
or welding neighboring segments of wires 5 together, etc. As used
herein, "struts" means segments of wires that are joined together
in any suitable manner such as twisting, encasing within a
sufficiently flexible piece of tubing, soldering, welding, etc.,
such that the portion of the stent formed from the struts is less
disruptive of the blood flow therethrough than would be the same
portion formed from a weave. The stent graft having struts 850 may,
like the stent grafts depicted in FIG. 55, be covered partially
with any suitable graft material, such as those relatively
stretchable materials disclosed above. Accordingly, the portions
surrounding struts 850 may be covered while leaving struts 850
uncovered and therefore arranged so that when delivered as shown in
FIG. 56, struts 850 are advantageously positioned within the
vasculature with regard to hemodynamics. The use of struts 850 in
this fashion may be advantageous in comparison to leaving a similar
portion of the stent utilized simply bare, as in FIG. 55, in that
struts 850 would be less likely to create turbulence in the blood
flow.
[0208] In one embodiment of the stent graft illustrated in FIG. 56
having struts 850, different portions of the stent may be provided
with different numbers of wires. Turning to such a stent, the weave
may begin at the end of the stent that will be placed in the renal
artery and made be made from n wires. The portion of the stent
occupied by struts 850 may also be made from n wires. The larger
portion of the stent that will occupy the aorta may use n+x wires,
where x denotes the number of additional wires utilized, and may be
between 1 and 2n. Preferably, x is selected from an integer between
2 and n, and more preferably x equals n. The template on which this
type of stent is formed may have pins 304 positioned, for example,
at locations proximate the end and beginning of struts 850.
Biodegradable Devices
[0209] Both the straight and the tapered stents of the present
invention (as well as the filters and occluders discussed below),
except for the single wire embodiments of these devices, may be
formed with filaments made of biodegradable material so as to form
self-expanding, bioabsorbable, biodegradable stents that may, in
addition to functioning as stents, function as drug or nutrient
delivery systems as a result of the material used.
[0210] Many factors may be considered in choosing materials from
which to form the biodegradable stents of the present invention. In
one embodiment, the biodegradable stents of the present invention
may be formed from materials of minimal thickness so as to minimize
blood flow blockage and facilitate bioabsorbtion. In another
embodiment, the material may be chosen so as to exhibit sufficient
radial strength to allow the body formed to function as a stent.
The material from which the biodegradable stents may be formed may
also degrade within the bloodstream over a period of weeks or
months, so as not to form emboli. The material may be chosen such
that the stent does not degrade before an endothelial layer forms
in the stented vessel or structure in cases in which stenosed
aortoiliac arteries with lengthy affected segments are treated. The
material chosen may be chosen to be compatible with surrounding
tissue in the vessel as well as with blood.
[0211] The body of a biodegradable stent may be formed by plain
weave using the methods above described. The size of the filaments
used may vary according to the application. In some embodiments,
the filaments may be reduced in size in comparison to the size of
wires used in comparable applications involving non-biodegradable
devices. In other embodiments, the number of filaments used may be
increased in comparison to the number of wires used in comparable
applications involving non-biodegradable devices.
[0212] The minimum number of filaments that may be used to create
the body of a biodegradable device (including stents, occluders and
filters) may be about 5. In one embodiment, 12 filaments may be
used. With regard to stents, in creating the body using plain
weave, the angle of the crossed filaments (described above as angle
a) may vary as described above, but is typically 150-160.degree..
In one embodiment, the angle of the crossed filaments may be as
large as possible to achieve the largest radial force possible and
further ensure that the stent may have enough expansile force to
remain in place after being delivered. The filament ends, after
plain weaving is complete, may be coupled together to form closed
structures using any suitable means such as by heat treatment or
sealing, gluing, tying, twisting, crimping, taping, or the like. In
another embodiment, a long body may be woven, and the body may be
cut into tubular segments. Closed structures may be formed at both
ends of the segmented bodies by coupling the filament ends together
as above described.
[0213] In one embodiment, the filaments used may be made of
polyglycolic acid ("PGA"), poly-L-lactic acid ("L-PLA"),
polyorthoesters, polyanhydrides, polyiminocarbonates, or inorganic
phosphates. These polymers are commercially available from United
States Surgical Corporation, Norwalk, Conn.; Birmingham Polymers,
Inc., Birmingham, Ala.; and Ethicon, Sommerville, N.J., for
example. One factor to consider in choosing a material from which
to make the filament will be the goal of the stent placement. For
example, in an embodiment in which the stent serves mainly as a
drug delivery system, PLA may be used because of its rapid
degradation time. In another embodiment in which the stent serves
mainly to maintain the patency of the vessel (i.e., keeping the
vessel open) and as a scaffold or frame for the development of a
new endothelial layer, PGA may be used considering its high
strength and stiffness. In other embodiments, glycolide may be
copolymerized with other monomers to reduce the stiffness of the
resulting fibers that may be used.
[0214] In another embodiment, any of these filaments may be
provided with about 0.05 to 0.25 percent by weight of a basic metal
compound, such as calcium oxide, calcium hydroxide, calcium
carbonate, calcium phosphate, magnesium oxide, magnesium hydroxide,
magnesium carbonate, magnesium phosphate, sodium phosphate,
potassium sulfate or the like, to increase the in vivo strength
retention of the biodegradable stent by about ten to twenty percent
or more, as described in U.S. Pat. No. 5,478,355 to Muth et al.
(1995), which is hereby expressly incorporated by reference. As
used herein, "in vivo strength retention" refers to the ability of
a biodegradable body to retain its strength (i.e., the breaking
load of the body) after being implanted or delivered into a living
creature. In yet another embodiment, a filament obtained from a
polymer containing about 15 to about 30 mole percent glycolide in a
melt spinning operation, as described in U.S. Pat. No. 5,425,984 to
Kennedy et al. (1995), which is hereby expressly incorporated by
reference, may be used to form a biodegradable body.
[0215] The filaments of the biodegradable devices may incorporate
one or more drugs that positively affect healing at the location
where the stent is delivered. In one embodiment, these drugs may
include anticancer drugs such as paclitaxel (which is commercially
available as TAXOL, from Bristol-Myers Squibb in Princeton, N.J.)
or docetaxel (which is commercially available as TAXOTERE, from
Phone-Poulenc Rorer in Collegeville, Pa.), fibroblast/smooth muscle
cell proliferation-preventin- g agents, and antithrombogenic drugs
such as heparin which is commercially available from Wyeth-Ayers in
Philadelphia, Pa.
[0216] One or more drugs may be incorporated into a polymer using
any suitable means. For example, in one embodiment, the drugs as a
solute may be dissolved in the biodegradable polymer as a solvent
to form a solution. The solution may then be hardened into a fiber
from which the stent may be woven. In another embodiment, simple
mixing or solubilizing with polymer solutions may be utilized. The
drugs may also be dispersed into the biodegradable polymer during
an extrusion or melt spinning process. In yet another embodiment,
the biodegradable fibers that have already been formed may be
coated with drugs.
[0217] The biodegradable filaments may be rendered radiopaque to
facilitate their monitoring under fluoroscopy and/or their
follow-up using radiographs, fluoroscopy, or computerized
tomography. The methods described above for incorporating the drugs
into the polymer may be used to mix radiopaque salts, such as
tantalum, with the polymer.
[0218] As used herein, "degradation time" refers to the time during
which the biodegradable device maintains its mechanical integrity.
One factor that should be considered in choosing a polymer in light
of its degradation time is that the polymer will loose its
mechanical integrity before it is completely absorbed into the
body. For example, pure polyglycolide (PGA) sutures lose about 50%
of their strength after 2 weeks, and 100% at 4 weeks, and are
completely absorbed in 4-6 months. For vascular applications (i.e.,
applications in which the stent is placed within a vessel in a
body), polymers having degradation times of about one to
twenty-four months may be used, depending on the application. In a
typical embodiment, a polymer having a degradation time of about
one to three months may be used. In choosing a polymer for
non-vascular applications such as the esophagus, colon, biliary
tree, ureter, etc., one should consider the polymer's ability to
withstand the chemical stimuli in the given environment.
[0219] During the degradation time of a biodegradable stent, a new
endothelial layer may form on the surface of the stent. The rate of
the release of the drugs which may be incorporated into the
polymers may be controlled by the rate of degradation of the
biodegradable material used. Thus, the rate of release of a drug
may act as a control quantity for the rate of degradation. At the
same time, other agents such as fibronectin from human plasma
(commercially available from Sigma, St. Louis, Mo.) may be added to
the polymer used (using any suitable means described above for
incorporating drugs into the chosen polymer) and may affect the
rate of biodegradation. For example, fibronectin may accelerate the
growth of cells around the surrounding stent, which, in turn may
accelerate the resorption reactions around the stent.
[0220] In one embodiment of a biodegradable body according to the
present invention, one or more shape memory wires may be added to
the body for reinforcement after it is formed using plain weave.
Such wires may comprise nitinol or any other comparable material
above described. In one embodiment, the wires may be formed from
nitinol having about 55 to 56% Nickel and 45 to 44% Titanium (Shape
Memory Applications). The wire or wires may be incorporated into
the woven biodegradable body by threading the wire in and out of
openings in the body several times. In one embodiment, the manner
in which the wire is threaded in and out of openings in the body is
shown in FIG. 31. In FIG. 31, designation 520 shows reinforcement
wire 510 passing outside biodegradable body 500, and designation
530 shows reinforcement wire 510 passing inside biodegradable body
500, thus showing how wire 510 may be threaded in and out of
openings in body 500. As shown in FIG. 31, the reinforcement
wire(s) 510 may be led between (i.e., parallel to) two
biodegradable filaments 540 and may follow their helical course. As
shown in FIG. 31, reinforcement wire 510 may be secured to body 500
with loops 550, or any other suitable means such as tying,
twisting, or the like. Loops 550 may be placed around a filament or
around the intersection of one or more filaments. As a result, the
wire can move in harmony with the weave and will not interfere with
the movement of the filaments in the weave. By activating the
superelasticity or thermal shape memory of reinforcement wire 510,
ends 560 and 570 of body 500 may be pulled together, resulting in a
tighter weave. As a result, the expansile force of the stent and
its resistance to outer compression may significantly increase. In
one embodiment, loops 550 may also be used in securing body 500 to
a delivery system.
[0221] In another embodiment shown in FIG. 32, in which a
reinforcement wire is threaded in and out of openings in a
biodegradable body according to the present invention,
reinforcement wire 510 may be bent at a selected point located
between its ends, typically at about the mid-point of the wire, and
a small loop 512 may be created (similar to the small closed loops
described above). As shown in FIG. 32, small loop 512 may be
entwined around a filament or the intersection of one or more
filaments, and reinforcement wire 510 may be threaded in and out of
the openings in body 500 as described above, and may be secured to
body 500 with loops 550, or any other suitable mean, as above
described. Both portions 514 of reinforcement wire 510 may be
symmetrically led along both sides of body 500 following the
sinuous/helical course of the biodegradable filaments. As described
earlier, by activating the superelasticity or thermal shape memory
of reinforcement wire 510, ends 560 and 570 of body 500 may be
pulled together, resulting in a tighter weave. As a result, the
expansile force of the stent and its resistance to outer
compression may significantly increase. In one embodiment, loops
550 may also be used in securing body 500 to a delivery system.
[0222] In one embodiment, the size of reinforcement wire 510 may
range from about 0.005 inches to about 0.012 inches. It is to be
understood that increasing the size of reinforcement wire 510 may
increase the force with which ends 560 and 570 are pulled together
when the shape memory of the wire is activated. It is to be
understood that using more than one wire may have the same effect
as increasing the size of the wire.
[0223] In one embodiment, reinforcement wire(s) 510 may be formed
around a template as above described. The reinforcement wire(s) may
then be programmed with superelasticity or shape memory as
described herein.
Bench-Work
[0224] With regard to the biodegradable version of the stents
according to the present invention, the inventors have used an
open-ended plain woven nylon body (that is, the filament ends were
not coupled together to form closed structures after weaving) for
initial bench work. The tubular body was woven using 0.007 inch
nylon filaments. The number of filaments used was 16, and the
unconstrained diameter of the tube was 11 mm. In an unconstrained
state, the size of the weave holes was approximately 1 mm. The
expansile force of the tube was relatively good, and after maximum
elongation the tube readily reverted to its unconstrained diameter.
Compressing the tube from its two ends longitudinally, the
expansile force could be increased considerably. At the maximal
longitudinal compression, the diameter of the tubular mesh was 13
mm. Holding both ends of the tube, the stent became virtually
incompressible.
[0225] A 0.006" nitinol wire was threaded through the holes of the
unconstrained mesh in the manner described earlier. The wire was a
straight nitinol wire and was not formed on a template and
programmed with either shape memory or superelasticity. The
straight wire caused the mesh to elongate and the unconstrained
diameter of the tube decreased to 9.5 mm (13% lumen-loss) though
the other characteristics of the mesh did not change. The woven
tubular structure could be elongated completely as well as
compressed maximally.
[0226] 1.5 Occluders
[0227] With reference to the illustrative embodiments shown in
FIGS. 33A-G, 34, and 35, there are shown occluders for insertion
and delivery into an anatomical structure. An occluder according to
the present invention may be used to substantially or completely
prevent the flow of blood through a vessel. Body 700 of the
occluder may be formed using plain weave by the methods above
described. The types of structures into which an occluder according
to the present invention may be placed include arteries, veins,
patent ductus arteriosus, and the ureter.
[0228] In one embodiment of the present invention, an occluder may
be formed by weaving a body for use as a stent as above described.
The body may then be heated and allowed to cool as above described.
The body may then be remodeled (i.e., mounted on another template
in a manner similar to the manner in which the body was coupled to
the first template (e.g., using a copper support wire)), and
reheated and cooled in a manner similar to the original heating and
cooling. The template that may be used in the remodeling may have
the desired shape of the occluder in one embodiment. In another
embodiment, a tubular template, preferably with a smaller caliber
than that of the original template, may be used. In this
embodiment, after securing one end of the body to the template
using support wire or any other suitable means, the distance
between the two ends of the body may be appropriately decreased. As
a result, the mid-portion of the body will balloon outward (FIG.
33B). Depending on the distance between the two ends of the body, a
series of different shapes may be created. The shapes may include a
round shape (FIG. 33A), an elongated fusiform shape (FIG. 33B), a
compressed fusiform shape (FIG. 33C), a compressed fusiform shape
with an inverted distal end (FIG. 33D), a flat disc configuration
(FIG. 33E), a shape in which the proximal end of the occluder is
inverted into the body of the occluder (FIG. 33F), a torpedo shape
(FIG. 33G), etc. After achieving the desired shape of the body, the
other end of the body may also be secured to the template. The
body/template unit may then be heated and cooled again. The heating
temperatures and times disclosed above may be utilized.
[0229] To increase the thrombogenicity of the occluder, (i.e., the
ability of the occluder to prevent the flow of fluid) thrombogenic
materials in the form of an occluding agent may be enclosed within
the body. Any suitable material may be used for the occluding
agent. The size and shape of the occluding agent may be varied
according to need. In one embodiment, one or more threads of
polyester may by used as an occluding agent. The threads may be
coupled to the body at one or both of the ends of the body using
any suitable means such as sutures. The threads may also be placed
loosely within the body. In another embodiment, DACRON threads may
be used as an occluding agent. The DACRON may be coupled to the
body at one or both ends of the body using any suitable means such
as monofilament sutures, glue, or the like. The DACRON may also be
placed loosely within the body.
[0230] In one embodiment of the present invention, a stretchable
jacket may be configured to cover at least a portion of the body of
an occluder (FIG. 34). Any suitable material may be used for the
jacket. In one embodiment, the jacket may be made of polyurethane.
In another embodiment, the jacket may be made of silicone. The
jacket may have a thickness of about 0.02 mm, but it will be
understood that any suitable thickness may be substituted therefor.
The jacket may be coupled to either the inner or outer surface of
the body using glue, heat, or any other suitable means. In one
embodiment, by coupling the jacket to the outer surface of the
body, the body may be easily manipulated within a hollow covering
such as a sheath during the insertion and delivery of the
occluder.
[0231] The closed structures of the ends of the body used as the
occluder may be held together using any suitable means. In one
embodiment, a monofilament suture (polypropylene, Prolene 5-0, 6-0,
7-0, from Ethicon) may be used to hold the closed structures of the
body together by threading the suture through the closed structures
or other nearby openings. In another embodiment, metal clips 710
may be used to hold the closed structures of the body together
(FIG. 35). In holding the closed structures together, in one
embodiment, the closed structures may be held together such that
the tubes of the delivery system (described in detail below) may
easily pass through the lumen of the occluder. In another
embodiment, the closed structures of the ends of the body may not
be held together.
[0232] During deployment of such as occluder, the interventionalist
is always able to correct any misplacement by simply restretching
the wire mesh and repositioning the body using the delivery system.
Even after the distal end of the occluder has been released, the
proximal end still remains attached to the delivery system offering
another safety feature for removal of the occluder.
[0233] The single wire embodiment may also be utilized as a
structure for causing vessel occlusion. Such an occluder should
have at least two loops. FIGS. 57A-D illustrate various single wire
embodiment occluders. FIG. 57A illustrates body 700 on template 300
after having been formed thereon using, for example, either the
hand weave or machine weave method described above. As shown, body
700 of the occluder has 3 loops. At this stage of the development
of the occluder illustrated in FIG. 57A, body 700 is simply a
single wire embodiment stent.
[0234] After the body/template unit has been annealed using, for
example, the annealing method described above for imparting body
700 with superelastic properties, body 700 may be removed from
template 300. Body 700 may then be stretched by pulling the two
ends thereof longitudinally apart, and collars 702 may be slipped
over either end and placed at the locations where first segment 704
and second segment 706 cross each other. Collars 702 may be small
pieces of metal, such as small pieces of a nitinol tube
(commercially available from Shape Memory Applications, Santa
Clara, Calif.). In doing this, segments 704 and 706 extend between
the loop-defining locations hidden by collars 702 so as to form
loops 710. A collar 702 may also be placed around the ends of the
wire forming body 700. At the loop-defining locations, which are
hidden by collars 702, segments 704 and 706 may be positioned
adjacent to each other. As used herein, segments that are
"adjacent" to each other may or may not touch each other, but such
segments are positioned in close proximity to each other such that
the distance separating them is generally no more than about 1 mm.
The length of the wire segments covered by collars 702 should be
sufficiently short so as not to impede the flexibility of the
single wire embodiment occluder.
[0235] Although not shown, it will be understood to those of skill
in the art, with the benefit of this disclosure, that any suitable
means may be used to secure segments 704 and 706 adjacent to each
other in the loop-defining locations. Such means include wrapping
the segments together with any suitable wire, crimping a piece of
metal around the segments, welding the segments together, and the
like.
[0236] With collars 702 in place, the shapes of loops 710 are
altered such that loops 710 possess generally compressed shapes. As
shown in FIG. 57B, the two largest of the three loops 710 have
fairly pronounced compressed shapes relative to the smallest loop
710. The compressed shape may exaggerated (i.e., made more
compressed) by decreasing the distance between collars. Laterally
pulling the portions of segments forming a given loop apart may be
done to alter the distance between collars. The collars should
maintain the shapes of the loops and thereby stabilize the occluder
within the anatomical structure into which it is delivered.
However, the collars may be crimped to further improve their
ability to maintain the shapes of the loops. In this same regard,
body 700 may be secured to a template having a suitable shape and
re-annealed so that the compressed shapes of loops 710 are
maintained. Further, re-annealing body 700 may improve the
expansile force and resulting self-anchoring capability of the
single wire embodiment occluder.
[0237] The number of loops utilized to form a single wire
embodiment occluder may be reasonably increased. For example, an
occluder formed using the single wire embodiment may have 3, 4, 5,
6 or more loops.
[0238] The shape of the loops of the single wire embodiment
occluders may be varied as desired to best cover the cross-section
of the anatomical structure to be occluded in a manner that will
likely cause occlusion in the most rapid manner possible.
Accordingly, a single wire embodiment occluder may have loops that
possess differing sizes, such as an occluder having one or more
loops near one end that are smaller than one or more loops near the
other end of the occluder. As used herein, the total length of the
segments that define a loop that is "smaller" than another loop of
a single wire embodiment is less than the total length of the
segments that define the larger loop. In another embodiment, the
occluder may appear tapered, where the loops decrease in size from
one end to the other. In another alternative embodiment, one or two
small loops may be arranged at or near the mid-portion of a single
wire embodiment occluder, while the loops at the proximal and
distal ends may be larger by comparison and possibly equal to each
other in terms of size.
[0239] In order to increase the thrombogenicity of the single wire
embodiment occluders, various occluding agents may be attached to
the occluder. Any suitable material may be used for the occluding
agent. For example, pieces of a metal coil, such as one made from
stainless steel, may be pulled over the wire segments prior to
slipping collars over them. In this regard, the single wire
embodiment occluder may be re-annealed as described above, the
collars may be removed, the coil pieces may be placed over the
segments, and the collars may be replaced at the loop-defining
locations. As illustrated in FIG. 57C, coil pieces 714 are placed
over the segments between collars 702. The coil pieces may also be
wires, such as stainless steel or nitinol wires, that are manually
wrapped around the segments and attached to the segments in any
suitable fashion. The coil pieces may be pre-formed hollow pieces
of coil made from any suitable metal or alloy.
[0240] Thrombogenic filaments (such as polyester fibers) may also
be attached to coil pieces 714 to further increase the
thrombogenicity of the single wire embodiment occluders. As
illustrated in FIG. 57D, polyester fibers 716 are attached to coil
pieces 714 at various locations along the coil pieces. The length
of the thrombogenic filaments may vary, as may the distance between
the filaments, in order to ensure that the resulting
thrombogenicity of the single wire embodiment occluder is
best-suited to the application. The thrombogenic filaments may be
individual fibers or bundles of fibers.
[0241] In another embodiment, segments of the single wire
embodiment occluder may be covered by bundles of thrombogenic
filaments, such as filaments made of polyester, such that the
bundles resemble the coil pieces, and additional thrombogenic
filaments, such as polyester fibers, may be attached to or braided
with the bundles of filaments such that they extend away from the
covered segments in the same fashion as fibers 716 illustrated in
FIG. 57D.
Delivery Systems for Stents, Stent Grafts and Occluders
[0242] With reference to FIG. 3, the delivery system 20 for body
10, tapered body 100 and body 700 (including biodegradable versions
thereof), may consist of two flexible tubes arranged coaxially.
These tubes may be formed of material such as TEFLON or NYLON,
which are commercially available from Cook, Inc. (Bloomington,
Ind.), or other similarly suitable materials. It is to be
understood that material that is less flexible or firmer than
TEFLON may also be used. Further, it is to be understood that
material with a thinner wall thickness than that of TEFLON tubing,
such as the material from which the WALLSTENT delivery system is
formed, may be utilized. In one embodiment, one or both tubes may
be made of metal, such as nitinol, which is commercially available
from Shape Memory Applications. Nitinol tubes may be particularly
well-suited for use in delivery systems that are relatively large
or rigid, such as for tracheal or bronchial stenting.
[0243] The size of the outer diameter of the distal, small caliber
tube 22 may range from 2.5 to 7.5 French ("F") depending on the
application of the stent, the size of the stent, and the number of
securing wires (to be discussed below) that may be used to secure
the stent to tube 22 (to be discussed below). For coronary
applications, for example, the size of tube 22 may be about 3-F.
For delivery of a medium stent into the renal or carotid arteries,
for example, the size of tube 22 may be about 5-F. The length of
tube 22 may range from 80 cm to about 120 cm depending on the
application of the stent and the size of the stent. In an exemplary
embodiment, for example, for delivery of an iliac artery stent from
a contralateral approach, the length of the tubing may be about 90
cm. In another exemplary embodiment, for carotid artery stenting,
the length of the tubing may be about 110 cm. The size of the stent
may also have affect the length of tube 22. Thus, in an exemplary
embodiment, the larger the stent diameter, the longer the stent is
in its completely elongated state.
[0244] Tube 22 as well as tube 40 (discussed below) may be provided
with a flange or hub near its proximal end so as to allow for
control of the position of tube 22 during delivery of the stent. In
an exemplary embodiment as shown in FIG. 25, a push button
lock/release mechanism 200 (such as a FloSwitch.RTM. HP device from
Meditech/Boston Scientific Corp., Watertown, Mass. or a CRICKETT
device from Microvena in White Bear Lake, Minn.) may be utilized
for securing tube 40 to tube 22 when necessary. As further
illustrated in FIG. 25, an end fitting 204 with a side arm may be
utilized with a Luer-lock mechanism and/or tightening screws for
further facilitating delivery of the stent. Although not shown, it
will be understood by those of skill in the art, with the benefit
of this disclosure, that the hub or flange that may be provided on
the end of tube 22 may be used to facilitate the connection between
end fitting 204 and tube 22. Similarly, although not shown, it will
be understood by those of skill in the art, with the benefit of
this disclosure, that the end of tube 40 may be provided with a hub
or flange that may be used to facilitate the connection between
push button lock/release mechanism 200 and tube 40. End fitting 204
may be equipped with separated lumens in a double channel system.
One or more steerable guidewires 203 may be utilized in the lumen
of tube 22 and in the lumen of end fitting 204 for facilitating
delivery of the devices described herein.
[0245] It is to be understood that radiopaque markers may be placed
on tube 22 at appropriate locations in a manner known in the art in
order to better enable viewing of tube 22 using fluoroscopy during
delivery of the stent.
[0246] As shown in FIG. 3, the distal, smaller caliber tube 22 is
equipped with proximal hole 24 and distal hole 26. Distal hole 26
may be typically located between about 0.5 and about 3.0 cm from
distal end 28 of tube 22, most typically about 1 cm. The location
of the radiopaque markers on tube 22 may affect this distance. The
distance between holes 24 and 26 may be typically about 3 to 8 mm,
but most typically about 3 to 5 mm. This distance may be affected
by the size of the securing wire 30. For example, the distance
between the holes may decrease as the diameter of wire 30
decreases.
[0247] Securing wire 30 may be placed within the lumen of tube 22
(the dotted line indicates that securing wire 30 is located within
tube 22), and may pass through holes 24 and 26 so as to form a
small-profile, tight securing loop 32 between the two holes. Distal
end 34 of securing wire 30 terminates at or near distal end 28 of
tube 22. Proximal end of securing wire 30 may be connected to a
handle 206 as shown in FIG. 25.
[0248] Securing loop 32 holds the small loops (6 and 106) or bends
(8 and 108) of distal end (12 or 102) of body 10 or tapered body
100 in position during delivery (delivery being described in more
detail below.) Advantageously, securing loop 32 also prevents
premature delivery of the stent. Thus, prior to delivery of the
stent, distal end 34 of securing wire 30 passes out through
proximal hole 24, passes through the small loops or bends of the
stent, and passes back into the lumen of tube 22 through distal
hole 26, terminating prior to distal end 28, thus securing the
distal end of the stent to tube 22. It is to be understood that
securing wire 30 may pass through one of the openings in the plain
weave of body 10 or tapered body 100 other than the small loop (6
and 106) or bend (8 and 108).
[0249] In most applications, securing wire 30 ranges in size from
about 0.006 inches to about 0.011 inches in diameter. However, the
size of securing wire 30 in any given application depends upon
several factors. For example, a larger (in terms of diameter)
securing wire provides more resistance to the propensity of a
stretched stent to contract than does a smaller wire. Additionally,
when more than one securing wire is utilized, the size of the wires
can be less than if only one securing wire were used. The securing
wires of the present invention may be made of any of the shape
memory materials described above. In one embodiment, the securing
wires of the present invention are made of nitinol. In another
embodiment, the securing wires of the present invention may be
formed of nitinol having about 55 to 56% Nickel and about 45 to 44%
Titanium (commercially available from Shape Memory Applications).
In an embodiment in which the securing wires of the present
invention are nitinol (including wires 30 and 46, discussed below),
the nitinol securing wires may be heat treated as described herein
or purchased from a manufacturer such that the superelastic
properties of the nitinol may be utilized.
[0250] The proximal, larger caliber tube 40 is also equipped with
proximal and distal holes 42 and 44 typically located in
approximately the same location from distal end 41 of tube 40 as
are holes 24 and 26 from distal end 28 of tube 22. The distance
between holes 42 and 44 is also comparable to the distance between
the holes in tube 22.
[0251] The size of the outer diameter of the proximal tube 40 may
range from about 4.5-F to about 10-F depending on the application
of the stent, the size of the stent, and the number of securing
wires that may be used to secure the proximal end of the stent to
tube 40 (to be discussed below). For coronary applications, for
example, the size of tube 40 may be about 5-F. In an exemplary
embodiment, for carotid artery stenting, the size of tube 40 may be
about 7 to about 8-F. The length of tube 40 may range from about 70
cm to about 110 cm depending on the application of the stent and
the size of the stent. In an exemplary embodiment, the length of
tube 40 may typically be about 10 cm to about 20 cm shorter than
the length of tube 22. It is to be understood that the proximal end
of tube 22 may extend beyond the proximal end of tube 40, just as
distal end 28 of tube 22 extends beyond distal end 41 of tube 40 as
shown in FIG. 3. In an exemplary embodiment, the factor that may
primarily influence the length of the delivery system (i.e., tubes
22 and 40) is the distance of the stented region from the access
site (typically the femoral artery). As with tube 22, tube 40 may
be provided with a flange or hub near its proximal end so as to
allow for control of the position of tube 40 during delivery of the
stent.
[0252] It is to be understood that radiopaque markers may be placed
on tube 40 at appropriate locations in a manner known in the art in
order to better enable viewing of tube 40 using fluoroscopy during
delivery of the stent.
[0253] Securing wire 46 is positioned with the lumen of tube 40,
and forms small-profile, tight securing loop 48 in the manner above
described. Securing loop 48 holds closed structures (4 and 104) of
proximal end (2 and 112) of body 10 and tapered body 100 in
position during delivery, and advantageously prevents premature
delivery of the stent. It is to be understood that securing wire 46
may pass through one of the openings of the plain weave of body 10
or tapered body 100 other than the closed structures. The closed
structures are secured using the manner described above for the
loops or bends.
[0254] Securing wire 46 and securing wire 30 may be formed from the
same materials as the wires making up the stent. Additionally,
securing wire 46 may be approximately the same size as securing
wire 30, and the same types of factors discussed above should be
considered in sizing securing wire 46.
[0255] In FIG. 3, although only one securing loop is shown on
either tube, it is to be understood that more than one securing
loop may be utilized on each tube to secure the proximal and distal
ends of the stent. More securing loops may be achieved with the
same securing wire, or by using more securing wires. As discussed
above, the number of securing wires that may be used may depend on
several factors, such as the amount of force needed to elongate or
constrain the stent prior to delivery. For example, the more
resistant the stent is to elongation, the more securing wires may
be used in order to facilitate the stretching or elongation of the
stent on the delivery system. By this means, the ends of the stent
can be suspended evenly around the tubes and the friction between
tubes and the profile of the elongated stent can be reasonably
decreased. An additional factor affecting the number of securing
wires may be the use of a guidewire (described below). In an
exemplary embodiment of the delivery system according to the
present invention, a guidewire may be utilized during delivery
(described below). As a result, the use of a guidewire will affect
the amount of space within tube 22 available for the use of the
securing wire or wires. It is also to be understood that securing
wires having tapered distal ends may be used no matter how many
securing wires are used.
[0256] Body 700 may be secured to the delivery systems of the
present invention the delivery system depicted in FIG. 3, in the
same manner in which body 10 and tapered body 100 may be secured to
these delivery systems as above described. In one embodiment in
which the ends of body 700 are secured to tubes 22 and 40, one
small-profile, tight securing loop may be used to secure each
end.
[0257] With reference to another illustrative embodiment of the
delivery system according to the present invention shown in FIG. 4,
delivery system 50 has tube 22 equipped with proximal and distal
holes 24 and 26 in the manner above described. As shown, delivery
system 50 may consist of thin-walled sheath 52 arranged coaxially
with tube 22. Sheath 52 may be formed of materials comparable to
those from which tubes 22 and 40 are formed. Sheath 52 may be about
1 cm to about 2.5 cm in length, but typically about 1.5 cm. The
distal end 54 of sheath 52 is connected or attached to tube 22 by
gluing, melting, heating or any other suitable means at a location
typically between about 8 cm to about 20 cm from distal end 28 of
tube 22, but most typically about 15 cm.
[0258] As shown in FIG. 4, delivery system 50 may consist of
inverse tabs 60 which are connected to or engaged with the distal
end of tube 40. Inverse tabs 60 are connected to or engaged with
tube 40 by any suitable means, including the use of a metal ring
friction fitted around tube 40, to which tabs 60 may be soldered,
welded, or integrally formed. Inverse tabs 60 are connected or
engaged with tube 40 at a location that may be determined based on
the completely stretched length of the stent. Inverse tabs 60 may
be made of any suitable material, including those from which the
wires of the stent may be made, and further including stainless
steel and other similar materials.
[0259] The following description applies to both body 10 and
tapered body 100. However, reference is made only to body 10 by way
of example. Inverse tabs 60 secure proximal end 2 of body 10 in the
following general manner. Inverse tabs 60 are placed within the
lumen of body 10. Proximal ends 62 of inverse tabs 60 are then
"threaded" through closed structures 4 or other holes located near
the proximal end 2 of body 10. Tube 40 is then moved in a proximal
direction until closed structures 4 (or other holes) are secured by
the inverse tabs. The space created between sheath 52 and tube 22
may be used to house inverse tabs 60 as below described.
Delivery of the Stents, Stent Grafts and Occluders
[0260] Body 10 and tapered body 100 (including biodegradable
versions thereof), and body 700 may be delivered in a similar
manner. Thus, the following description of methods of delivery for
the stents and occluders references only body 10 by way of
example.
[0261] Prior to delivery, a stent in the form of body 10 may be
manually secured to tubes 22 and 40. This may be accomplished by
using either securing loops in the manner described above with
reference to FIG. 3 (hereinafter "version 1"), or by securing loop
32 and inverse tabs 60 in the manner described above with reference
to FIG. 4 (hereinafter "version 2").
[0262] In either version, a stent is first stretched so as to
reduce its diameter by an amount appropriate to allow delivery to
occur. Thus, the stent may be stretched maximally or just to an
extent such that it may be inserted into a vessel or non-vascular
structure, and may pass through the lumen of the vessel or
non-vascular structure as the stent is being positioned prior to
being delivered into the vessel or non-vascular tubular structure.
When delivering the single wire embodiment discussed above, it
should be noted that the ratio of the constrained length of the
body to the unconstrained length of the body may be significantly
greater in this embodiment than in the embodiments that utilize
multiple wires. Therefore, the single wire embodiment may require a
greater length within the vessel or non-vascular structure in which
to be manipulated and prepared for delivery than may other
embodiments that utilize multiple wires.
[0263] The stent to be delivered may be stretched by increasing the
distance between the distal ends of tubes 22 and 40. This may be
accomplished by moving or sliding tube 40 in a proximal direction
over tube 22 while holding tube 22 stationary, or by moving or
sliding tube 22 in a distal direction while holding tube 40
stationary, or by moving or sliding the tubes in the aforementioned
directions simultaneously. Once the stent has been appropriately
stretched, tubes 22 and 40 may be locked together in a manner well
known in the art, such as with the use of tightening screws or push
button mechanisms which are easily lockable and unlockable. If
version 2 is used, an outer sheath 70 as shown in FIG. 5A may be
used to cover inverse tabs 60.
[0264] In an illustrative embodiment, it is preferable to use a
guidewire placed through the lumen of tube 22 for use in guiding
the stent to its proper location in a manner well known in the art.
The guidewire may be formed of any material from which the wires
forming the stent may be made. The guidewire may be between about
0.014 inches and about 0.035 inches in diameter. In one embodiment,
the guidewire may be made of nitinol (commercially available from
Microvena). In another illustrative embodiment, a hollow covering
such as a sheath may be placed over a stent secured to tubes 22 and
40 so as to prevent contact between the stent and the vessel or
non-vascular structure during delivery of the stent.
[0265] The first step of inserting either delivery system into the
body is to establish an access (arterial or venous). After
puncturing the vessel using an adequate needle, a guidewire is
inserted into the body. The needle is removed, and over the
guidewire an introducer sheath with a check-flow adapter and
preferably with a side-port is advanced. The guidewire is then
removed. This introducer sheath, the size of which is determined by
the size of the delivery system to be used, serves as an access for
the intervention.
[0266] In version 1, when the stent, still stretched on delivery
system 20, is positioned in the desired location of the vessel or
non-vascular tubular structure to be stented, the sheath covering
the stent may be withdrawn, and the tubes may be unlocked. The
stent may be positioned and then shortened so as to achieve its
unconstrained diameter in a variety of manners. In an exemplary
embodiment, the distal end of the stent may be positioned in its
final location prior to shortening the stent. Then, while
maintaining the position of the distal end of the stent, tube 40,
to which the proximal end of the stent is secured, may be moved
distally over tube 22. As a result, the distance between the two
ends of the stent will be shortened and the diameter of the stent
will approach, and may reach, its unconstrained, preformed
diameter. In another embodiment, the proximal end of the stent may
be positioned in its final location prior to shortening the stent.
As such, tube 40 may be held steady and tube 22 may be moved
proximally within tube 40 in order to shorten the stent. In another
embodiment, the middle of the stent may be positioned in its final
location prior to shortening, and tubes 22 and 40 may be moved
toward each other by equivalent distances. The many manners in
which the stent may be positioned and subsequently shortened during
delivery thereof benefit the operator by providing him or her with
the versatility necessary to deliver stents within a variety of
anatomical structures.
[0267] The ability to compress the woven devices disclosed herein
with the present delivery systems prior to releasing them is
advantageous for several reasons. Not only does it assist the
operator in achieving adequate contact between the woven device and
the wall of the anatomical structure such that the woven device is
anchored as securely as possible, it also allows the compressed
device to occupy the least amount of space along the length of the
anatomical structure as possible. When using the present occluders,
for example, care should be taken to limit the space along the
length of the structure where occlusion is taking place so as to
avoid potential complications like the undesired occlusion of side
branches, and the prevention of the formation of collateral vessels
supplying the structures not affected by the treated lesion.
Further, when using the present filters, for example, the space
along the vessel available for filter placement may be limited by
the presence of the thrombotic disease and/or other anatomical
considerations, such as the proximity of renal veins in the IVC,
the short, free segment of the SVC, etc.
[0268] Another advantage afforded by the present delivery system
relating to the ability of an operator to manipulate either or both
ends of the woven body being delivered prior to releasing those
ends is the ability afforded the operator to position the present
woven devices accurately in irregularly diseased anatomical
structures. Anatomical structures are frequently irregularly
stenosed; the distensibility or enlargeability of the diseased
segment may be irregular due to the presence of tough scar tissue
or a tumor, for example; and lengthy vessels are naturally tapered.
Because both ends of one of the present woven devices may be
simultaneously manipulated while using the middle of the woven
device as a point of reference prior to release, the operator may
be able to position the mid-portion of the device (such as a stent)
proximate the mid-portion of the diseased segment of the vessel and
maintain that relationship while simultaneously withdrawing tube 22
and advancing tube 40 so as to accurately position the stent along
the diseased segment. Further, by increasing the ability of the
operator to accurately position the woven device and,
correspondingly, reducing the possibility that the woven device
will need to be resheathed and reinserted, the present delivery
systems allow the operator's job of delivery less potentially
disruptive to the diseased segment of the patient.
[0269] Additionally, another advantage flowing from the fact that
the present delivery systems allow for compression of woven devices
lies in the resulting ability of the operator delivering a stent
graft having a relatively non-stretchable graft material like PTFE
to achieve a mesh tightness that, in turn, may serve to create
better contact between both the woven stent and the graft material
as well as between the stent graft and the wall of the anatomical
structure.
[0270] One of the benefits of using the present stents with the
present delivery systems is that the anatomical structure being
treated can always be overstented. The diameter of an anatomical
structure that is "overstented" is slightly smaller than the
unconstrained diameter of the stent delivered therein. In contrast,
overstenting is not necessarily achievable using delivery systems
that do not possess the present delivery systems' capability to
manipulate the distance between the ends of the device being
delivered prior to stent release. Stents that are released using
such delivery systems may remain elongated within the anatomical
structure into which they are delivered and, as a result, may not
have a radial force sufficient to resist outer compression, which
in turn could compromise the patency of the structure. Further,
insufficient radial force could lead to stent migration. With the
present delivery system, however, the present stents, for example,
may be chosen such that their diameter is significantly greater
than one hundred and ten percent of the anatomical structure being
stented (110% being the norm for balloon-expandable stents, for
example), such as one hundred and twenty percent, for example.
Consequently, the present stents may be delivered so as to be
slightly elongated within the anatomical structure in which they
may be delivered (i.e., the mesh tightness of the stent may be less
than the tightest achievable), yet may retain enough expansile
force to keep the structure patent, withstand outer compressive
forces and be unlikely to migrate.
[0271] The overdistention or overstenting of an anatomical
structure using one of the present stents that is substantially or
completely compressed may be beneficial for several reasons. For
example, the overstenting helps ensure that the stent will remain
fixed in its original location and will not likely migrate. The
inventors have discovered that when the present woven bodies are
compressed prior to being released, they contact the anatomical
structure more securely than if they are released without first
being compressed. Further, as the overstenting may be achieved
using a substantially or maximally compressed stent, the
near-maximum or maximum radial force of the stent may also increase
the stent's ability to withstand greater outer compressive forces
without elongating and thereby compromising the patency of the
structure being stented. Although overstenting is described above,
those of skill in the art will understand with the benefit of the
present disclosure that the same principle applies with equal force
to the woven filters and occluders disclosed herein, and the single
wire embodiments of each, and may be achieved in the same
manner.
[0272] The Wallsten patent discloses a delivery system for the
WALLSTENT that allows the distance between the ends thereof to be
manipulated prior to the release of the WALLSTENT. However, this
delivery system (depicted in FIGS. 5 and 6 of the Wallsten patent)
suffers from a number of shortcomings that are overcome by the
present delivery systems. For example, the Wallsten delivery system
involves a number of intricate parts (such as annular members,
latches, rings, cables for displacing the rings, and a casing) that
version 1 does not utilize and that would likely be time-consuming
and expensive to manufacture and assemble. In contrast, the simple
design of version 1--i.e., two tubes and multiple securing
wires--has few parts, and those parts are easily obtainable.
[0273] Another advantage afforded by the present delivery systems
is that the device being delivered is clearly visible during
delivery. No parts, once any delivery sheath has been removed from
around the present delivery systems, obstruct the view of the
location of the ends of the device being manipulated. Additionally,
the profile of the present delivery systems is no greater than that
of the device being delivered over tube 40 (the larger of the
delivery tubes). This is advantageous because the smaller the
profile of the delivery system, the less likely the diseased
segment of the structure will be unnecessarily disrupted or
traumatized during the positioning and delivery of the woven
device.
[0274] It is possible to overstent anatomical structures utilizing
the present delivery systems and present stents through the
longitudinal movement of tubes 40 and 22 in both version 1 and
version 2, the latter of which is described below. As described
above, these tubes may be moved relative to each other such that
the stent being delivered is compressed maximally or nearly
maximally prior to being released.
[0275] If the stent is not in the desired location after reaching
its preformed diameter, it can advantageously be restretched and
repositioned by moving tube 40, proximally and locking tube 40 to
tube 22 if so desired. After locking has occurred, the stent may be
repositioned and the process above described may be repeated as
needed. This process may be complete when the stent is positioned
in the desired location, and the stent fits in the vessel or
non-vascular tubular structure in a way that the stent is nearly
maximally expanded and/or the tissue of the vessel or non-vascular
tubular structure is stretched slightly.
[0276] After performing this process, the distal end of the stent
may then be released from its secured position. The distal end of
the stent may be so released by pulling securing wire 30 (or wires)
back into the lumen of tube 22. If the stent is still in the proper
position, the proximal end of the stent may be released in the same
manner so as to deliver the stent into the vessel or non-vascular
structure, and the delivery system may be withdrawn back into a
sheath and out of the body. If the stent is no longer positioned in
the desired location after releasing the distal end of the stent,
the stent may be pulled proximally back into a sheath by proximally
moving tube 40 to which the proximal end of stent is still secured
and/or distally moving the sheath. After doing so, the stent and
delivery system may be removed from the body.
[0277] It is to be understood that the proximal end of the stent
may be released from its secured position prior to releasing the
distal end of the stent. Upon doing so, however, the ability to
withdraw the stent back into a sheath (if a sheath is used) as
described above is no longer present. Therefore, typically, the
proximal end may be released first when the desired location of the
stent will likely be maintained after such release.
[0278] In version 2, the stretched stent may be positioned in the
desired location of the vessel or non-vascular tubular structure to
be stented. Then, prior to unlocking the tubes, a sheath used to
cover the stent, if used, may be proximally withdrawn so as to
expose the stretched stent. Also prior to unlocking the tubes,
outer sheath 70 covering inverse tabs 60 may be moved proximally so
that inverse tabs 60 are exposed (see FIG. 5A). In an exemplary
embodiment, the outer sheath 70 may be withdrawn but not removed.
The tubes may then be unlocked. It is to be understood that the
tubes may be unlocked prior to withdrawing either a sheath used to
cover the stretched stent, or outer sheath 70. Once this has
occurred, either the distal end or proximal end of the stent may be
released from its secured position as follows. In an exemplary
embodiment, it may be preferable to release the distal end of the
stent first because the secured proximal end may offer the
possibility of removing a misplaced stent as above described. It is
to be understood, however, that because of the completely
controlled nature of the delivery system of the present invention,
the need to remove a misplaced stent may be very low, and,
therefore, the proximal end of the stent may be released first
without great risk.
[0279] When the distal end is to be released first, tube 40 may be
moved distally over tube 22 (see FIGS. 5B and C) until the distal
end of tube 40 reaches a pre-determined point located on tube 22,
which in an exemplary embodiment, may be denoted through the use of
a radiopaque marker. The point is located along tube 22 such that
the proximal end of the stent will not be unhooked from inverse
tabs 60 when the distal end of tube 40 reaches it. When the point
is reached by the distal end of tube 40, the tubes are locked
together. Additionally, another marker may also be used on the
proximal shaft of tube 22 to denote the same point. If the stent is
no longer in its ideal position at this point, outer sheath 70 may
be moved distally and/or tube 40 may be moved proximally to cover
inverse tabs 60, and the delivery system and the stent may be
withdrawn into a sheath and removed from the body. If the proper
position has been achieved, the distal end of the stent may then be
released in the manner above described. Next, the proximal end of
the stent may be released by unlocking the tubes, and moving tube
40 distally over tube 22 until inverse tabs 60 release the openings
or closed structures through which they were threaded. Tube 40 may
then be further advanced distally until inverse tabs 60 are hidden
or housed within sheath 52 as shown in FIG. 5D. At this point, the
tubes may be locked together to maintain the position of the
inverse tabs within sheath 52. After both ends of the stent have
been released (see FIG. 5E), delivery system 50 may be withdrawn
into a sheath and removed from the body.
[0280] In version 2, if the proximal end of the stent is to be
released first, the sequence of events just described may occur
(including the ability of the stent to be restretched and
repositioned), except that the distal end of tube 40 may extend
distally beyond the predetermined point such that inverse tabs 60
unhook the proximal end of the stent and then go on to being hidden
or housed within sheath 52 as shown in d. of FIG. 5. After the
proximal end has been released, the distal end of the stent may be
released in the manner above described. At this point, the tubes
may be locked together to maintain the position of the inverse tabs
within sheath 52. Delivery system 50 may then be withdrawn from the
body as above described.
[0281] The delivery of the present stent grafts that utilize graft
material that is stretchable as described above may be achieved
with the same delivery systems and in the same manner as the
delivery of the present "naked" stents. When a graft material that
is formed from relatively non-stretchable material, such as PTFE,
is utilized, however, although the same delivery systems may be
utilized, the manner in which the stent graft may be delivered is
slightly different from the manner in which the naked stents may be
delivered in terms of the manner in which the stent graft may be
repositioned, if necessary.
[0282] For example, if after releasing the distal end of the stent
graft, whether the graft material is attached to the stent at the
proximal or distal end thereof, the stent may be restretched over
the delivery tubes and the stent's completely elongated position
may be secured using the proximal lock mechanism. Then, the
introducer sheath may be advanced over the proximal end of the
stent graft, possibly as it is rotated, in order to recapture the
graft material and the stent itself. Attaching the graft material
to the stent at the proximal end thereof may make it easier to
re-sheath the graft material using the process just described, and
thus may facilitate repositioning, if necessary, because the graft
material may take on a funnel shape prior to the release of the
proximal end of the stent graft.
Delivery of Stents in Side-By-Side Relationship
[0283] The delivery of these stents may be accomplished relatively
simultaneously, such that neither stent occupies more space within
the aorta than does the other. Initially, the stents may be secured
to either version of the delivery systems described above using the
methods described above. As illustrated in FIGS. 58A-D, in addition
to securing the ends of the stent to tubes 22 and 40, the stent may
also be secured to either tube (tube 22 as shown, for example) near
the portion of the stent that will be positioned near the bilateral
aorto-renal junction 830, which consists of aorta 832, left renal
artery 834 and right renal artery 836. FIGS. 58A-D illustrate only
one stent being delivered, but it will be understood to those of
skill in the art, with the benefit of this disclosure, that, as
stated above, two stents may be released and delivered relatively
simultaneously in the fashion described below. As shown, guidewire
203 may be utilized to enhance the maneuverability of the delivery
system. (The fittings that may be used to secure tubes 22 and 40 to
each, which are illustrated in FIGS. 25 and 26, are not illustrated
in FIGS. 58A-D for the sake of simplicity.) This third secured
portion may be achieved using the low-profile, tight securing loops
described above. After stretching the stent on the delivery system
and positioning the distal end of the stent in right renal artery
836 in the manner described above (FIG. 58A), the release and
delivery of the stent may take place by first releasing the
proximal end of the stent (FIG. 58B), then the distal end (FIG.
58C), and finally the portion of the stent near junction 830 (FIG.
58D). Tubes 22 and 40 and guidewire 203 may then be withdrawn from
the patient. It will be understood to those of skill in the art,
with the benefit of this disclosure, that the release of the
various secured portions of the stents may take place in any order
suited to the anatomical structure in question.
Combined Treatment of Aneurysms Consisting of Stent Placement and
Transcatheter Embolization
[0284] In one embodiment of the present invention, the straight
stent may be used for aneurysm treatment without being equipped
with a graft material. In this embodiment, the "naked" stent may
serve as a scaffold for developing an endothelial layer on the
newly formed vessel lumen, while the aneurysmal sac may be excluded
from circulation by transcatheter embolization.
[0285] Generally, the stent may be delivered into place, and an
embolic agent 96 may be inserted into the surrounding aneurysmal
sac as shown in FIG. 36.
[0286] As shown in FIG. 36, once the stent is in the appropriate
position, an angiographic catheter 95 (5-French to 7-French) that
is chemically compatible with the embolic agent (and not made from
polyurethane when the embolic agent contains DMSO) may be inserted
and advanced into the lumen of the stent. In advancing the
angiographic catheter into the lumen of the stent, one may use the
same guidewire which may have been used in delivering the stent.
However, one may advance the angiographic catheter without the use
of a guidewire. An adequately sized microcatheter 97 (2-French to
4-French) that is also chemically compatible with the embolic agent
may then be advanced through the angiographic catheter, on an
appropriate size guidewire (0.014-inches to 0.025-inches). The tip
of the microcatheter may then be led through the weave of the stent
into the aneurysmal sac. If the openings in the weave of the stent
are approximately 2.0 to 2.5 mm, angiographic catheter 95 may also
be advanced into the aneurysmal sac. An embolic agent 96 may then
be inserted into the aneurysmal sac through the microcatheter.
Embolic agent 96 may be chosen so as to be: non-toxic,
non-irritant/reactive to the tissues; easily handled; suitable for
continuous injection; adequately radiopaque; capable of filling the
space contiguously without leaving unoccupied spaces; and
non-fragmented, thereby not getting back through the stent's weave
into the newly formed lumen which could result in peripheral
embolization.
[0287] Although, several fluid embolic materials (alcohol,
poly-vinyl alcohol, cyanoacrylates, Ethibloc etc.,) are available
for transcatheter vessel occlusion, none of them is considered
ideal or even suitable for this purpose. Recently, a nonadhesive,
liquid embolic agent, ethylene vinyl alcohol copolymer (EVAL), has
been used clinically for treatment of cerebral AVMs in Japan (Taki,
AJNR 1990; Terada, J Neurosurg 1991). The co-polymer was used with
metrizamide to make the mixture radiopaque and may serve as the
embolic agent for the present invention.
[0288] Very recently, a new embolic agent (similar to EVAL),
EMBOLYX E (ethylene vinyl alcohol copolymer) (MicroTherapeutics
Inc., San Clemente, Calif.) was developed which was designed for
aneurysm treatment (Murayama, Neurosurgery 1998), and may be
utilized as an embolic agent in one embodiment of the present
invention. The embolic agent is composed of a random mixture of two
subunits, ethylene (hydrophobic) and vinyl alcohol (hydrophilic).
Micronized tantalum powder is added to it to obtain an appropriate
radiopacity, and DMSO (di-methyl sulfoxide) is used as an organic
solvent. When the polymer contacts aqueous media, such as blood,
the solvent should rapidly diffuse away from the mixture causing in
situ precipitation and solidification of the polymer, with
formation of a spongy embolus and without adhesion to the vascular
wall. Any kind of material with characteristics similar to those of
EMBOLYX E may be used as an embolic agent for the present
invention.
[0289] The method just described may be utilized when the stent is
covered as well. In such an embodiment, angiographic catheter 95,
which may be 5-F in size, and microcatheter 97, which may be 3-F in
size, may advanced into the lumen of the covered stent as described
above. A trocar, such as one having a 0.018-inch pencil-point or
diamond-shaped tip and made of any suitable material such as
stainless steel or nitinol, may then be inserted into the lumen of
microcatheter 97. The sharp tip of the trocar may extend beyond the
tip of microcatheter 97 by about 2 to 4 mm. The proximal ends of
microcatheter 97 and the trocar may be locked together using a Luer
lock mechanism. By doing so, a sheath-needle unit (well known in
the art) may be created, which may then be used to puncture the
graft material and the stent mesh. Thereafter, using fluoroscopy
and/or CT in guiding the sheath-needle unit, the sheath-needle unit
may be safely advanced into the aneurysmal sac. The trocar may then
be removed, and microcatheter 97 may be used for injecting the
embolic agent as described earlier.
[0290] Both abdominal and thoracic abdominal aneurysms may be
treated as above described. In some other locations (e.g., external
iliac artery), pesudoaneurysm and/or tumor-induced corrosive
hemorrhage may also be treated as above described.
[0291] The size of the delivery system that may be used to deliver
a stent without a graft cover may be sufficiently small, such that
insertion of the stent into the vessel may take place following a
percutaneous insertion. The delivery system would also be
well-suited to negotiating through tortuous vascular anatomy. The
treatment described above may be performed using interventional
radiology techniques, thereby eliminating the need for surgery. The
embolization may occlude the lumbar arteries from which the
excluded aneurysmal sac is frequently refilled. As a result of
using the treatment described above, the endoleak from the patent
lumbar arteries may be eliminated.
[0292] 2. Filters
Low-Profile Woven Cava Filters
[0293] The wires of the cava filters of the present invention may
be made of the same materials as the wires of the stents. The same
number of wires may be used in forming the cava filters as are used
to form the stents. However, in an exemplary embodiment, less wires
are preferably used for the cava filters than for the stents. As
with the stents, in an exemplary embodiment, as few as 5 wires may
be used to form the cava filters for any given application except
the single wire embodiment, which utilizes only one wire.
[0294] The cava filters may be created with a relatively loose
weave allowing the blood to flow freely. In an exemplary
embodiment, it is preferable that the distal end of the cava
filters is not completely closed. See FIGS. 6-8. Instead, the bent
ends of the wires (FIG. 7 and FIG. 8 show small closed loops, but
bends may also be used) or the coupled ends of the wires (FIG. 6)
are arranged to form a relatively round opening with a diameter of
about 2 to 5 mm. The size of the wires that may be used for forming
the cava filters other than the barbless stent filter (discussed
below) ranges from between about 0.009 inches and about 0.013
inches, but is most typically about 0.011 inches. The size of the
wires that may be used for forming the barbless stent filter ranges
from between about 0.008 inches and about 0.015 inches, but is most
typically about 0.011 inches.
[0295] As with the stents of the present invention, the angle
between the crossing wires of the cava filters is preferably
obtuse. Similarly, at the proximal end (e.g., FIG. 6) of the
filter, either a loop or bend may be formed by bending the wires as
above described. When such closed structures are made at the distal
end of the filters, the angle formed may be acute as shown in FIGS.
7, 8 and 9A. At the distal (e.g., FIG. 6) or proximal end (e.g.,
FIG. 7 and FIG. 8) of the cava filters, the wire ends may be
coupled together to form closed structures as above described.
[0296] Advantageously, the portions of the wires forming the closed
structures may be bent outwardly into multiple barbs to anchor the
filter, when located at the proximal ends of the cava filters
(e.g., FIG. 7 and FIG. 8). As used herein, "barbs" are portions of
the ends of the wires that may be used to form the cava filter. By
carefully selecting the size, orientation and shape of the barbs,
they may penetrate the vessel wall in order to better anchor the
filter during use, but they may also be disengaged from the vessel
wall as the filter is being retrieved but prior to the filter being
withdrawn such that the possibility of causing any damage to the
vessel wall is minimal. As illustrated in FIG. 59, barb 74 of
closed structure 4 is penetrating vessel wall 73 at an angle 75
that is acute. Although angle 75 may be obtuse, the inventors have
found that barb 74 generally anchors the filters more securely when
angle 75 is acute rather than when it is obtuse. Beginning at side
77 of vessel wall 73 and extending to the end of barb 74, barb 74
may be about 1 to 2 mm long. As shown, wire end 7 may be oriented
at an angle that is roughly perpendicular to the angle of barb 74
such that barb 74 is prevented from more deeply penetrating vessel
wall 73. Another example of suitably shaped barbs may also be found
on the RECOVERY filter, which is commercially available from C. R.
Bard, Inc. (www.crbard.com; Murray Hill, N.J., 800 367-2273).
[0297] The cava filters of the present invention may be formed by
plain weave using the methods described above for forming the
stents. Of course, an appropriately shaped template may be chosen.
Shapes for the cava filters include a cone (FIG. 6 and FIG. 7), a
dome (FIG. 8), an hourglass shape (FIG. 9), and the shape of the
barbless stent filter (FIG. 51). The cava filters may also be
heated as the stents are, and may be allowed to cool as the stents
are. Additionally, in an exemplary embodiment, as with the tapered
stent, the filters may be woven on a cylindrical template, heated
and allowed to cool, then the body formed may be remodeled and then
reheated on another template. In an exemplary embodiment of the
hourglass filter, for example, the body formed by weaving may be
heated and cooled, and then may be remodeled into the shape of an
hourglass by narrowing the central portion using a material
suitable for reheating such as copper/brass wire; then the
hourglass shaped body may be reheated.
[0298] In an exemplary embodiment of the cava filters of the
present invention, it may be preferable to flare and compress the
woven structure near the proximal end of a conical or dome shape
filter or near both the proximal and distal ends of an hourglass
filter, forming a cylindrical portion with a relatively tight weave
(see portions 140 in FIG. 6, FIG. 7 and FIG. 9) prior to heating.
The diameter over this portion may be virtually constant. In an
exemplary embodiment, this portion may be formed using the
above-described method of heating and cooling a filter that may not
possess the desired portion, reconstraining or remodeling the
filter to achieve the desired shape of the portion, securing the
given portion of the filter in the desired shape and heating and
cooling the constrained filter again.
[0299] In an exemplary embodiment, this constant-diameter portion
and/or the flared ends of the cava filters may be advantageously
used for anchoring. By achieving strong contact between the filter
and the vessel wall, the filter's intraluminal position can be
further secured. The expansile force of the cava filter (which
depends partly on the number and size of the wires which are used
for making the structure) may be chosen so as to ensure such strong
contact. The use of the flared portions as well as the suitable
barbs may virtually eliminate the possibility of migration.
[0300] The cava filters of the present invention will be further
described in more detail below by the way of specific examples.
[0301] a. Conical Filter--FIGS. 6 and 7
[0302] With reference to the illustrative embodiments shown in
FIGS. 6 and 7, there are shown conical filters for insertion and
delivery into vascular anatomical structures. The conical filters
include a plurality of wires which may be arranged in a plain weave
as described above so as to define an elastically deformable body
150. As shown in FIGS. 6 and 7, body 150 has a wide and/or flared
proximal end 142 and a distal end 144. The diameter of body 150 is
larger at proximal end 142 than at distal end 144. The diameter of
body 150 decreases from proximal end 142 to distal end 144. Distal
end 144 may be formed in such a way that almost no opening is left
through which fluid might flow. As discussed above, however, in an
exemplary embodiment, it is preferable to leave a relatively round
opening with a diameter of about 2 to 5 mm.
[0303] b. Dome Filter--FIG. 8
[0304] With reference to the illustrative embodiment shown in FIG.
8, there is shown a dome filter for insertion and delivery into a
vascular anatomical structure. The dome filter includes a plurality
of wires which may be arranged in a plain weave as described above
so as to define an elastically deformable body 152. As shown in
FIG. 8, body 152 like body 150, may have a wide and/or flared
proximal end 142 and a distal end 144. The diameter of body 150 is
larger at proximal end 142 than at distal end 144. The diameter of
body 150 decreases from proximal end 142 to distal end 144. The
degree of the decrease in the diameter from the proximal to the
distal end is not as steep as in the conical version, however. As a
result, body 152 more resembles a hemisphere than a cone. Because
of its hemispherical shape, the dome filter may occupy less
longitudinal space within the cava than other filters.
[0305] c. Hourglass Filter--FIG. 9
[0306] With reference to the illustrative embodiment shown in FIG.
9, there is shown an hourglass filter for insertion and delivery
into a vascular anatomical structure. The hourglass filter includes
a plurality of wires which may be arranged in a plain weave as
described above so as to define an elastically deformable body 154.
As shown in FIG. 9, body 154 has two conical or dome portions 146
bridged by a narrow portion 148. The diameter of distal and
proximal ends 144 and 142 is larger than the diameter of portion
148. In an exemplary embodiment, distal end 144 is preferably not
equipped with barbs. The closed structures of proximal end 142 may
be bent outwardly to form barbs. The lumen size of narrow portion
148 may be selected so as not to close the lumen of the filter
completely. The hourglass filter shown in FIG. 9 has multiple
filtrating levels; in an exemplary embodiment there may be almost
no difference in the filtrating capacity between the filtrating
capacity of the center of the filter and the filtrating capacity of
the periphery of the filter because the blood may be filtered by
the peripheral weave of both the proximal and distal portions 146.
FIG. 10 shows an hourglass filter placed in the IVC.
[0307] d. Barbless Stent Filter--FIG. 51
[0308] With reference to the illustrative embodiment shown in FIG.
51, there is shown a barbless stent filter for insertion and
delivery into a vascular anatomical structure. The barbless stent
filter includes a plurality of wires which may be arranged in a
plain weave as described above so as to define body 400, which,
like all the other bodies in this disclosure, is suitable for
implantation into an anatomical structure. As shown in FIG. 51,
body 400 may consist of base 402, mid-portion 404, and dome
406.
[0309] Base 402 may be made as a straight stent (as described
above) with a given diameter. As a result, base 402 may serve to
anchor the filter within a vessel and may not participate in blood
filtration. In another embodiment of this filter, base 402 may also
be made with a changing diameter. For example, its lumen may be
slightly tapered from base 402 to mid-portion 404. The mesh
tightness of base 402 may approach the maximum-achievable tightness
(i.e., 180.degree.). Accordingly, the radial force of the anchoring
portion (base 402) will increase as the mesh tightness
increases.
[0310] Additionally, by carefully selecting the diameter of base
402, body 400 may be configured to retain its position within a
vessel without the use of barbs. As a result, the task of carefully
selecting the size, orientation, and shape of the barbs that could
otherwise be used such that those barbs may be elevated from the
caval wall so as to greatly reduce the possibility of damaging the
vessel wall during resheathing (as a result of repositioning or
removing the filter) may be eliminated. In an exemplary embodiment
of the barbless stent filter, the diameter of base 402 may be 26-30
mm, which represents operable diameters in ninety-five percent of
the population, which has an inferior vena cava of less than 28 mm
in diameter. In an exemplary embodiment of the barbless stent
filter, the length of base 402 may not exceed 10-15 mm.
[0311] As shown in FIG. 51, mid-portion 404 of the barbless stent
filter includes struts 408, which are formed of twisted wires 5.
Struts 408 are arranged so as to be oriented in substantially
parallel relationship with the axis of the portion or segment of
the vessel in which they are delivered or released. Struts 408 may
serve to further stabilize the barbless stent filter within the
vessel or non-vascular structure into which the filter is
delivered. For example, in the embodiment of the barbless stent
filter shown in FIG. 52, struts 408 may be slightly bent or bowed
outward so as to increase the frictional forces between the
delivered filter and the vessel wall. As a result, the
self-anchoring capability of the filter may be increased. In an
exemplary embodiment of the barbless stent filter, the length of
mid-portion 404 may be about 5-10 mm.
[0312] Turning to the third portion of the barbless stent filter,
as shown in FIG. 51, the mesh tightness of dome 406 may be loose.
In one embodiment of this filter, the top portion of the dome may
be equipped with hook 410 to facilitate the removal of the filter.
In such an embodiment, hook 410 may be small and made of metal or
any other suitable material, and may be firmly and permanently
attached to wires 5. Similarly, although not illustrated, with the
benefit of the present disclosure one of ordinary skill in the art
will understand that hook 410 may also be provided on the proximal
ends of the other cava filters disclosed herein. Additionally, the
hooks on these filters may be used during the possible
repositioning or retrieval of such filters in the same way as may
be used on the barbless stent filter, described below in greater
detail.
[0313] In another embodiment, the barbless filter may be provided
with two filtration levels. As shown in FIG. 53, such a filter is
composed of two domes 406 (arranged inversely), a mid-portion 404
having a tight stent mesh similar to the mesh of base 402 in the
embodiments in FIGS. 51 and 52, and two, intermediate segments 412
having short, struts 408 between domes 406 and mid-portion 404. In
one version of this embodiment, both the top and bottom portions of
the domes may be equipped with hook 410 to facilitate the removal
of the filter. Alternatively, either the top or bottom may be
equipped with hook 410.
[0314] The end of the barbless stent filters located proximate hook
410 depicted in FIGS. 51-53 may be positioned so as to achieve a
variety of configurations. For example, the end may be stretched
such that the shape of domes 406 is closer to a triangle than the
shape depicted in FIGS. 51-53, or the end may be compressed.
[0315] The shape of the barbless stent filters may be formed using
the methods described above for forming the stents and other cava
filters. For example, the barbless stent filter may be woven on an
appropriately shaped template. Then the filter and template may be
heated and cooled as above described. Alternatively, the barbless
stent filter may be woven on a cylindrical template and heated and
allowed to cool. Alternatively, prior to heating and cooling,
certain portions such as the mid-portion and dome may be
reconstrained or remodeled, and the remodeled portion of the filter
may then be secured and heated and cooled again.
[0316] e. Biodegradable Filters
[0317] As indicated above, all of the filters of the present
invention (including the BI filter discussed below) may be formed
with filaments made of biodegradable material so as to form
self-expanding, self-anchoring, bioabsorbable, biodegradable
filters that may, in addition to functioning as filters, function
as drug or nutrient delivery systems as a result of the material
used. In one embodiment, the biodegradable filters of the present
invention may be provided with reinforcement wires as above
described.
[0318] The factors that may be considered in choosing the materials
from which to form the biodegradable stents, the materials
themselves, the methods of forming the biodegradable stents and
reinforcing the stents with wires, apply to the filters as well. In
addition, one may also consider the following: the flow conditions
of the vessel into the biodegradable filters are placed (e.g., high
flow conditions within the vena cava), to better ensure that the
material and weave of the filter are chosen such that the filter
may anchor properly within the vessel; the rate of degradation of
the chosen material as well as the time at which the degradation
will begin so that if the filter is used as a temporary filter (as
described below), the entrapped thrombi may be attended to before
the filter degrades to an extent that the entrapped thrombi could
be released back into the bloodstream.
[0319] Any of the cava filter embodiments disclosed herein may be
made from both wires 5, (wires 5 may be made from any of the
materials described above, such as nitinol) and appropriate
biodegradable filaments 540. Although the barbless stent filter is
described below in this regard, it is by way of example only, and
with the benefit of the present disclosure, one having skill in the
art will understand that wires 5 and biodegradable filaments 540
may be connected to each other as hereinafter described for the
other embodiments of the cava filters disclosed herein.
[0320] Base 402 may be formed from wires 5, while dome 406 may be
formed from filaments 504, which may be formed from an appropriate
biodegradable material, such as one described above in greater
detail. In this embodiment, the transition between the two
materials may be created in mid-portion 404. The connection between
each nitinol wire and the corresponding filament may be made by
using any suitable means such as glue, heat, by wrapping the
filament around the wire, or any combination of thereof. After
biodegradation of dome 406 has taken place, base 402 may, like a
self-expanding stent, be left behind in the body.
[0321] f. Single-Wire Embodiment Filter
[0322] As with the occluders, the single wire embodiment may also
be utilized as a structure for filtering thrombi within a vessel.
The single wire embodiment filters may be formed in the same manner
as the single wire embodiment occluders are formed. Moreover, the
single wire embodiment filters are simply the single wire
embodiment occluders without any thrombogenic agents attached to
the body of the single wire embodiment filters. In this regard,
FIG. 60 illustrates body 700 of a single wire embodiment filter.
The body has first segment 704 and second segment 706 separated by
a bend in the wire that is in the form of closed loop 6. The body
is provided with multiple collars 702, which hide multiple
loop-defining locations where the segments are positioned adjacent
to each other. (Adjacent has the same meaning with respect to the
single wire embodiment filters as it has with respect to the single
wire embodiment occluders.) The segments 704 and 706 extend between
the loop-defining locations so as to form multiple loops 710, which
are designated in FIG. 60 by the segments that outline them.
Another embodiment of the present single wire filters is
illustrated in FIG. 15. As illustrated in both FIGS. 60 and 15,
loops 710 of bodies 700 possess compressed shapes.
Delivery System of the Cava Filters
[0323] Version 1 shown in FIG. 3 may be used as the delivery system
for the cava filters (including each of the versions described
above) according to the present invention.
Delivery of the Cava Filters
[0324] Prior to insertion and delivery, a cava filter in the form
of a body 150, 152, 154, 400 (or biodegradable versions thereof),
or body 700 may be manually secured to tubes 22 and 40 of version 1
as above described. The cava filter may then be stretched as
described above so as to reduce the diameter of its largest portion
by an amount appropriate such that the filter may be inserted into
a vessel (preferably with the use of an access sheath), and may
pass through the lumen of the vessel as the filter is being
positioned prior to being delivered into the vessel. FIG. 28 shows
a filter secured to a delivery system in a completely stretched
state.
[0325] In one embodiment of the method for delivering the cava
filters of the present invention, a hollow covering such as a
guiding sheath may be placed over the filter secured to the
delivery system to prevent contact between the filter and the
vessel wall as the filter is inserted and positioned for delivery.
In another embodiment, a short, introducer sheath with a check-flo
adapter may be used at the access site to prevent contact between
the filter and the vessel into which the filter may be inserted
during insertion of the filter; in such an embodiment the
introducer sheath may or may not be used to cover the filter beyond
the access site of the vessel.
[0326] The cava filters of the present invention may be stretched
completely on the delivery system, reducing their diameters as much
as possible, as shown in FIG. 28, for example. In one embodiment,
after being secured to the delivery system and stretched to some
extent, a filter may be delivered into the inferior vena cava
("IVC"). In such an embodiment, the filter may be inserted into
either the right or the left femoral vein, allowing for a femoral
approach. In such an embodiment, the filter may be inserted into
the internal jugular vein, allowing for a jugular approach. In such
an embodiment, a filter and delivery system with a relatively small
profile, such as 7-F, for example, may be inserted into a
peripheral vein (pl. antecubital vein), allowing for a peripheral
approach, if the system is sufficiently flexible. As discussed
above with regard to the delivery of the stents, the construction
of the delivery system enables one to use a guidewire in the lumen
of tube 22 for delivery of the filter, in an exemplary embodiment
of the present invention. It is to be understood however, that a
guidewire may not be utilized at times.
[0327] Each of the cava filters may be delivered into place in the
manner described above with regard to the delivery of the stents
using version 1 (see, Delivery of the Stents). All the advantages
described above with regard to repositionability, etc., including
the advantage of being able to compress the filter being delivered
and achieve as tight a mesh in the cylindrical portions thereof
(such as base 402 of the barbless stent filter) as possible, apply
equally to the delivery of the cava filters. Further, in instances
in which one of the present cava filters is delivered in the IVC,
for example, the elasticity of the IVC wall allows the operator to
achieve an even tighter mesh than the mesh originally created after
the annealing process. That is, a filter configured with an angle a
of 155.degree. may be compressed during delivery until angle a is
170.degree., and, if the filter is properly oversized, the
elasticity of the IVC wall may maintain angle a at very close or
equal to 170.degree.. The ability of the present delivery system to
achieve this scenario is especially advantageous when the filter is
created without barbs so as to maintain its position within the
vessel into which it may be delivered by virtue of the radial force
between the filter and the vessel wall.
[0328] The weave of the present filters (including those discussed
below) is especially suitable to advantageously allow mechanical
thrombus-suction to remove the entrapped clots without the risk of
dislodging the thrombi and allowing them to travel to the systemic
and pulmonary circulation. In so doing, an adequately sized
catheter with a large lumen may be inserted into the filter's lumen
and used to suck the thrombi out. This method may be used in
combination with thrombolysis.
[0329] a. Non-Permanent Cava Filter Applications
[0330] All of the woven cava filters, particularly the conical,
dome, and barbless stent filters, may be used in temporary
applications. A basic need exists to remove entrapped thrombi
safely and successfully before removal of a temporary filter. The
emboli entrapped by any kind of temporary filter can be dealt with
in a variety of ways, such as thrombolysis, placement of a
permanent filter, or allowing small thrombi to embolize to the
lungs. The woven structure of the cava filters of the present
invention seems favorable to prevent escape of the entrapped clots
during thrombolysis. As a result, there is probably no need to
place another filter above the woven temporary filter. This would
otherwise be impossible if the temporary filter is delivered from a
jugular approach. The temporary applications of the cava filters
include both temporary and retrievable filter designs.
[0331] Temporary filters may be attached to a catheter or sheath, a
tube or a guidewire that may project from the insertion site (e.g.,
using a hub with a cap which is sutured to the skin for fixation),
so as to allow for easy removal of the filter. Retrievable filters
are permanent filters that have a potential to be removed.
[0332] Both the temporary and the retrievable filters may be
delivered via a jugular approach. It is to be understood, however,
that these filters may also be delivered via a femoral or
antecubital approach.
[0333] In one embodiment, a temporary filter may be created by
manually securing a cava filter to two tubes in the manner
described above. The outer tube to which the proximal end of the
filter may be secured may comprise a catheter or sheath, or it may
comprise a tube such as tube 40 described above. Being a low
profile design, the temporary filter typically does not require an
outer tube larger than 7 French.
[0334] After properly positioning the temporary filter, the distal
end of the temporary filter may be released using the above
described method. If the temporary filter is no longer in the
proper position, the filter may be withdrawn as shown in FIGS. 27A
and B. FIGS. 27A and B illustrate tube 71 (which may, for example,
be any suitably-sized catheter or sheath) being advanced over a
filter such that barbs 74 of the filter that penetrate vessel wall
73 are disengaged from vessel wall 73 as tube 71 is advanced and
the filter is held stationary. A monofilament (not shown) may be
threaded through one or more of the bends or closed loops defining
the proximal end of the filter. Both ends of the monofilament may
be positioned in an easily accessible location (such as exterior of
the patient). The operator can then advance tube 71 over the ends
of the monofilament (as described below with respect to
monofilament loop 172 depicted in FIG. 12) while holding the
monofilament steady to disengage barbs 74 from vessel wall 73 prior
to the withdrawal of the filter.
[0335] After releasing the distal end of the filter, the holes in
the superelastic tubing through which the securing wire or wires
were threaded may be used for injection of some urokinase or tissue
plasminogen activator (TPA) to lyse entrapped thrombi within the
mesh. FIG. 26 depicts the situation in which the distal end of the
filter has been released. As shown in FIG. 26, openings 27 may be
provided in tube 22, in addition to proximal and distal holes 24
and 26, through which urokinase or TPA may as just described. FIG.
26 also depicts introducer sheath or catheter 99, which may be
utilized in conjunction with the present delivery system to
facilitate the insertion of the delivery system, including tubes 22
and 40, into the patient. (Note that push button lock/release
mechanism 200 shown in FIG. 25 as connecting tube 40 and 22 is not
depicted in FIG. 26.) Introducer catheter 99 may be attached to end
fitting 204, as shown in FIG. 26, with a Luer connection. FIG. 26
also illustrates that multiple securing wires 46 may be utilized
for securing the proximal end of the filter to tube 40. In this
regard, although not shown, it will be understood to those of skill
in the art, with the benefit of this disclosure, that securing
wires 46 may be controlled by creating openings in tube 40 near the
proximal end of tube 40 and threading the proximal ends of securing
wires 46 through those holes. In this way, the proximal end of the
filter or other device may be released by pulling the proximal ends
of securing wires 46. Tightening screw 205 may be provided on the
end of the side arm of end fitting 204, as shown in FIG. 26, for
fixing the relative positions of securing wires 30 (not shown).
Additionally, although not shown, it will be understood to those of
skill in the art, with the benefit of this disclosure, that a
tightening screw may be provided on the end of end fitting 204 for
fixing or securing the relative position of any guidewires that are
utilized as well.
[0336] In this embodiment of the invention, there may be no need to
apply barbs/tabs at the distal end of the temporary filter. For
example, the barbless stent filter, by nature, will not be equipped
with barbs. However, such barbs or tabs may be supplied as shown in
FIG. 27A to the other filters. The proximal end of the outer tube
may be secured to the skin using surgical sutures. When the filter
is to be removed, the temporary filter may be withdrawn into a
catheter/sheath (such as tube 71) and the device may be withdrawn
from the body.
[0337] An additional manner in utilizing the barbless stent filter
as a temporary filter exists that does not involve leaving an outer
tube in the body. In one embodiment, hook 410 may be used as a tool
for removing a temporary filter. At the appropriate time, a foreign
body snare, such as the Amplatz Goose Neck snare (Microvena Corp.,
White Bear Lake, Minn.) may be used to grasp hook 410 and retract
the filter into an appropriately sized thin-walled sheath for
removal from the body. The snared end of the filter may be held
stationary and an appropriately-sized sheath (approximately
2-French sizes larger than the delivery system) may be advanced
over the shaft of the foreign body snare to capture the filter.
[0338] For the retrievable filter, the distal end may be equipped
with barbs/tabs. At the proximal end of the retrievable filter, a
monofilament loop is threaded through the small closed loops (or
bends) created from the bent wires such that the small closed loops
become interconnected by the monofilament loop (see, e.g., FIG.
12); thus, pulling on the monofilament loop will result in drawing
the small closed loops together thus reducing the diameter of the
stent at the proximal end. The retrievable filter may be secured to
the same delivery system used for delivery of the temporary filter
in the same way.
[0339] Delivery may also be carried out in the same way. In an
exemplary embodiment, the filter may be delivered from a right
jugular approach. It is to be understood that if the delivery
system is small enough, an antecubital approach may be acceptable,
especially for a short time filtration. It is to be understood that
delivery from a femoral approach may require the filter to be
positioned inversely. After delivery of the retrievable filter from
a jugular approach, for example, the delivery system may be removed
and, only the monofilament loop may be left within the vasculature.
The very proximal end of the loop may be attached to the skin as
above described. In this form, the retrievable filter may be used
as a temporary filter. Both the flared base with the tighter mesh
and the barbs/tabs may serve to anchor the retrievable filter
within the cava. In the case of the barbless stent filter, base 402
may serve the function of the flared base of the other filters,
which may or may not be provided with barbs or tabs. If it is
necessary to convert the temporary filter into a permanent one, the
monofilament loop may be severed and removed from the small closed
loops of the filter as well as from the body.
[0340] If a decision is made to remove a retrievable filter, a
short metal straightener may be advanced over the proximal end of
the monofilament loop. A short introducer sheath may then be
inserted in the access vein over the straightener. Through the
introducer, an adequate size sheath may be advanced to the distal
end of the filter. Stretching the monofilament loop, the sheath may
be advanced over the filter. As a result, the barbs/tabs, if
utilized, will be retracted from the caval wall, and the filter's
removal can be achieved without causing injury to the vessel
wall.
[0341] The time period for leaving a temporary filter in a patient
will vary from case to case, but, generally, temporary filters may
be left in place for no more than about two to three weeks. Leaving
them in place for a longer period of time may result in the
formation of a neointimal layer on the temporary filter, which
would impede its removal. To increase the period of time during
which these filters may be left in the body without being embedded
into the neointimal layer, the filters may be coated with some
biologically active materials (e.g., cytostatics, fibroblast growth
factor [FGF-1] with heparin, Taxol, etc.) or the metal of the
filter may be rendered .beta.-particle-emitting producing a
low-rate radiation at the site of the filter placement (Fischell,
1996).
[0342] The main advantage of the retrievable filter is that if the
conversion from temporary to permanent filtration is necessary,
there is no need to remove the temporary filter and deploy a
permanent one. Both versions are suitable for intraluminal
thrombolysis both from a jugular or a femoral approach or possibly
an antecubital approach.
[0343] The retrievable filter provides additional advantages in
that they are easily retrievable, they possess equal filtering
capacity in the center and at the periphery of the cava, they
provide safe thrombolysis, they are self-centering and
self-anchoring, and unless hook 410 is utilized in conjunction with
the barbless stent filter, it is unnecessary to use a foreign-body
retrieval device which might involve lengthy manipulations.
However, it is to be understood that, in some embodiments, small
tabs may be coupled to the ends of the filters of the present
invention for facilitating the removal of the filter with a foreign
body retrieval device.
[0344] The cava filters of the present invention provide the
advantage of improved filtration. The extended coverage of the
filtering level comes with an improved thrombus capturing capacity
of the cava filters. The presence of a thrombus in a traditional
conical filter decreases the capture rate for a second embolus
(Jaeger, 1998). The succeeding thrombus will not be able to get
into the apex of the cone and has a higher chance of passing
through the filter (Kraimps, 1992). The flow velocity, and
therefore, the hydrodynamic force are increased at the stenotic
site of the filter. Because conical filters predominantly capture
thrombi in the apex of the cone, the site of increased velocity is
located at the periphery of the filter. As long as the diameter of
the thrombi is smaller than or equal to that of the stenotic
opening, the locally increased velocity and hydrodynamic force will
push the thrombi through the filter periphery.
[0345] Using the cava filters of the present invention, the thrombi
will be primarily captured by the distal end of the conical and
dome filters and by the dome of the barbless stent filter; in the
case of the hourglass filter, the first filtration level is the
narrow portion of the proximal end of the filter. Any subsequent
emboli will be diverted to the periphery of the cava where the
filter has approximately the same filtration capacity as in the
center of the filter.
[0346] The filtration capacity of a filter can be estimated by
looking at it from the top or below. The wires/mesh arrangement in
the projected cross-section of the filtered segment of the IVC
gives a good estimate about the "coverage" of the IVC by the
filter. For example, FIG. 29 depicts a projected cross section of
one of the present hourglass filters taken across the middle
portion of the filter. In the case of the hourglass filter, the
blood is primarily filtered by the proximal half of the filter,
similar to the case using the dome or conical filter. The blood
which is going proximally alongside the caval wall will be filtered
the peripheral mesh of both the proximal and the distal "dome". As
a result, as in the case of the barbless stent filter, there is
virtually no difference in filtration capacity of the filter in the
center and at the periphery of the vessel. Additionally, with
respect to each of the filters, the immediate opening and symmetric
arrangement of the bases of the filters serves to self-center them
and prevent them from being tilted. Some filter designs (especially
the Greenfield-filter) are sensitive to intraluminal tilting, which
negatively affects their filtration capability.
[0347] The flexibility of the mesh of the cava filters, as is the
case with all the woven intravascular devices of the present
invention, makes it possible to advance the delivery system through
tortuous vessels. This feature together with the small size of the
delivery system enables one to deliver these filters via every
possible access site of the body. Further, as with all the
intravascular devices of the present invention, the plain weave of
the cava filters allows for the production of one coherent element,
which does not possess any kind of joints.
[0348] The cava filters according to the present invention may
possess (depending on the material used to form the wires thereof)
a non-ferromagnetic character making them, as well as stents formed
therefrom, MRI compatible.
[0349] The cava filters of the present invention are also suitable
for intravascular thrombolysis. After placement of any kind of
filtering device, the development of caval thrombosis/occlusion
frequently occurs (Crochet, 1993). In acute cases, a possible
therapeutic option is to recanalize the IVC by pharmaco-mechanical
thrombolysis. Doing so in the presence of the currently available
filters poses a high risk of developing pulmonary emboli, because
large fragments of the IVC thrombus can break off and be carried
away in an uncontrolled way after urokinase/TPA treatment. One of
the acceptable options in that situation is to place another filter
above the thrombosed filter to avoid pulmonary embolism due to
thrombolysis. Unlike other designs, the cava filters according to
the present invention may offer the possibility of a safe and
successful thrombolysis without the need for the placement of two
filters.
Bi-Iliac Tube Filter
[0350] The wires of the BI filter according to the present
invention may be made of the same materials as the wires of the
stents. The same number of wires may be used in forming the BI
filter as are used to form the stents. However, in an exemplary
embodiment, less wires are preferably used for the BI filter than
for the stents. It is to be understood that although only 4 wires
appear in FIGS. 11-13, 2 more wires are not shown. The BI filter
may be created with a relatively loose mesh allowing the blood to
flow freely. The size of the wires that may be used for forming the
BI filter ranges from between about 0.008 inches and about 0.011
inches, but is most typically about 0.009 inches.
[0351] The BI filter according to the present invention may be
formed using the above described methods for forming the stents. Of
course, an appropriately shaped template may be chosen. In weaving
body 160 of the BI filter, as shown in FIGS. 11-13, the angle a
between the crossing wires is preferably obtuse. It is to be
understood that angle a may also be less than or equal to
90.degree.. End 164 may have a plurality of closed structures which
may be small closed loops 166 (FIGS. 12 and 13) or bends 168 (FIG.
11), like the above stents and filters. The angles of those closed
structures may be similar to the angles for the closed structures
of the stents as above described. The wire ends at 162 of body 160
may be coupled together in the manner above described.
[0352] Body 160 of the BI filter may also be heated as the stents
are, and may be allowed to cool as the stents are.
[0353] In one embodiment, the mid-portion of the BI filter may be
constructed with a larger diameter than that of the ends which are
used for fixation. This may be achieved in a variety of ways using
the remodeling methods above described. For example, one may weave
a straight stent with a caliber useful for filtration (larger
lumen). Then, smaller caliber ends may be formed by remodeling the
filter on a smaller caliber template. In such a case, the weave of
the filtering level will be looser than those of the legs. In
another embodiment, the weave of the filtering level may be tighter
than those of the legs by weaving the BI filter is on a template
sized for the legs, and then remodeling the filter by ballooning
the mid-portion of the filter outward. Many variations in shape are
thus possible.
[0354] The BI filter of the present invention may be stretched
completely on the delivery system, reducing its diameter as much as
possible. It may be delivered in that stretched state into the
inferior vena cava ("IVC"). It is to be understood that it may also
be delivered into the IVC in a state that is not completely
stretched. The filter may be inserted from either femoral vein and
placed into both iliac veins forming an inverse U-shape bridging
over the confluence of these veins. Unlike traditional IVC filters,
the filtration according to the present invention will
substantially take place through the cephalad surface 163 of the
weave at about the mid-portion of body 160 located at the junction
of the iliac veins, as shown in FIG. 11.
[0355] The BI filter is suitable for temporary filtration. In this
embodiment of the present invention shown in FIG. 12, the coupled
wire ends form the distal end of the filter, while the multiple
small closed loops 166 located proximally are connected by a
monofilament loop 172 as described above and shown in FIGS. 12 and
13. FIGS. 12 and 13 illustrate Bi-filter 160 delivered within left
iliac vein 157 and right iliac vein 158, beneath the inferior vena
cava 159. Using a contralateral approach, the filter may be
inserted from either femoral vein and its front end may be
positioned into the contralateral iliac vein. After delivery of the
filter, the monofilament loop may be led outside the body and
secured to the skin. When there is no further need for the filter,
it may be withdrawn by pulling it back by the monofilament loop
through an advanced sheath.
[0356] In another possible embodiment of this invention shown in
FIG. 13, a flexible, superelastic wire or microtubing 174 made from
nitinol (or similar superelastic/shape memory material described
above) is led through the lumen of the BI filter. The distal end of
the nitinol wire/microtubing is attached or coupled to one twisted
wire-end 170 of the filter by any suitable means, including
soldering, point welding, wrapping of fibers, and the like. The
proximal end of the wire/microtubing may be attached to the skin
(along with the monofilament loop). When the BI filter is being
withdrawn, the wire/microtubing may be held steadily, while the
monofilament loop is pulled. As a result, the BI filter will be
partially stretched facilitating the filter's removal. The BI
filter may also be removed in the fashion described above for
removing the temporary filter.
[0357] As discussed above, given the design of the BI-filter, one
may catheterize the lumen of the filter and, using an adequate size
catheter, thrombus-suction may be easily performed before filter
removal.
Delivery System of the BI Filter
[0358] Version 1 shown in FIG. 3 may be used as the delivery system
for the BI filter (including a biodegradable version) according to
the present invention.
Delivery of the BI Filter
[0359] A preferably preformed guiding catheter or a guiding sheath
(Balkin sheath-type) (FIG. 3) may be used for insertion of the
delivery system for the embodiments discussed above. The BI filter
may be secured to and stretched out on the surface of the delivery
system in a manner described above, and may be delivered from the
ipsilateral femoral/iliac vein through the caval junction into the
contralateral iliac vein. As discussed above with regard to the
delivery of the stents, the construction of the delivery system
enables one to use a guidewire in the lumen of tube 22 for delivery
of the filter, which is preferable in an exemplary embodiment of
the present invention. It is to be understood however, that a
guidewire may not be utilized if a preformed sheath is in
place.
[0360] The BI filter may be delivered into place in the manner
described above with regard to the delivery of the stents using
version 1. All the advantages described above with regard to
repositionability, etc., apply equally to the delivery of the BI
filter. In an exemplary embodiment of the delivery method for the
BI filter, the distal end of the BI filter may be released
first.
[0361] Advantageously, the BI filter according to the present
invention may offer the possibility of a safe and successful
thrombolysis, like the cava filters above discussed.
[0362] All of the methods and apparatus disclosed and claimed
herein can be made and executed without undue experimentation in
light of the present disclosure. While the methods and apparatus of
the present invention have been described in terms of illustrative
embodiments, it will be apparent to those of skill in the art that
variations may be applied to apparatus and in the steps or in the
sequence of steps of the methods described herein without departing
from the concept, spirit and scope of the invention. More
specifically, it will be apparent that certain agents which are
both chemically and physiologically related may be substituted for
the agents described herein while the same or similar results would
be achieved. All such similar substitutes and modifications
apparent to those skilled in the art are deemed to be within the
spirit, scope and concept of the invention as defined by the
appended claims.
REFERENCES
[0363] The following references, to the extent that they provide
exemplary procedural or other details supplementary to those set
forth herein, are specifically incorporated herein by
reference.
[0364] Ben-Menachem, Coldwell, Young, Burgess, "Hemorrhage
associated with pelvic fractures: causes, diagnosis, and emergent
management," AJR, 157:1005-1014, 1991.
[0365] Bing, Hicks, Figenshau, Wick M, Picus D, Darcy M D, Clayman
R V. "Percutaneous ureteral occlusion with use of Gianturco coils
and gelatine sponge, Part I. Swine model" JVIR; 3:313-317, 1992
(a)
[0366] Bing, Hicks, Picus, Darcy. "Percutaneous ureteral occlusion
with use of Gianturco coils and gelatine sponge, Part II. Clinical
Experience," JVIR; 3:319-321, 1992 (b)
[0367] Cambier, Kirby, Wortham, Moore, "Percutaneous closure of the
small (<2.5 mm) patent ductus arteriosus using coil
embolization," Am. J. Cardiol., 69:815-816, 1992.
[0368] Crochet, Stora, Ferry et al., "Vena Tech-LGM filter:
long-term results of a prospective study," Radiology, 188:857-860,
1993.
[0369] Dorfman, "Percutaneous inferior vena cava filters,"
Radiology, 174:987-992, 1990.
[0370] Dutton, Jackson, Hughes et al., "Pulmonary arteriovenous
malformations: results of treatment with coil embolization in 53
patients," AJR, 165:1119-1125, 1995.
[0371] Fischell, Carter, Laird, "The .beta.-particle-emitting
radiosotope stent (Isostent): animal studies and planned clinical
trials," Am. J. Cardiol., 78(Suppl 3A):45-50, 1996.
[0372] Furuse, Iwasaki, Yoshino, Konishi, Kawano, Kinoshita, Ryu,
Satake, Moriyama, "Hepatocellular carcinoma with portal vein tumor
thrombus: embolization of arterioportal shunts," Radiology,
204:787-790, 1997.
[0373] Gianturco, Anderson, Wallace, "Mechanical device for
arterial occlusion," AJR, 124:428-435, 1975.
[0374] Grassi, "Inferior vena caval filters: Analysis of five
currently available devices," AJR, 156:813-821, 1991.
[0375] Grifka, Vincent, Nihill, Ing, Mullins, "Transcatheter patent
ductus arteriosus closure in an infant using the Gianturco Grifka
vascular occlusion device," Am. J. Cardiol., 78:721-723, 1996.
[0376] Guglielmi, Vinuela, Duckwiler, Dion, Stocker, "Highflow,
small-hole arteriovenous fistulas: treatment with electrodetachable
coils," AJNR, 16:325-328, 1995.
[0377] Hammer, Rousseau, Joffre, Sentenac, Tran-van, Barthelemy,
"In vitro evaluation of vena cava filters," JVIR, 5:869-876,
1994.
[0378] Hendrickx, Orth, Grunert, "Long-term survival after
embolization of potentially lethal bleeding malignant pelvic
turnouts," Br. J. Radial., 68:1336-1343, 1995.
[0379] Hijazi and Geggel, "Results of anterograde transcatheter
closure of patent ductus arteriosus using single or multiple
Gianturco coils," Am. J. Cardiol., 74:925-929, 1994.
[0380] Hijazi and Geggel, "Transcatheter closure of patent ductus
arteriosus using coils," Am. J. Cardiol., 79:1279-1280, 1997.
[0381] Hosking, Benson, Musewe, Dyck, Freedom, "Transcatheter
occlusion of the persistently patent ductus arteriosus,"
Circulation, 84:2313-2317, 1991.
[0382] Jaeger, Kolb, Mair, Geller, Christmann, Kinne, Mathias, "In
vitro model for evaluation of inferior vena cava filters: effect of
experimental parameters on thrombus-capturing efficacy of the Vena
Tech-LGM filter," JVIR, 9:295-304, 1998.
[0383] Kato, Semba, Dake, "Use of a self-expanding vascular
occluder for embolization during endovascular aortic aneurysm
repair," JVIR, 8:27-33, 1997.
[0384] Katsamouris, Waltman, Delichatsios, Athanasoulis, "Inferior
vena cava filters: In vitro comparison of clot trapping and flow
dynamics," Radiology, 166:361-366, 1988.
[0385] Knya, Wright, Wallace, "Anchoring coil embolization in a
high-flow arterial model," JVIR, 9:249-254, 1998.
[0386] Knya, Wright, "Preliminary results with a new vascular
basket occluder in swine. JVIR, 10:1043-1049, 1999.
[0387] Koran, Reed, Taylor, Pantecost, Teitelbaum, "Comparison of
filters in an oversized vena caval phantom: intracaval placement of
a Bird's Nest filter versus biiliac placement of Greenfield,
Vena-Tech-LGM, and Simon nitinol filters," JVIR, 3:559-564,
1992.
[0388] Krichenko, Benson, Burrows, Moes, McLaughlin, Freedom,
"Angiographic classification of the isolated, persistently patent
ductus arteriosus and implications for percutaneous catheter
occlusion," Am. J. Cardiol., 63:877-880, 1989.
[0389] Latson, "Residual shunts after transcatheter closure of
patent ductus arteriosus," Circulation, 84:2591 2593, 1991.
[0390] Levey, Teitelbaum, Finck, Pentecost, "Safety and efficacy of
transcatheter embolization of auxiliary and shoulder arterial
injuries," JVIR, 2:99-104, 1991.
[0391] Lipton et al., "Percutaneous Retrieval of two Wallstent
endoprostheses from the heart through a single jugular sheath,"
JVIR, 6:469-472, 1995.
[0392] Lloyd, Fedderly, Mendelsohn, Sandhu, Beekman, "Transcatheter
occlusion of patent ductus arteriosus with Gianturco coils,"
Circulation, 88:1412-1420, 1993.
[0393] Magal, Wright, Duprat, Wallace, Gianturco, "A new device for
transcatheter closure of patent ductus arteriosus: a feasibility
study in dogs," Invest. Radiol., 24:272-276, 1989.
[0394] Marks, Chee, Liddel, Steinberg, Panahian, Lane, "A
mechanically detachable coil for the treatment of aneurysms and
occlusion of blood vessels," AJNR, 15:821-827, 1994.
[0395] Masura, Walsh, Thanopoulous, Chan, Bass, Gousous, Gavora,
Hijazi, "Catheter closure of moderate to large sized patent ductus
arteriosus using the new Amplatz duct occluder: immediate and short
term results," J. Am. Coll. Cardiol., 31:878-882, 1998.
[0396] Milward, "Temporary and Retrievable inferior vena cava
filters: Current status," JVIR, 9:381-387, 1998.
[0397] Murayama, Vinuela, Ulhoa, Akiba, Duckwiler, Gobin, Vinters,
Greff, "Nonadhesive liquid embolic agent for cerebral arteriovenous
malformations: Preliminary histopathological studies in swine rete
mirabile," Neurosurgery, 43:1164-1175, 1998.
[0398] Nancarrow, Fellows, Lock, "Stability of coil emboli: an in
vitro study," Cardiovasc. Intervent. Radiol., 10:226-229, 1987.
[0399] O'Halpin, Legge, MacErlean, "Therapeutic arterial
embolization: report of five years' experience," Clin. Radiol.,
354:85-93, 1984.
[0400] Pozza, Gomes, Qian, Ambrozaitis, Kim, Amplatz,
"Transcatheter occlusion of patent ductus arteriosus using a newly
developed self-expanding device: evaluation in a canine model,"
Invest. Radiol., 30:104-109, 1995.
[0401] Prahlow et al., "Cardiac perforation due to Wallstent
embolization: a fatal complication of the transjugular intrahepatic
portosystemic shunt procedure," Radiology, 205:170-172, 1997.
[0402] Prince, Salzman, Schoen, Palestrant, Simon, "Local;
intravascular effects of the nitinol wire blood clot filter,"
Invest. Radiol., 23:294-300, 1988.
[0403] Punekar, Prem, Ridhorkar, Deshmukh, Kelkar, "Post-surgical
recurrent varicocele: efficacy of internal spermatic venography and
steel-coil embolization," Br. J. Urol., 77:12-128, 1996.
[0404] Rashkind, Mullins, Hellenbrand, Tait, "Nonsurgical closure
of patent ductus arteriosus: clinical application of the Rushkind
PDA occluder system," Circulation, 75:583-592, 1987.
[0405] Reidy and Qureshi, "Interlocking detachable platinum coils,
a controlled embolization device: early clinical experience,"
Cardiovasc. Intervent. Radiol., 19:85-90, 1996.
[0406] Sagara, Miyazono, Inoue, Ueno, Nishida, Nakajo,
"Recanalization after coil embolotherapy of pulmonary arteriovenous
malformations: study of long term outcome and mechanism for
recanalization," AJR, 170:727-730, 1998.
[0407] Schmitz Rode, Timmermans, Uchida, Kichikawa, Hishida,
Gunther, Rosch, "Self-expandable spindle for transcatheter vascular
occlusion: in vivo experiments," Radiology, 188:95-100, 1993.
[0408] Schurmann et al., "Neointimal hyperplasia in low-profile
nitinol stents, Palmaz stents, and Wallstents: a comparative
experimental study," Cardiovasc. Intervent. Radiol. 19:248-254,
1996.
[0409] Schild, Mildenberger, Kerjes, "Effectiveness of platinum
wire microcoils for venous occlusion: a study on patients treated
for venogenic impotence," Cardiovasc. Intervent. Radiol.,
17:170-172, 1994.
[0410] Schwartz, Teitelbaum, Kantz, Pentecost, "Effectiveness of
transcatheter embolization in the control of hepatic vascular
injuries," JVIR, 4:359-365, 1993.
[0411] Selby Jr., "Interventional radiology of trauma," Radiol.
Clin. N. Am., 30:427-439, 1992.
[0412] Sharaffuddin, Gu, Cervera Ceballos, Urness, Amplatz,
"Repositionable vascular occluder: experimental comparison with
standard Gianturco coils," JVIR, 7:695 703, 1996.
[0413] Sharafuddin, Gu, Titus, Sakinis, Pozza, Coleman,
Cervera-Ceballos, Aideyan, Amplatz, "Experimental evaluation of a
new self expanding patent ductus arteriosus occluder in a canine
model," JVIR, 7:877 887, 1996.
[0414] Simon, Rabkin, Kleshinski, Kim, Ransil, "Comparative
evaluation of clinically available inferior vena cava filters with
an in vitro physiologic simulation of the vena cava," Radiology,
189:769-774, 1993.
[0415] Sommer, Gutierrez, Lai, Parness, "Use of preformed nitinol
snare to improve transcatheter coil delivery in occlusion of patent
ductus arteriosus," Am. J. Cardiol., 74:836-839, 1994.
[0416] Taki, Yonekawa, Iwata, Uno, Yamashita, Amemiya, "A new
liquid material for embolization of arteriovenous malformations,`
AJNR, 11:163-168, 1990.
[0417] Teitelbaum, Reed, Larsen, Lee, Pentecost, Finck, Katz,
"Microcatheter embolization of non-neurologic traumatic vascular
lesions," JVIR, 4:149-154, 1993.
[0418] Terada, Nakamura, Nakai et al., "Embolization of
arteriovenous malformations with peripheral aneurysms using
ethylene vinyl alcohol copolymer," J. Neurosurg., 75:655-660,
1991.
[0419] Tometzki, Arnold, Peart et al., "Transcatheter occlusion of
the patent ductus arteriosus with Cook detachable coils," Heart,
76:531-535, 1996.
[0420] Uzun, Hancock, Parsons, Dickinson, Gibbs, "Transcatheter
occlusion of the arterial duct with Cook detachable coils: early
experience," Heart, 76:269-273, 1996.
[0421] Vedantham, Goodwin, McLucas, Mohr, "Uterine artery
embolization: an underused method of controlling pelvic
hemorrhage," Am. J. Obstet. Gynecol., 176:938-948, 1997.
[0422] Vesely et al., "Upper extremity central venous obstruction
in hemodialysis patients: treatment with Wallstents," Radiology,
204:343-348, 1997.
[0423] Wallace, Granmayeh, deSantos, Murray, Romsdahl, Bracken,
Jonsson, "Arterial occlusion of pelvic bone tumors," Cancer, 43:
322-328, 1979.
[0424] Wallsten, U.S. Pat. No. 4,655,771, 1987.
[0425] Wessel, Keane, Parness, Lock, "Outpatient closure of the
patent ductus arteriosus," Circulation, 77:1068 1071, 1988.
[0426] White, Pollak, Wirth, "Pulmonary arterivenous malformations:
diagnosis and transcatheter embolotherapy," JVIR, 7:787-804,
1996.
[0427] Xian, Roy, Hosaka, Kvernebo, Laerum, "Multiple emboli and
filter function: An in vitro comparison of three vena cava
filters," JVIR, 6:887-893, 1995.
[0428] Yune, "Inferior vena cava filter: Search for an ideal
device," Radiology, 172:15-16, 1989.
[0429] Zubillaga, Guglielmi, Vinuela, Duckwiler, "Endovascular
occlusion of intracranial aneurysms with electrically detachable
coils: correlation of aneurysm neck size and treatment results,"
AJNR, 15:815-820, 1994.
* * * * *